Behavioural Co-morbidities in Rat Models of Neuropathic Pain by Legg, Ewen & Legg, Ewen
1 
 
Behavioural Co-morbidities in Rat Models of 
Neuropathic Pain 
 
 
 
 
Thesis submitted for the degree of Doctor of Philosophy from 
Imperial College London 
 
 
 
 
Ewen Legg 
 
Pain Group 
Academic Anaesthetics  
Department of Surgery and Cancer 
Chelsea and Westminster Hospital Campus 
Imperial College London 
 
Supervisor: Prof. Andrew S.C. Rice 
2 
 
Abstract: 
 
Pain is a complex experience involving both sensory and emotional aspects. Neuropathic pain 
syndromes, which remain a major area of unmet clinical need, are often associated with 
behavioural co-morbidities such as anxiety and depression. Recent studies have demonstrated 
changes in a number of affect-related outcome measures in rodent models of neuropathic pain. 
The expansion of such outcome measures offers one possible route for the improvement of 
studies aimed at creating novel therapies for neuropathic pain. 
 
Bias reduction through randomisation requires mixed housing of animals with peripheral nerve 
injuries with non-injured conspecifics. Such mixed housing was shown to alter behaviour in the 
open field. Therefore, in the following studies treatments were allocated to cage groups as a 
whole. Anxiety-like behaviour was demonstrated in L5 spinal nerve transected (L5 SNT) rats in a 
novel dark/light preference test and the utility of this test in detecting efficacious analgesics was 
investigated. The possible presence of neuropathy-induced depression-like behaviour following 
L5 SNT was then investigated using the forced swim test. However, animals showed no increase 
in depression-like behaviour, as measured by time spent immobile in the forced swim test, at 
either two or three weeks post-neuropathy. Assessment of burrowing behaviour, a novel 
behavioural outcome measure thought to reflect over all well being in rodents, was then carried 
out in rats following L5 SNT and partial sciatic nerve ligation. A reduction in burrowing 
behaviour was demonstrated in both models of neuropathic pain compared to naive animals. 
 
The use of novel outcome measures, such as those detailed above, both as outcome measures in 
drug development and in studies into pathophysiology will improve the quality of studies aimed 
at creating novel therapies for neuropathic pain.  
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Foreword: 
 
The following essay was written at the beginning of my PhD studies. Although it does not fit 
easily into the general introduction of this thesis it was felt that it would be of interest and would 
help readers understand some of the background thinking that went into the studies herein. 
 
Introduction: 
 
The Norway Rat (Rattus norvegicus) is arguably the most widespread and successful member of 
the order Rodentia, by far the largest mammalian order, which accounts for some 40% of all 
mammalian species. The species’ success is largely due to the formation of a commensal 
relationship with the most dominant of mammalian species, man. However, in the last hundred 
years the increasing use of rats as laboratory animals and the ever growing number of medical 
advances to which the use of the Norway rat has been essential have begun to blur the distinction 
between commensalism and symbiosis in the human-rat relationship. 
 
To achieve reproducible and relevant results from any experiment involving laboratory animals a 
basic knowledge of their behaviour is essential. A good place to start gaining such knowledge is 
with an investigation into the behaviour and ecology of their wild cousins. In this essay we will 
investigate the behaviour of the wild Norway rat and the effects domestication has had on its’ 
behaviours.  
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The wild Norway rat: 
 
It is difficult to define the natural habitat of the Norway rat, the species originated in the plains of 
Mongolia and Northern China but has since followed man to almost every corner of the globe 
(Hedrich and Krinke, 2000). Rats can be found almost everywhere humans inhabit with cases as 
extreme as oil rig infestations being reported (Heavey, 2003). The 2001 English House Condition 
Survey showed the presence of rats on the property of 2.9% of occupied residences with the 
incidence increasing in more rural areas and along with dilapidation (Central Science Laboratory, 
2005).  
 
Rats are fossorial (burrow-dwelling) rodents which dig tunnels for shelter and which will climb 
and even swim readily. Interestingly although they are generally nocturnal it is apparent that rats 
have the ability to shift their circadian rhythm in response to local conditions such as the 
prevalence of predators (Fenn and MacDonald, 1995;Silverman, 1978;Boice, 1981a). Studies 
conducted on truly free living rats are few and far between with the majority of those that do exist 
concentrating on their impact as pests rather than ethological considerations. As a result much of 
our current knowledge is based on studies of wild caught rats living within enclosures which 
attempt to mimic natural habitats. Despite their large size (Steiniger, 1950 = 64m2; Calhoun, 1962 
= 1012m2) it is likely that by their very nature these enclosures affect behaviour (Steiniger, 
1950;Calhoun, 1962).  
 
Rats are social animals and live in colonies, the introduction of wild Norway rats from disparate 
free-living groups into a large outdoor enclosure resulted in a single breeding male and female 
establishing a colony following the elimination of all conspecifics within the area (Steiniger, 
1950). A similar pattern of colony formation was observed by Calhoun in his 1962 study in 
 which the
female (C
range, of 
rats betwe
introduce
norvegicu
injured m
 
Rats dig c
a nest ch
connected
to move b
(Barnett, 
caches ad
 
 
Figure 1: C
 four gene
alhoun, 19
around 30m
en colonie
d rats is hig
s the only 
ale which l
omplex bu
amber at 
 to the surf
etween bu
2005). As 
ded (Fig 1)
omplex rat bu
rations, 200
62). It app
2, close to 
s does occu
h (Steinige
evidence of
ater went on
rrow system
the bottom
ace from b
rrows and 
the burrow
  
rrow showin
 individua
ears that th
where they
r, most com
r, 1950). I
 attempted
 to die (Mc
s (Fig 1), p
. As the y
eneath the g
areas where
 systems g
g food caches
ls, were ult
e majority 
 were born
monly in 
n a 1 year 
 immigratio
Guire et al
regnant fem
oung matu
round (Cal
 resources
rows furthe
 and numbere
imately de
of rats stay
 (Davis et a
adult males
study of a f
n from oth
., 2005).  
ales will t
re tunnels 
houn, 1962
 are availab
r nest cham
 
d entry point
rived from 
 within a r
l., 1948). A
 (Calhoun,
arm based 
er colonies
ypically dig
are extend
). Most act
le via track
bers are c
s Taken from
a single w
elatively sm
lthough di
 1962), agg
population
 consisted 
 a short bu
ed radially
ive at night
s known a
onstructed
 (Calhoun, 19
26
ild caught 
all home 
spersal of 
ression to 
 of Rattus 
of a badly 
rrow with 
 and are 
, rats tend 
s rat runs 
 and food 
62). 
27 
 
Conflict, aggression and dominance hierarchies: 
 
Following the introduction of adult males into established groups of both sexes dominance 
hierarchies are quickly established (Barnett, 1975). Miczek and de Boer describe a dominant or 
alpha rat as “prevailing most often over rival, or beta, males and over subordinate, or omega, 
animals in aggressive confrontations”. Beta males adapt to a submissive role and tend to avoid 
contact with the alphas and survive well. Omega males in contrast bear the brunt of most attacks 
which, although short in length and interspersed with large periods of non-aggressive behaviour, 
appear to have a great effect on behaviour. Omegas often appear cautious when eating, decline in 
weight and become dishevelled in appearance. This decline, which has been attributed to stress 
induced immunosuppression and negative features associated with cytokine release, often ends in 
the death of the animal (Miczek and de Boer, 2005;Barnett, 2005).     
 
Anthony Barnett has made detailed studies of agonistic encounters between male rats within 
enclosures. Following the introduction of an unknown rat into the ‘territory’ of a dominant rat a 
stereotyped series of behaviours is observed. One rat may crawl beneath the stomach of the other 
(Barnett, 1975), allogrooming is also a common behaviour, this generally involves the nibbling of 
the neck area and is sometimes termed aggressive neck grooming (Miczek and de Boer, 2005). 
Although these behaviours often precede a fight Barnett suggests that they may be designed to 
deter attack and can be interpreted as “social sedation” related activities. Should an encounter 
escalate to violence, attack generally consists of one male diving at the other with rapid 
movements of its forelimbs. This attack may also include a swift bite, however, it is rare for a 
Norway to bite and hold another. Such lunging attacks are interspersed with other behaviours 
such as the so called ‘threat’ posture: arched back and extended legs accompanied by piloerection 
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or ‘boxing’ where the two males rear on their hind limbs and push each other with their paws 
(Barnett, 2005).  
 
The observations detailed above were made on wild Norway rats within relatively enclosed 
environments and do not appear to hold true for free living colonies or those in larger enclosures. 
Steiniger maintained that following colony formation no hierarchical structure existed (Steiniger, 
1950). However, studies by Robitaille and Bovet (1976) and Calhoun (1962) refute this, with 
both studies noting a complex social system within colonies (Calhoun, 1962;Robitaille and Bovet, 
1976). In his 1975 work ‘The rat: a study of behaviour’ Barnett talks of the formation of 
territories by dominant males, later authors drawing on his work appear to see this as the norm 
with a colony (Miczek and de Boer, 2005;Barnett, 1975). However, the observations of Calhoun, 
in large enclosures, and Robitaille and Bovet, in the wild, state that the formation of such 
territories is rare (Calhoun, 1962;Robitaille and Bovet, 1976). Only a very few particularly large 
rats were seen to behave in a territorial manner. In both these studies population density was high 
and the authors suggest that the energy expenditure required for territorial defence would be too 
high to make it viable. It may be that at lower population densities territoriality is the norm.  
 
As will be detailed later the formation of territories appears to have reproductive advantages. 
Indeed the formation of hierarchies without territoriality may be detrimental (Calhoun, 1962). At 
high population densities fighting between males is common and no submissive/social sedation 
behaviours, such as those described by Barnett, are observed (Robitaille and Bovet, 1976). 
Neither was aggressive grooming or adoption of the ‘threat’ posture apparent. However, boxing, 
jumping attacks and wrestling were observed frequently. In all confrontations the losing 
individual took flight and was often pursued and bitten on the rear. It is possible that behaviours 
such as aggressive grooming may have been missed due to the increased difficulties involved in  
29 
 
observing wild rats without disturbing them. However, the authors believe that the 
aforementioned behaviours are more likely the product of rats encountering one another in 
enclosed environments with no opportunity to escape or avoid confrontation. In both the above 
studies the increased social conflict caused by dense populations is sighted as a likely cause of 
crashes in rat populations. 
 
In the rare cases where a large male does defend a territory the area usually consists of a burrow 
system containing a few females and young rats. The dominant male will vigorously defend this 
area against entry by any other male. However, these aggressive encounters are tightly restricted 
to the territory. Indeed Calhoun (1962) observed a male attacking a subordinate who strayed into 
his territory before following him out of the area and eating by his side (Calhoun, 1962).         
 
Females also display territoriality during lactation; both males and females will be attacked if 
they come too close to the nest area. Females will, however, accept other lactating females and 
communal nesting may also take place (Calhoun, 1962;Steiniger, 1950). 
 
Feeding: 
 
The sometimes startling adaptability of the Norway rat is perhaps most evident in their foraging 
behaviour. Geographically distinct variations in techniques for gathering food range from living 
entirely off human refuse, to diving for fresh water molluscs and even hunting and killing ducks 
and other small birds (Galef, 2005). Norway rats are omnivorous and, like all rodents, they have 
specialised incisors that grow throughout life. This adaptation allows them to gnaw through 
natural and manmade barriers to reach various foodstuffs (Hedrich and Krinke, 2000). Rats are 
conditioned to recognise safe and desirable foodstuffs by learning from the diets of others. 
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Surprisingly this process begins prenatally and continues throughout life. The importance of this 
sociobiological form of learning was first demonstrated by Steiniger (1950) following 
investigations into the efficacy of permanent poisoned baiting stations in the control of rat 
infestations. Steiniger observed that despite an initially high death toll following the 
establishment of a bait station the colony quickly recovered. This recovery was attributed to the 
total avoidance of poisoned bait by the offspring of rats whom had survived the initial poisoning 
(Steiniger, 1950;Galef, 2005). Laboratory studies have shown that prenatal exposure to 
substances associated with adverse stimuli during gestation will cause avoidance behaviours in 
the postnatal period (Smotherman, 1982). Equally exposure to foods through a mother’s diet can 
predispose rats to that food in adulthood (Hepper, 1988). Learning from the mother’s diet 
continues during suckling after which point the learning becomes more socially based with young 
rats copying adults in their selection of their first food (Galef, Jr. and Henderson, 1972;Galef, Jr. 
and Sherry, 1973;Galef, 1974;Galef, 2005). 
 
During adulthood two conflicting behavioural adaptations dictate the behaviour of rats towards 
potential food. Norway rats are naturally curious and will range out from set trails across their 
territory. During such forays the first places to be investigated are often those which have not 
been recently visited. It is interesting to note that such exploratory behaviour continues even in 
the absence of any observable need for food, water etc. Such behaviour is termed ‘neophilia’ and 
is evident in the behaviour of rats towards food (Barnett, 2005). When various food stuffs are 
available rats will sample from each before concentrating on a preferred source. Once sated the 
rat will again repeat its sampling, even if the food is tainted with unpleasant substances such as n-
butyl mercaptan (skunk odour) (Barnett and Spencer, 1953). It is easy to see how such a 
behavioural adaptation would be advantageous to an omnivorous creature, allowing the selection 
of the best food available within a locality for the animal’s current dietary needs.  
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Conversely, wild rats have been shown to display ‘neophobia’ when presented with new objects, 
including food, within areas with which they are familiar. As noted by Silverman (1978) placing 
an unfamiliar item on a rat run will lead to the trail being completely avoided for some time 
(Silverman, 1978). In the case of unfamiliar foods, the food is first avoided, then sampled, 
following this sample the avoidance behaviour returns. This resurgence in avoidance behaviour 
allows the animal to assess if the food source causes any ill effects. Indeed rats show ‘learning 
after a long delay’ and will, in future, avoid any food that caused illness (Barnett, 2005). 
Neophobia is an adaptable behaviour and is absent in some rat populations, e.g. those resident in 
dumps where the presence of novel objects in familiar surroundings is the norm (Boice, 1972). 
Interestingly other commensal members of the Muridae are neophobic while the only 
independently living member of the genus Rattus so far studied is not. This raises the possibility 
that neophobia is a product of evolution in the presence of man (Galef, 2005). 
 
Predator Avoidance: 
 
Rats are prey animals hunted by both land and air based predators (Spiegel et al., 1974;Fenn and 
MacDonald, 1995). As such they are naturally cautious creatures and when in the open will tend 
to move quickly between areas of shelter (Berdoy et al., 2002). Because rats are generally 
nocturnal they rely heavily on olfactory cues to detect predators. However, visual recognition is 
also an important determinant of behaviour. If sufficient distance exists between a rat and a 
possible threat the animal will engage in risk assessment behaviour. This is characterised by the 
orientation of the animal towards the stimuli, the adoption of a flattened posture and forward 
movement, similar to that of a stalking predator (Blanchard et al., 1981;Blanchard and Blanchard, 
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2005). Such risk assessment behaviour has been shown to be important in the learning of 
defensive reactions in rats (Pinel et al., 1989). 
 
Rats have numerous behavioural responses to predators including flight, alarm calls, freezing, 
defensive attack and the previously mentioned risk assessment behaviour (Blanchard and 
Blanchard, 2005). The response elicited by the presence of a predator is influenced by the 
environment in which it is encountered. For example, if shelter is available and conspecifics 
present a rat is likely to hide and emit alarm calls, while the removal of an escape route will 
modify the behavioural response from flight to freezing (Blanchard et al., 1991;Blanchard et al., 
1981).  
 
The importance of predator avoidance in determining the behaviour of rat colonies is underlined 
by the fact that entire colonies will switch from nocturnal to diurnal activity cycles in order to 
avoid predators such as foxes (Fenn and MacDonald, 1995).  
 
Sexual Behaviour: 
 
Sexual behaviour within wild rat colonies is driven by the female cycle of ovulation. Rat oestrous 
is non-seasonal with a cycle length of 4-5 days (Jenkins and Becker, 2005). Rats begin displaying 
sexual behaviours around the age of 80 days and are fully active at 115 days after birth (Calhoun, 
1962). 
 
Sexual interactions between males and females take two forms, both extensively studied by 
Calhoun (Calhoun, 1962). Calhoun’s earlier observations are backed up by a 1976 ethological 
investigation carried out on a truly free living rat colony (Robitaille and Bovet, 1976). In both 
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cases the most common form of mating was polyandrous. As oestrous begins females are seen to 
increase their movements often travelling beyond their home ranges. They appear to seek out 
males who at this early stage will sniff the genital region and in some cases follow for a short 
period before returning to their earlier activities. The females will frequently scent mark areas 
attracting males to follow. Calhoun observed males rubbing and rolling in scent marked areas 
particularly those outside burrows containing fertile females.  
 
Mounting usually begins on the second night of oestrus. The female will leave her burrow at 
speed followed by one or more males who have gathered outside. Groups of males numbering up 
to 12 have been observed following females (Calhoun, 1962;Berdoy et al., 2002). Mountings last 
around 3 seconds during which the female may or may not enter lordosis. Following copulation 
the female will often ‘box’ the male before moving on followed by the remaining males. Males 
who copulate engage in genital licking before rejoining the pursuing pack. Such activity may last 
for up to 6 hours after sundown (Robitaille and Bovet, 1976). Females intermittently rest in their 
burrows, while the males wait outside spreading out to cover all possible exits. It is rare for a 
male to enter a burrow containing a female although it may happen if the female is underground 
for an unusually long time. Males rarely fight during the pursuit of a female although fighting 
outside burrows is more common (Calhoun, 1962).  
 
The second less common form of sexual interaction occurs when a dominant male controls access 
to a harem of females. The male will stand guard side-on to the burrow and drive off all intruders. 
If the female attempts to exit the burrow she will often be pushed back inside. Occasionally the 
male will allow the female to exit the burrow and will mount her before pushing her back inside 
(Robitaille and Bovet, 1976). Subordinate males will sometimes sneak in and copulate with the 
female if the dominate male is engaged in defence of the territory elsewhere (Calhoun, 1962). 
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The birth rates in dominant controlled harems are significantly higher than those observed 
following polyandrous mating. This is likely due to the stress caused to the female during pursuit 
and may be a factor in population crashes often seen when rats exist at high densities (Calhoun, 
1962;Barnett, 1975).    
 
Maternal Care: 
 
At birth rat pups are blind, hairless and helpless. As previously mentioned dams become highly 
territorial following the birth of their litters, this is likely due to the occasional occurrence of 
infanticide by male rats (Calhoun, 1962;Barnett, 1975). Mortality of litters is high; in Calhoun’s 
study the majority of rat litters were lost within the first two days. Pups nurse for about 40 days 
and the mother-pup bond continues for sometime after the cessation of lactation. Pups are known 
to emit ultrasonic vocalisations if left alone by their mothers (Koolhaas, 1999). Low social status 
appears to correlate with poor maternal care although this does improve with experience 
(Calhoun, 1962). 
 
Domestication: 
 
Before entering into an investigation of the possible behavioural differences between wild and 
domestic rats it is important to examine the process of domestication. Wild rats display a number 
of the favourable characteristics for domestication as defined by Hale. Namely; large social 
groups; hierarchical structure; males affiliated with female groups; promiscuous mating; sexual 
movements or postures; omnivorous diet and adaptability to a wide range of environments (Hale, 
1969).  
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During the 18th and 19th century albino and hooded mutant rats were often used in baiting due to 
their unusual appearance. The use of albino rats in the scientific research began in the early 19th 
century when they were utilised in physiological research (Hedrich and Krinke, 2000). It is likely 
that domestication began with the capture and cross breeding of rats with albino, non-agouti 
black and piebald coat colour mutations. The resulting genotype, homozygous for all three 
mutant genes (c, a and h respectively), is the genotype of the classic laboratory rat (Castle, 1947).  
 
Wild and domesticated Norway rats a comparison: 
 
Domestication has brought about a number of changes to the biology of the Norway rat. Changes 
in pigmentation are the most obvious, although albino and other coat colour mutants do appear in 
the wild they are the norm within the laboratory environment (Hedrich and Krinke, 2000). Albino 
rats have less acute vision than pigmented or wild rats (Fig. 2). However, it is interesting to note 
that this does not appear to affect their performance in simple visual discrimination tasks 
(Andrews et al., 1992;Andrews and Holtzman, 1988). Laboratory females tend to be significantly 
smaller than their wild counterparts while the reverse is true for males (Fig. 3). In laboratory rats 
life-span varies considerably with strain, in Wistar rats male life span is around double that of 
their wild counterparts; 1200 days for males and 1400 days in females (Koolhaas, 1999). 
Laboratory rats also reach sexual maturity more quickly becoming active at around 60 days 
compared to between 75 and 95 days for wild rats (Calhoun, 1962).  
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domestic animals to highlight changes caused by domestication. This approach assumes that the 
wild stock is representative of the animals from which the current domesticated animals are 
derived (Price, 1984;Boice, 1981a). However, biological variation between different geographical 
locations is likely and when studying behaviour ‘cultural’ variation e.g. in foraging tactics must 
also be taken into account (Silverman, 1978;Price, 1984). The second approach involves the 
breeding of wild populations in the laboratory and the study of phenotypic changes that occur 
over generations (Price, 1984). Although such a study has been carried out using wild Norway 
rats by Helen King and colleagues at the Wistar Institute it unfortunately did not investigate 
behavioural changes (Boice, 1981a).  
 
Early observations made in 1929 by Donaldson also at the Wistar institute, where the first widely 
documented inbred strain was created (Hedrich and Krinke, 2000), noted behavioural differences 
between the recently imported albino rats and those caught in the wild around the institute. He 
described the wild rats temperament as ‘more excitable and much more savage’ than their albino 
counter parts (Castle, 1947). It is apparent from studies in a number of species, including rats, 
that mutations affecting coat colour also affect behaviour (Keeler et al., 1968;Trut et al., 2000). It 
has been shown that selective breeding of wild Norways for ‘reduced aggressive-fearful 
behaviour toward humans’ results in almost universal expression of the hooded phenotype (Trut 
et al., 2000). Thus, it would appear to be likely that the combined effects of genetic changes, such 
as coat mutation-linked behavioural changes, alongside both conscious and unconscious selection 
for tameness during domestic breeding would affect the natural behavioural repertoire of the 
Norway rat. 
 
One train of thought concerning domesticated animals, including laboratory rats, maintains that 
they represent degenerate versions of their wild counterparts (Lockard, 1968;Price, 1984). Indeed, 
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concerning behavioural research involving laboratory rats Lockard stated “It is at least a waste of 
time, if not an outright folly, to experiment upon the degenerate remains of what is available 
intact in other animals”. The roots of the degeneracy argument are easy to see as domesticated 
animals tend to be more docile and less reactive to humans, conspecifics, and the environment 
around them (Price, 1984). Such changes could be interpreted as the loss of the natural instincts 
that allow rats to survive in the wild. 
 
The degeneracy theory was strongly refuted by Robert Boice and through a series of comparative 
studies he set out to show that laboratory rats were not merely degenerate shadows of their wild 
counterparts. Boice first attempted to ensure he trapped wild rats that were representative of their 
population. By trapping on landfill sites, where rats do not display the same degree of neophobia 
as in more static environments he was able to secure rats in better condition than the scar-marked 
individuals often secured elsewhere (Boice, 1972;Boice, 1981a). Behavioural testing showed that 
scar-marked rats represented a subordinate class of rats who were likely forced to seek food in 
traps due to social exclusion from desirable sources (Boice, 1972). Having secured what he felt 
was a more representative sample population Boice compared laboratory rats with first generation 
laboratory born wild rats in a number of behavioural paradigms designed to test learning abilities. 
Laboratory rats were shown to outperform their wild counterparts in both classical conditioning 
paradigms and avoidance learning paradigms (Boice, 1981a;Boice, 1968).  
 
It could be argued that such tests put wild rats at an unfair disadvantage, indeed Boice thoroughly 
discusses his attempts to account for this in his 1981 review (Boice, 1981a). Would tests more 
akin to challenges experienced in the wild reveal the degenerate nature of the laboratory rat? 
Studies on predator avoidance in semi-natural environments showed little difference in predation 
between laboratory rats and laboratory reared wild rats by either air or ground predators (Spiegel 
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et al., 1974;Price, 1984). It is striking that little or no degeneracy is apparent in a behaviour that 
has no obvious selective advantage in domestic rats and such a great one in free living Norways. 
Interestingly, in a similar test where wild caught and first generation laboratory bred wild rats 
were predated by European Polecats wild caught rats were significantly better at avoiding capture. 
These data suggest that early experience is more important than natural genotype in predator 
avoidance behaviour (Price, 1984).   
 
Although Anthony Barnett did not agree with the degeneracy theory he emphasised the large 
differences in the behavioural repertoire between wild a domesticated rats (Barnett, 1975). This is 
particularly evident in his observations of agonistic behaviour. Barnett saw in the agonistic 
encounters of laboratory rats evidence of neoteny, the persistence of immature behaviours during 
adulthood, and believed that domestic rats were incapable of displaying the full range of 
behaviours observed in agonistic encounters between wild Norway rats. Later studies have, 
however, shown laboratory rats are capable of levels of aggressive behaviour comparable to those 
of wild animals (Adams, 1976;de Boer et al., 2003). However, in order to elicit high levels of 
aggression in laboratory rats manipulation of their environment is required. For example, social 
isolation increases aggression in male rats, and differences in housing conditions such as rearing 
in burrows can also increase aggression (Nikoletseas and Lore, 1981;Adams, 1976;Boice, 1981b). 
Thus, it is apparent that in agonistic encounters differences in behaviour observed between 
laboratory and wild rats are a result of altered thresholds of activation in domestics rather than a 
reflection of a different or immature behavioural repertoire. 
 
Differences in threshold are also observed in other behaviours, for example while wild rats will 
dig burrows readily when given the opportunity, domestics, while creating indistinguishable 
burrow structures, are unlikely to start burrowing without an object to dig under (Boice, 1977). In 
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some behaviours a lowering of behavioural threshold is apparent, for example laboratory rats will 
more readily interact with unknown individuals, indicating a drop in the behavioural threshold for 
social interaction. This “lack of social inhibitions” has been put forward as an explanation for the 
fact that laboratory rats show dominance in both spontaneous and competitive interactions with 
wild rats (Boreman and Price, 1972). Another important behaviour in which a change in 
behavioural threshold is apparent, is the neophobic response to new objects. Laboratory rats have 
been shown to be less neophobic than wild rats (Barnett, 1958;Mitchell, 1976). However, 
neophobia in laboratory rats increases when rats are raised in semi-natural environments (Boice, 
1981a). Such observations have led to the now widely accepted view that changes in rat 
behaviour due to domestication are quantitative rather than qualitative in nature, resulting in 
differences in activation thresholds but not major changes to the rat behavioural repertoire (Price, 
1984). 
 
Table 1: Table detailing a series of behaviours, whether these behaviours can be carried out by wild and laboratory 
rats in their typical environments, and whether the ability to carry out behaviours has been maintained in laboratory 
rats. 
Behaviour Wild Laboratory Retained 
Foraging Yes No Yes 
Sexual Yes No Yes 
Agonistic Yes Yes Yes 
Predator Avoidance Yes No Yes 
Neophobia Yes No Yes 
Neophilia Yes No Yes 
Burrowing Yes No Yes 
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Mechanisms Influencing Behavioural Changes: 
 
Rats have only been domesticated for a relatively short length of time so it is perhaps not 
surprising that activation thresholds rather than actual behaviours have been altered. Further, the 
fact that, as mentioned above, wild rats display many of the ideal characteristics for 
domestication means that less behavioural modifications are required to allow adaptation to a 
domestic environment (Hale, 1969;Price, 1984).  
 
Both genetic changes and the influence of the captive environment contribute to the development 
of the domestic phenotype (Boice, 1981a). We have already mentioned how aggressive and 
neophobic behaviours in laboratory rats can be modulated by environment (Boice, 1981a;Adams, 
1976). In wild rats a more domestic-like temperament can be elicited by raising them in the 
manner of laboratory rats (Price, 1978;Barnett et al., 1979). For example, raising male rats 
together in groups reduces aggression within the group and early handling increases tameness 
(Galef, 1970;Barnett et al., 1979). However, even in behaviours which are influenced by 
environment the effect of genetics cannot be ignored. Futhermore, although laboratory rats reared 
in burrows are more aggressive than those raised in cages there is no discernable difference in 
levels of aggression between burrow and cage reared wild Norways (Boice, 1981b). Thus some 
genetic difference between laboratory and wild rats must be allowing the expression of different 
behavioural phenotypes in laboratory rats raised in different environments (Price, 1984). 
 
A number of different factors affect the genetics of animals during the domestication process, 
these include inbreeding and selection. The effects of selection can be subdivided into artificial 
selection, natural selection in a captive environment and the relaxation of natural selection (Price, 
1984;Boice, 1981a). Artificial selection can be both active and passive. Using the selection for 
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tameness as an example, it may be that tamer rats were purposely selected for breeding in order to 
produce tamer offspring, while it is equally likely that tameness was passively selected simply 
through tamer rats being easier to catch when selecting breeding pairs. Natural selection under 
captive conditions may have directly affected the behavioural phenotype of laboratory rats as 
wild caught females which behave more like domestics are more likely to reproduce in captivity. 
Thus, genes conferring a domestic phenotype would be preferentially passed on to successive 
generations (Price, 1984). Relaxation of selection pressure brought to bear on certain behaviour 
traits, such as predator avoidance, is likely during the domestication process (Price, 1984). 
Although, as previously stated, laboratory rats differ little from their wild counterparts in their 
ability to avoid predators the expression of certain avoidance behaviours have been altered due to 
relaxed selection (Spiegel et al., 1974;Price, 1984;Price, 2002). One such behaviour is ‘freezing’ 
which is exhibited by wild rats, but not by laboratory breed rats in response to certain changes to 
their environment (Price and Huck, 1976;Price, 1984). 
 
Inbreeding is a common driver of genetic change in captive animals due to small population size 
and can lead to inbreeding depression: ‘the lowering of vigour or fitness brought about by the 
expression of deleterious genes previously masked by dominant genes’ (Price, 2002). In the case 
of laboratory rats inbreeding has been used to reduce the disparity in experimental outcome 
caused by genetic variation. Further, use of inbreeding alongside artificial selection has been 
utilised to create rat strains with specific phenotypes (Festing, 1981;Hedrich and Krinke, 2000). 
 
An inbred strain is defined as a group of animals produced by at least 20 brother x sister crosses 
and derived from a single breeding pair at the 20th or a later generation. All members of a truly 
inbred strain should display isogenicity, identical genetics, at 99% of the loci that were different 
in the original population (Festing, 1981). In the year 2000 more than 220 inbred strains and 
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various sub-strains of rat were in use (Hedrich and Krinke, 2000). Artificial selection and 
inbreeding can significantly amplify a desired phenotype in a small number of generations. 
During the development of the Roman high and low avoidance strains, bred from Wistar albinos, 
significant differences in shock avoidance behaviour were evident after five generations (Hewitt 
et al., 1981). Inbred strains are often created to model human disorders such as high blood 
pressure and depression (Overstreet, 1993;van den Buuse, 1994). However, inbreeding can often 
have unexpected behavioural consequences for example the Wistar-Kyoto strain was originally 
bred to act as a control in studies of hypertension but later found to display behavioural 
idiosyncrasies that made it a candidate for research into depression (Andrews, 1996;Pare and 
Redei, 1993). As behavioural testing becomes more important in investigating the efficacy of 
novel pharmacological agents the confounding effects of strain specific behavioural traits in both 
inbred and outbred stains must be taken into account. This had been highlighted within the sphere 
of dementia research where one of the most commonly used strains the Brown Norway has been 
shown to have learning deficits making it unsuitable for use in tests of cognitive function (van der 
Staay and Blokland, 1996). 
 
Feralisation: 
 
Feralisation can be viewed in a number of ways; feral animals can be defined as any domestic 
animal living in a wild environment (Shank, 1972). Others define feralisation as the process of 
domestication in reverse, suggesting that some genetic alteration leading to the establishment of a 
wild phenotype is required (Price, 1984). For our purposes we will view feralisation as the 
establishment of a reproductively viable colony in the absence of care by humans. 
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As previously mentioned wild rats are well suited for domestication, as such the process of 
readjustment to a wild environment should not require extensive changes to the domestic 
phenotype (Hale, 1969). Rats are also highly adaptable creatures making it likely that they would 
adjust well to introduction into the wild. Examples of domestic rats living wild have been 
reported (Minckler and Peaseh, 1938). Recently a group of scientists from Oxford University 
introduced 50 Wistar and Lister hooded rats into an enclosed farm yard environment. The rats 
were reared to full size in a laboratory environment and included both male and female 
individuals. The rats were exposed to predation and the full force of the elements in their new 
environment and were given no help from the observing scientists. Nevertheless the rats quickly 
began to display many of the behaviours typical of wild rats, creating burrow structures and 
establishing a colony with a hierarchical structure. Rat runs were created between food sources 
and over time rats reverted to an increasingly nocturnal activity pattern. The colony displayed 
predator avoidance behaviours and became cautious in their movements above ground moving 
quickly between areas of shelter. Polyandrous mating behaviour was observed and offspring were 
successfully reared. By the end of the six month study the domestic rats had apparently 
established a flourishing reproductively viable colony (Berdoy et al., 2002).  
 
The apparent ease with which these rats adapted to the wild environment despite 200 generations 
of domestic breeding further illustrates the strength of the wild rat’s behavioural phenotype and 
the lack of major changes elicited by the domestic environment (Berdoy et al., 2002). 
 
Conclusion: 
 
The Norway rat has made and continues to make a great contribution toward human scientific 
progress. A basic understanding of the natural behaviour of rats is essential if researchers wish to 
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design experiments that fully utilise the behavioural repertoire of this adaptable and intelligent 
animal. Further, knowledge of wild and domesticated rat behaviour can help in animal husbandry 
which will reduce the confounding effects of stress on experiments as well as improving animal 
welfare. 
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1.1 Acute and Chronic Pain 
The experience of pain is by its nature almost universal and yet completely subjective. Pain 
perception and its function have fascinated and divided thinkers for millennia. The International 
Association for the Study of Pain (IASP) defines pain as ‘An unpleasant sensory and emotional 
experience caused by actual or potential tissue damage or described in terms of such damage’ 
(Merskey et al., 1994). As can be seen from the experiences of those born with congenital 
deficiencies in pain sensation (Cox et al., 2006) and the strong phylogenetic preservation of pain 
systems, pain has an extremely important role in the survival of organisms.  
Acute pain is an adaptive mechanism arresting current activity and causing withdrawal from 
damaging stimuli. Prolonged subchronic pain serves a similar purpose, promoting quiescence and 
guarding behaviours which facilitate the healing of wounds. Conversely, chronic pain appears to 
serve no adaptive purpose; rather it emerges from pathological physiological changes resulting in 
abnormal activity within the sensory system. In chronic pain states the very same features which 
make pain such an important survival trait may lead to maladaptive behavioural responses, often 
resulting in increases in suffering and associated disability (Andrew et al., 2003).  
 
1.2 From Nociception to Pain: Peripheral, Spinal and Supraspinal Sensory Systems 
 
1.2.1 Peripheral Physiology: 
 
In the periphery and spinal cord, activity evoked by noxious pain generating stimuli is termed 
nociception. The experience of pain requires extensive emotional and cognitive processing which 
can only occur in a complex network of brain nuclei. In the following subsection the transmission 
of noxious stimuli from the periphery to the spinal cord will be discussed.  
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Nociception begins, under normal physiological circumstances, with the activation of primary 
afferent nociceptors. These nociceptive fibres represent the peripheral branch of bifurcated axons, 
the cell bodies of which reside in the dorsal root ganglia. The second branch of these axons 
projects to the spinal cord carrying nociceptive information to the CNS.  Specific populations of 
primary afferent fibres innervate visceral, muscular and cutaneous tissues. As the major model 
used in this project involves damage to a nerve fibres innervating skin the focus of the following 
subsection will be on cutaneous primary afferents. The majority of cutaneous nociceptors can be 
subdivided anatomically into unmyelinated C-fibres and myelinated small diameter Aδ-fibres, 
although a proportion of nociceptors with conduction velocities in the Aβ range does exist 
(Djouhri and Lawson, 2004). From an electrophysiological point of view nociceptors can be 
separated into those that respond to unimodal stimuli and those that respond to multiple sensory 
modalities (Fig. 1.2.1 A). These so called polymodal nociceptors make up the majority of the C-
fibre population.  
 
The activation of polymodal C-fibre nociceptors is thought to convey a burning pain sensation 
(Meyer et al., 2006). C-fibres likely represent a phylogenetically ancient group of sensory fibres 
which, as well as the modality of the sensory input to which they respond, can be categorised 
both by the receptors and neurotransmitters which they express. From a molecular biological 
standpoint two major classes of C-fibre exist recognisable by their expression of 
neurotransmitters and particularly their distinct sensitivity to growth factors. In early 
development virtually all cells destined to become small diameter nociceptors are sensitive to 
nerve growth factor (NGF) and express the Trk A receptor (Silos-Santiago et al., 1995). 
Differential growth factor sensitivity is established during the first three postnatal weeks in rats 
and mice when half of the cells loose their Trk A receptors and up-regulate Ret. Increased Ret 
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Following injury inflammatory mediators are released from local tissues. These include 
prostaglandins, bradykinin and leukotrienes as well as compounds which also act as 
neuromodulators at central sites such as substance P and serotonin. These inflammatory 
mediators directly activate or sensitise nociceptors resulting in the tonic pain and hypersensitised 
responses which characterise areas of tissue injury (Meyer et al., 2006). 
 
Following activation of nociceptive fibres in the periphery action potentials travel to the dorsal 
root ganglion where they are transduced to the central projection of the nociceptor resulting in 
release of neurotransmitters in the spinal cord. 
 
1.2.2 Spinal Physiology: 
 
The publication of Melzack and Wall’s gate control theory, which had inhibitory spinal 
interneurons at its centre (Melzack and Wall, 1965), lead to a flurry of research aimed both at 
supporting and bringing down the new hypothesis. This research resulted in a great increase in 
the understanding of the physiology and pharmacology of spinal nociceptive processing (Melzack, 
1999). Researchers continue to add to the increasingly complex picture of intrinsic spinal 
processes and the extrinsic influences, such as those exerted by descending modulatory systems, 
exerted upon them. Spinal nociceptive processing involves four principal neuronal components; 
central terminals of primary afferents; intrinsic spinal neurons; ascending projection neurons and 
descending supraspinal neurons (Todd and Koerber, 2006). 
 
The neuroanatomist Bror Rexed defined layers of the cat spinal cord, termed lamina,  based on 
the varying size and density of the neuronal population (Rexed, 1952). His system has since been 
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adapted for numerous other species including the rat (Fig. 1.2.2 A). The superficial dorsal horn, 
laminae I and II, is the primary destination for the terminals of nociceptive primary afferent fibres, 
although some do synapse in deeper laminae (Todd and Koerber, 2006). Lamina I receives 
extensive input from both Aδ nociceptors and peptidergic C-fibres (Light et al., 1979; Averill et 
al., 1995). Increased knowledge of the targets of specific primary afferent fibres has led to the 
separation of lamina II in to inner (IIi) and outer (IIo) portions (Todd and Koerber, 2006). The 
targeting pattern of Aδ and peptidergic C-fibres crosses into the outer portion of lamina IIo (Light 
et al., 1979; Averill et al., 1995) while non-peptidergic C-fibres have their major termination in 
lamina IIi suggesting a putative functional separation (Todd and Koerber, 2006). Some Aδ 
nociceptors also project more deeply synapsing with neurons in laminae IV and V (Light et al., 
1979). It should be noted that although lamina I and II receive high levels of nociceptive input, 
other sensory fibres, such as those responsible for cutaneous cooling and low threshold 
mechanoreception in skin and muscle, also target this area (Light and Willcockson, 
1999;Hoheisel et al., 1989). Evidence of postsynaptic functional segregation in the superficial 
dorsal horn is emerging, for example the majority of cells projecting to neurons sensitive to 
inhibition by opioids represent nociceptors (Light and Willcockson, 1999). 
 
Interneurons represent the majority of spinal cells and have a particularly high density in laminae 
I-III (Todd and Koerber, 2006). Most interneurons in the superficial dorsal horn have short axons 
and terminate within a few spinal segments of their cell bodies. However, a small but significant 
proportion of superficial spinal interneurons have axons that travel through several spinal 
segments (Bice and Beal, 1997).  
 
 Figure 1.
Rexed’s l
 
Both exci
ergic neu
respective
2006;Tod
(VGLUT2
terminals 
glutamate
 
A specific
the centr
Koerber, 
also recei
express n
2.2 A: Sch
aminae. Ta
tatory and i
rons make 
ly, with al
d and Sull
) alongsid
suggests 
rgic (Todd 
 population
al terminal
2006). Lam
ve dense i
europeptid
ematic rep
ken from (
nhibitory in
up approxi
l these cell
ivan, 1990)
e marker
that a larg
et al., 2003
 of inhibit
s of C-fib
ina I projec
nnervation 
e Y (Polga
resentation
Kato et al., 
terneurons
mately 28%
s likely rep
. The use 
s distingui
e proportio
).  
ory interneu
re primary
tion neuron
from a sp
r et al., 1
 of the rat
1997). 
 are presen
, 31%, an
resenting i
of staining
shing betw
n of spin
rons are th
 afferents 
s which ex
ecific popu
999). Whil
 spinal cor
t within the
d 46% of n
nhibitory in
 for the ve
een intern
al neurons
ought to m
through ax
press the S
lation of G
e a popula
 
d at the lu
 superficial
eurons in 
terneurons
sicular glu
eurons an
 in the su
odulate tran
o-axonic 
P receptor N
ABAergic
tion of lam
mbar leve
 dorsal horn
laminae I, 
 (Todd and
tamate tran
d primary
perficial la
smitter rel
synapses (
eurokinin
 neurons w
ina II int
52
l showing 
. GABA-
II and III 
 Koerber, 
sporter 2 
 afferent 
mina are 
ease from 
Todd and 
-1 (NK-1) 
hich also 
erneurons 
53 
 
transmits nociceptive information from non-peptidergic nociceptive primary afferents to lamina 
V projection neurons (Braz et al., 2005). These data indicate that interneurons have an important 
role in modulating nociceptive input to the spinal cord as well as output from it. In addition they 
suggest that circuits containing interneurons may be arranged in a functionally specific manner 
(Todd and Koerber, 2006). 
 
Spinal projection neurons are responsible for conveying nociceptive information to supraspinal 
centres. The vast majority, 93%, of lamina I projection neurons are nociception specific with the 
remaining 7% representing wide dynamic range neurons that respond to input from both high and 
low threshold afferent fibres (Hylden et al., 1989;Hylden et al., 1986). Most projection neurons in 
lamina I represent either spinothalamic neurons with collaterals to the midbrain or 
spinomesencepthalic neurons with collaterals to the medullary reticular formation (Bice and Beal, 
1997). The whole body activation profile of some lamina I spinomedullary neurons projecting to 
the dorsal reticular nucleus suggest these cells likely code affective aspects of nociceptive 
processes rather than discriminative information (Villanueva et al., 1988).  A small number of 
lamina II projection neurons are also present in the rat spinal cord (Giesler, 1979; Lima and 
Coimbra, 1991). 
 
 One major population of lamina I spinal neurons receiving input from nociceptive afferents are 
the aforementioned NK-1 positive projection neurons (Todd et al., 2002). The vast majority of 
afferent inputs to NK-1 receptor expressing neurons come from SP positive primary afferent 
fibres, all of which appear to be nociceptors, indicating an important role for NK-1 receptor 
expressing neurons in transmitting nociceptive information to the brain (Todd, 2002;Sakamoto et 
al., 1999;Lawson et al., 1997). Immunocytochemical investigations have revealed dense NK-1 
expression in lamina I with 45% of all neurons and 80% of projection neurons expressing the 
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neuropeptide receptor (Todd et al., 1998;Nakaya et al., 1994;Todd et al., 2002). A further 
population of NK-1 projection neurons which have their cell bodies in lamina III and IV and 
dendrites which extend dorsally to lamina I also exists (Todd et al., 2000). Electron microscopy 
reveals that NK-1 positive neurons in the dorsal horn express the receptor throughout their cell 
bodies and dendrites (Liu et al., 1994).  
 
The fact that NK-1 positive cells are selectively innervated by peptidergic primary afferent fibres 
represents a further putative example of postsynaptic functional specificity (Todd et al., 2002). 
The ascending fibres of NK-1 positive neurons target various nuclei important in supraspinal 
nociceptive processing including the lateral parabrachial area, caudal ventral medulla and the 
thalamus (Spike et al., 2003;Marshall et al., 1996).  
 
In contrast to peptidergic C-fibres, which directly connect to lamina I neurons, non-peptidergic 
GDNF positive cells transmit information to a lamina V projection neurons via lamina II 
interneurons (Fig. 1.2.2 B) (Braz et al., 2005). These wide dynamic range (WDR) neurons 
respond to both nociceptive and non-nociceptive input and once again project to various brain 
centres involved in nociceptive processing, as well as to the globus pallidus an area important in 
movement control (Braz et al., 2005). 
 
As previously mentioned, ascending fibre tracts project to a number of midbrain and brainstem 
nuclei. These nuclei have an important role in integrating nociceptive input with other sensory and 
homeostatic information as well as acting as relay points for the delivery of nociceptive 
information to higher brain centres (Tracey and Mantyh, 2007). In addition these nuclei are 
involved in the descending modulation of nociceptive activity in the spinal cord and receive input 
from higher limbic, subcortical and cortical structures. Early evidence of midbrain derived 
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RVM result in blockade of nocifensive behaviours (Fields et al., 2006) and lesions of this area 
result in the attenuation of stress induced analgesia (Fields and Heinricher, 1985). Disruption of 
RVM function through lesions, lidocaine injection and microinjection of excitatory amino acid 
antagonists all result in at blockade of PAG stimulation induced analgesia. Indicating that the PAG 
executes control over spinal cord nociceptive activity through its connection to the RVM. The 
RVM contains two populations of cells through which the PAG exerts its control over spinal 
nociception, off cells which inhibit nociceptive activity and on cells which exert a facilitatory 
effect. The RVM also contains a population of neutral cells (Fields et al., 2006). 
 
Activation of the PAG-RVM descending pathway also results in activity in a parallel 
noradrenergic pathway originating within the dorsolateral pontine tegmentum (DLPT)  (Hammond 
et al., 1985;Fields et al., 2006). These descending projections appear to be important in tonic and 
long term nociceptive state rather than acute pain responses (Jasmin et al., 2003). Evidence from 
studies utilising depletion or antagonism of spinal noradrenaline suggest that descending systems 
originating in the DLPT are recruited following nerve injury and suppress the resulting 
hypersensitivity (Jasmin et al., 1997;Xu et al., 1999).  
 
The amygdala plays an important role in the descending modulatory system. Reciprocal 
connections exist between the central amygdala (CeA) and the PAG (Rizvi et al., 1991), 
descending inhibitory control is exerted directly through the amygdaloid-PAG pathway as well via 
the RVM (Helmstetter et al., 1998). The amygdala appears to be a critical component for some 
forms of stress induced analgesia (Helmstetter, 1992;Helmstetter and Bellgowan, 1993). In 
addition, injection of neuropeptide receptor agonists, including morphine, into the amygdala has 
been shown to result in analgesia (Helmstetter et al., 1993;Kalivas et al., 1982). Indeed, the 
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antinociception resulting from systemic morphine injection appears to be disrupted by lesions of 
the CeA in the formalin test (Manning and Mayer, 1995). 
 
1.2.3 Supraspinal Physiology: 
 
The experience of pain is subjective in nature and may be influenced by numerous physiological 
and psychological factors. The context within which pain is experienced may, for example, 
profoundly influence its perceived intensity. The World War II physician Henry K. Beecher noted 
the dramatic reduction in perceived pain intensity displayed by soldiers in combat situations 
(Beecher, 1946). Further, experimental manipulation of a subject’s emotional state can alter their 
pain perception (Meagher et al., 2001a;Rhudy et al., 2006;Villemure et al., 2003). These 
psychological and contextual influences on pain perception have their route in the supraspinal 
processing of nociceptive inputs and the resulting tone that supraspinal centres exert on spinal 
activity, as detailed above. The effects of such contextual manipulation on nociceptive responses 
can be replicated in animals exposed to stressful stimuli (Hayes et al., 1978;Maier et al., 1982). 
 
The gate control theory enshrined the concept of the brain as a central player in the physiology of 
pain processing (Melzack and Wall, 1965;Melzack, 1999). The theory proposes activation of brain 
nuclei through ascending spinal tracts followed by a consequential modulatory descending 
activity. The presence of phantom body pain in paraplegics could not, however, be explained 
through nociceptive spinal input and suggested the presence of a ‘pattern generating mechanism’ 
within the brain (Melzack and Loeser, 1978). The neuromatrix theory of somesthesis hypothesises 
that nociceptive input entering the brain activates a genetically determined and experientially 
influenced network of neurons producing activity that represents a ‘pain signature’ in the brain. 
However,   this network may be activated erroneously resulting in the experience of pain in the 
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absence of nociceptive input  (Melzack, 1999;Melzack and Loeser, 1978;Melzack, 2005). Social 
experiences, such as empathy, and techniques such as hypnosis can also activate similar neuronal 
populations to those active during nociceptive input (Singer et al., 2004;Singer et al., 2004;Raij et 
al., 2005;Derbyshire et al., 2004).   
 
This pattern generating system, often termed the ‘pain matrix’ is spread throughout a complex 
network of limbic, cortical and subcortical nuclei involved in both serial and parallel processing of 
signals arising from noxious stimuli (Fig. 1.2.3 A) (Price, 2000;Tracey, 2005;Lorenz et al., 
2003;Peyron et al., 2000). These nuclei may be differentially activated depending on the nature of 
the nociceptive input and various other psychological or physiological factors (Melzack, 
2005;Melzack, 1999;Tracey and Mantyh, 2007). Functional imaging analysis shows that nuclei 
can be both activated by pain and play a role in its control (Peyron et al., 2000). The system feeds 
back upon itself with areas like the amygdala receiving input both from ascending pathways 
(Burstein and Potrebic, 1993;Bernard and Besson, 1990) and from cortical and thalamic nuclei 
(Pare et al., 2004). The precise identity of the brain nuclei that make up the pain matrix is a subject 
of some controversy with inconsistencies apparent between different studies (Apkarian et al., 
2005). Tracey and Mantyh reflect that these inconsistencies must be considered from the point of 
view that the pain matrix is ‘not…a standalone entity but…a substrate that is significantly and 
actively modulated by a variety of brain regions’ (Tracey and Mantyh, 2007). The following 
subsection contains a brief overview of some important supraspinal nuclei involved in pain 
perception. 
 
The thalamus, often dubbed the gateway to the cortex, acts as the major centre for the relay of 
ascending nociceptive information to higher brain centres. Much of the work on the organisation 
of thalamic nuclei comes from work on primates, in which the thalamic nuclei are significantly 
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As previously stated emotional state, or affect, can alter pain perception in humans. Aspects of the 
affective pain experience appear to be processed within a subset of supraspinal centres known to 
be involved in emotional function, which receive input from nociceptive neurons both directly 
(Burstein and Potrebic, 1993;Burstein et al., 1987) and indirectly, via relay nuclei (Bernard and 
Besson, 1990;Monconduit et al., 1999). Major ascending pathways involved in affective 
processing include the spinoparabrachioamygdaloid pathway (Gauriau and Bernard, 2002) and the 
dorsal portion of the spinothalamic tract (Millan, 1999).  
 
A major component of the affective pain network is the amygdala, an almond shaped area of the 
brain which forms part of the limbic system. Evidence for the amygdala’s key role in emotional 
functioning emerged as early as 1888 through experiments on the effects of temporal lobe lesions 
on Rhesus monkeys. This work that was later built on by Kluver and Bucy who described a 
syndrome of hypo-emotionality, hyper-sexuality, increased aggression and decreased fear which 
became manifest following lesions in the region of the amygdala (Kluver and Bucy, 1939). A 
number of human imaging studies have demonstrated activation of the amygdala following 
application of noxious heat stimuli (Derbyshire et al., 1997;Becerra et al., 1999;Bingel et al., 
2002;Bornhovd et al., 2002).  
 
The amygdala receives nociceptive input both directly from the spinal cord and indirectly via the 
spinoparabrachioamygdaloid pathway via the CeA. These inputs synapse in the lateral capsular 
area of the CeA which is hence termed the ‘nociceptive amygdala’ (Burstein and Potrebic, 
1993;Gauriau and Bernard, 2002). In addition the CeA receives extensive inputs from cortical and 
subcortical structures important in nociceptive processing via the lateral and basolateral areas (LA-
BLA) (Neugebauer et al., 2004;Adwanikar et al., 2007). It is likely that these LA-BLA inputs 
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carry affect related information which is then integrated into the direct nociceptive information 
received by the CeA (Neugebauer et al., 2004;Neugebauer, 2007). The CeA is the major output 
nucleus of the amygdala and sends reciprocal connections to a number of cortical, subcortical and 
brainstem nuclei (Neugebauer et al., 2004;LeDoux, 2000;Rizvi et al., 1991;Bourgeais et al., 2001). 
 
The amygdala is a highly plastic structure prone to physiological alterations following a number of 
behavioural, pharmacological and electrophysiological manipulations (Neugebauer et al., 
2004;Neugebauer and Li, 2003;Neugebauer et al., 1997;LeDoux, 2000). Such changes are also 
apparent in animal models of chronic pain and are suggestive of a phenotypic switch in the role of 
the amygdala in chronic pain states (Neugebauer, 2007;Neugebauer and Li, 2003;Ikeda et al., 
2007). The potential significance of amygdaloid plasticity in chronic pain states will be addressed 
in later chapters. 
 
CeA shares a strong connection with the hypothalamus. The ventromedial portion of the 
hypothalamus (VMH) has a central role in the generation of affective behaviours related to threat 
and has been shown to be involved in affective portion of the pain experience (Borszcz, 2006).  
 
Areas such as the dorsolateral prefrontal cortex appear to be important in controlling pain 
perception by dissociating affect from nociceptive input through the modulation of activity in 
affective pathways (Lorenz et al., 2003). The anterior cingulate cortex (ACC) is likely to play a 
central role in the feedback process within the ‘pain matrix’ through the integration of emotional, 
somatosensory, and cognitive inputs (Devinsky et al., 1995;Price, 2000). While in human imaging 
studies regression analysis has revealed the importance of activity in the prefrontal cortex (PFC) 
during the anticipation of pain and the consequent descending opioid inhibition originating in the 
PAG (Wager et al., 2004).  
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1.3 Neuropathic Pain: Clinical Prevalence and Treatment  
 
Neuropathic pain  is a common form of chronic pain defined as ‘pain arising as a direct 
consequence of a lesion or disease affecting the somatosensory system’ (Treede, 2007). This 
recent redefinition by a group of neurologists and pain experts clarifies neuropathic pain’s 
position as a separate pain syndrome from those arising from neuroplastic changes secondary to 
nociceptive input, as well as from chronic pain states of a inflammatory or musculoskeletal nature 
that may arise concomitantly to neurological disorders (Treede, 2007). 
 
Neuropathic pain is often difficult to treat, long lasting and debilitating in nature (Dworkin et al., 
2003;Dworkin et al., 2007;Rice and Hill, 2006;Finnerup et al., 2010). Complex positive and 
negative sensory symptoms are common in patients with neuropathic pain syndromes. Positive 
symptoms include persistent pain of a lancinating or burning nature which is often perceived 
alongside evoked pain which may take the form of hyperalgesia, heat/cold allodynia or 
mechanical allodynia (Woolf and Mannion, 1999;Jensen and Baron, 2003). In addition painful 
paroxysms, shooting attacks of pain, may be present (Jensen and Baron, 2003). Alongside painful 
symptoms negative symptoms such as sensory loss are commonly observed often in the same 
dermatome (anaesthesia dolorosa) and in some cases motor deficits may be present (Jensen and 
Baron, 2003;Smith et al., 2007). This apparently contradictory combination of positive and 
negative symptoms reflects one of the central driving forces in the development of peripheral 
neuropathic pain. Namely, the reduction of afferent input due to lesion or disease of the nervous 
system, resulting in negative symptoms, followed by regeneration and disinhibition or 
sensitisation, resulting in positive symptoms (Jensen and Baron, 2003).  
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A wide range of nervous system insults can result in neuropathic pain, major causes include 
metabolic disorders, therapeutic interventions (i.e. antiretroviral or cancer therapies), viral 
infection and traumatic injury (Table 1.3 A). Epidemiological data on the prevalence of 
neuropathic pain is still sparse (Bouhassira et al., 2008). However, a number of studies focusing 
on conditions known to be associated with neuropathic pain have been carried out (Daousi et al., 
2004;Davies et al., 2006;Osterberg et al., 2005;Jung et al., 2004;Siddall et al., 2003;Andersen et 
al., 1995;Caraceni and Portenoy, 1999;Schmader, 2002;Smyth et al., 2007). The current drive 
towards the creation of reliable, straightforward and reproducible diagnostic procedures is likely 
to lead to an increase in both the quality and quantity of epidemiological data (Bennett et al., 
2007). A recently published paper by Bouhassira and colleagues used the DN4 questionnaire, 
developed and validated in house, to investigate the prevalence of neuropathic pain in the general 
population of France (Bouhassira et al., 2008;Bouhassira et al., 2005).  The recorded prevalence 
of 6.9% (Bouhassira et al., 2008) is in line with a figure of 8% found using an alternate 
questionnaire, the S-LANSS, in three cities in the United Kingdom (Torrance et al., 2006). This 
compares to a prevalence of significant-severe chronic pain of 16.4% in the general population of 
the Grampian region of Scotland (Smith et al., 2001). Assuming that rates of chronic pain are 
comparable these findings suggest that pain of a neuropathic origin makes up a significant portion 
of chronic pain affecting the general proportion. The general utility of questionnaires in 
neuropathic pain diagnosis as well as the strengths and weaknesses of individual screening tools 
are discussed in detail in a recent review by Bennett and colleagues (Bennett et al., 2007).  
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Table 1.3 A: Common types of neuropathic pain.  
 
Peripheral Neuropathic Pain 
Acute and chronic inflammatory demyelinating polyradiculoneuropathy 
Alcoholic polyneuropathy 
Chemotherapy-induced polyneuropathy 
Complex regional pain syndrome type II 
Entrapment neuropathies (e.g. carpal tunnel syndrome) 
HIV sensory neuropathy 
Iatrogenic neurogenic neuralgias (e.g. postmastectomy pain or postthoracotomy pain) 
Idiopathic sensory neuropathy 
Nerve compression or infiltration by tumour 
Nutritional deficiency-related neuropathies 
Painful diabetic neuropathy 
Phantom limb pain 
Post-herpetic Neuralgia 
Post-radiation plexopathy 
Radiculopathy (cervical, thoracic or lumbosacral) 
Toxic exposure-related neuropathies 
Trigeminal neuralgia (Tic douloureux) 
Posttraumatic neuralgias 
 
Central Neuropathic Pain  
Compressive myelopathy from spinal stenosis 
HIV myelopathy 
Multiple sclerosis-related pain 
Parkinson’s disease related pain 
Post ischaemic myelopathy 
Post radiation myelopathy 
Post stroke pain 
Posttraumatic spinal cord injury pain 
Syringomyelia 
 
 
 
 
65 
 
Classes of agent used in the treatment of neuropathic pain are very disparate; these include 
tricyclic antidepressants, topical local anaesthetics, topical capsaicin, opioids and anticonvulsant 
drugs such as gabapentin. These treatments as well as recommended second and third-line 
therapies often display narrow therapeutic ranges and variable levels of efficacy both from patient 
to patient and condition to condition. Thus there is great scope for the improvement of current 
pharmacological therapies used to treat neuropathic pain (Dworkin et al., 2007;Rice and Hill, 
2006;Finnerup et al., 2010). Physicians should be aware of the impact that psychological co-
morbidities, such as anxiety and depression, which often accompany chronic neuropathic pain 
can have on patient quality of life and should discuss the utility of non-pharmacological therapies 
with patients. Further, the importance of careful explanation as to the nature of a patient’s pain 
and the logic behind a treatment strategy cannot be overstated (Dworkin et al., 2007).   
 
Since it may be possible to identify pain of neuropathic origin by the range of symptoms with 
which a patient presents, is it also possible to use these symptoms as a guide to the treatment 
which should be offered? There are inherent problems with this approach not least that pain is 
subjective and as such will be experienced and described differently from one individual to 
another. Pain questionnaires such as those described above should go some way to ameliorating 
this difficulty (Bennett et al., 2007). An approach based around combining symptoms and 
aetiology with specific pathological mechanisms may offer a route to increased pain relief and the 
development of more efficacious analgesic therapies (Woolf et al., 1998;Woolf and Decosterd, 
1999;Sindrup and Jensen, 1999;Finnerup et al., 2010;Jensen and Baron, 2003). However, this 
approach too is fraught with difficulties. A single symptom may be elicited by a number of 
underlying pain mechanisms. Similarly, a single mechanism may be responsible for a number of 
different symptoms (Woolf et al., 1998;Woolf and Decosterd, 1999;Jensen and Baron, 2003). 
Further, there are intrinsic difficulties in determining the mechanisms underlying neuropathic 
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pain, not least that techniques to directly evaluate pain mechanisms in patients are currently few 
and far between (Woolf and Decosterd, 1999). Despite these difficulties progress is being made 
in understanding forms of neuropathic pain from this standpoint. For example, three separate pain 
generating mechanisms have been identified in patients with post-herpetic neuralgia (PHN), 
namely abnormally sensitised nociceptors; small fibre deafferentation with large diameter 
afferent dysfunction and small fibre deafferentation with spontaneous activity. These three 
mechanisms result in distinct symptom profiles which can be identified through careful 
questioning of the patient and quantitative sensory testing (Fields et al., 1998). The use of 
symptom focused questionnaires, such as the Neuropathic Pain Symptom Inventory (NPSI) 
(Bouhassira et al., 2004), combined with quantitative sensory testing and direct examination of 
pathophysiology, such as the use of punch biopsies to investigate the extent of deafferentation 
(Fields et al., 1998), likely represents the first step in a much needed revision of the classification 
of patients with neuropathic pain (Fields et al., 1998;Woolf et al., 1998;Woolf and Decosterd, 
1999;Jensen and Baron, 2003). 
 
1.4 Pathophysiology of Neuropathic Pain 
 
Mechanisms of neuropathic pain are generally divided according to their locus within the nervous 
system, either central or peripheral, and can be further subdivided by the cell type primarily 
responsible (Table 1.4 A). Although all neuropathic pain arises from sensory dysfunction only a 
small percentage of insults to the somatosensory system result in chronic pain states. Why similar 
diseases and lesions result in neuropathic pain in some cases and not others remains unclear, 
however, recent results suggest that genetic factors may play a role (Tegeder et al., 2006;Tegeder 
et al., 2008). 
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As with inflammatory and acute pain the majority of neuropathic pain research has focused on 
sensory-discriminative aspects of nervous system function. However, the need for more 
integrative research investigating the pain experience as a whole is beginning to be recognised. 
The focus of many researchers is beginning to shift to changes in supraspinal nuclei involved in 
pain affect such as the amygdala and insula (Ikeda et al., 2007;Neugebauer et al., 2004;Coffeen et 
al., 2007;Viisanen and Pertovaara, 2007).  
 
Table 1.4 A: Over view of the pathophysiological changes important in the development of 
neuropathic pain. 
Pathophysiology Location 
Primary Cell 
Types 
References 
Collateral sprouting of 
primary afferents. 
CNS Neurons (Woolf et al., 1992) 
Glial Activation CNS and PNS 
Microglia, Schwann 
cells, Astrocytes, 
Satellite Cells. 
(Scholz and Woolf, 2007) 
Activation of immune 
cells 
CNS and PNS 
Macrophages, T-cells, 
Neutrophils. 
(Scholz and Woolf, 2007) 
Ectopic discharges PNS Neurons (Wall and Gutnick, 1974) 
Ephaptic conduction PNS Neurons 
(Amir and Devor, 1996;Utzschneider et al., 
1992) 
Sprouting of 
sympathetic fibres into 
the dorsal root ganglia  
PNS Neurons (McLachlan et al., 1993) 
Central sensitization CNS Neurons (Laird and Bennett, 1993) 
Nociceptor 
Sensitization 
PNS Neurons (Schafers et al., 2003;Shim et al., 2005) 
Cortical 
Reorganisation 
CNS Neurons (Maihofner et al., 2003) 
Reduced inhibitory 
activity. 
CNS Neurons 
(Castro-Lopes et al., 1995;Castro-Lopes et al., 
1993) 
Spinal Reorganisation CNS Neurons (Wang et al., 2007) 
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1.4.1 Peripheral Mechanisms: 
 
Due to the relative lack of protection afforded to nervous tissue compared to the CNS, as well as 
the potential for aberrant regeneration following damage, insults to the peripheral sensory system 
are responsible for the majority of cases of neuropathic pain. Peripheral mechanisms of 
neuropathic pain result in a change in the nature of the information received by the spinal cord. 
Functional changes in both nociceptive and non-nociceptive afferents may contribute to 
alterations in the sensory system resulting in neuropathic pain. There are a myriad of different 
mechanisms by which primary afferent input can be altered. In some cases these changes in 
function are enough in themselves to result in altered pain sensation, while in others they 
contribute to plasticity in the central nervous system. A good place to start in the examination of 
peripheral mechanisms is the nature of sensations reported by patients with neuropathic pain 
syndromes. Sensory loss is commonly reported alongside pain of an ongoing or paroxysmal 
nature. In addition painful reactions to sensory input characterised by hyperalgesia and allodynia 
are observed. The varied and somewhat contradictory nature of these symptoms begins to 
illustrate the complexity of nervous system changes that contribute to neuropathic pain. Although 
it goes without saying that the contribution of the central nervous system to neuropathic pain 
must not be disregarded, considering these sensory phenomena purely from the point of view of 
the peripheral sensory system would suggest the presence of a number of phenomena: (1) the 
destruction of sensory neurons or their peripheral terminals (sensory loss), (2) hyperactivity of 
nociceptive neurons (hyperalgesia/paroxysmal pain), (3) altered functioning of non-nociceptive 
sensory neurons (allodynia). The past two decades of intensive study into peripheral mechanisms 
of neuropathic pain, which will be briefly summarised in the following subsection, have provided 
evidence of physiological changes fitting into all these categories.  
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Any peripheral nerve fibre subject to an insult will contain a heterogeneous population of primary 
afferent neurons both in respect of the sensory information they carry and the extent to which 
they have been directly affected by the insult. A logical first step in investigating peripheral 
neuropathic pain is to study the physiology of damaged neurons due to the probability that the 
nature of their input to the spinal cord has been altered. In the L5 spinal nerve ligation model of 
peripheral mononeuropathy blockade of neuronal function by the topical application tetrodotoxin 
(TTX) or local anaesthetics to the L5 dorsal root ganglion (DRG) attenuated hind-limb 
hypersensitivity (Lyu et al., 2000;Sukhotinsky et al., 2004;Campbell and Meyer, 2006) 
suggesting a role for damaged nociceptors in maintaining neuropathic pain.  
 
Following axotomy the section of the neuron distal to the injury degrades while the proximal 
portion is supported by the cell body. Areas of demyelination appear close to the site of injury 
and in some cases at the DRG (Devor, 1991). The distal stump of the supported axon attempts to 
regenerate. However, due to lack of appropriate guidance from Schwann cells, swellings known 
as axonal ‘endbulbs’ often form and may clump together to form masses known as neuromas 
(Devor, 1991;Campbell and Meyer, 2006). Schwann cells activated by injury are also responsible 
for producing chemical mediators that both promote and inhibit hyperalgesia, such as tumour 
necrosis factor-α (TNFα) and erythropoietin (Campana, 2007). Another consequence of the 
continuing support of the transected axon by the DRG cell body is the build up of transport 
vesicles containing ion channels at the distal end of the axon. In some cases these transport 
vesicles will insert into the plasma membrane resulting in build up of Na channels in neuromas 
and demyelinated sections of the axon (Devor, 2006). Na channels have an important role in the 
initiation and propagation of action potentials, thus, these areas of Na channel build up effectively 
act like pathologically active nodes of Ranvier. The TTX-sensitive channel Nav 1.3, which is 
normally present at very low levels, is also up-regulated in injured DRG neurons (Black et al., 
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1999;Campbell and Meyer, 2006) as is the beta2 subunit which regulates assembly gating and 
cell surface expression of TTX-sensitive channels (Lopez-Santiago et al., 2006;Campbell and 
Meyer, 2006;Pertin et al., 2005). Development of hind limb hypersensitivity following spared 
nerve injury is attenuated in beta2 null mice further underlining the important role of Nav channel 
expression in neuropathic pain (Pertin et al., 2005). Spontaneous activity in injured neurons as 
well as ectopic activity originating in the neuroma has been reported, likely as a result of these 
areas of Na channel build up (Blumberg and Janig, 1984;Devor, 2006;Campbell and Meyer, 
2006).  
 
Surprisingly, injury induced spontaneous activity appears to be confined to A and not C-fibres 
and is often associated with areas of demyelination (Boucher et al., 2000;Liu et al., 2000;Devor, 
1991). Evidence suggests that A fibres may begin to express SP, a neurotransmitter normally 
found exclusively in nociceptive neurons, following axotomy (Noguchi et al., 1994). This 
phenotypic switch combined with spontaneous activity may result in the activation of nociceptive 
specific projection neurons which express the NK-1 receptor, and thus contribute to neuropathic 
pain. However, conclusive evidence of SP release from the terminals of large myelinated primary 
afferents has yet to be presented (Allen et al., 1999;Malcangio et al., 2000). Alternatively these 
spontaneously active large diameter fibres may represent the myelinated nociceptors mentioned 
previously allowing them to directly influence the dorsal horn nociceptive system (Djouhri and 
Lawson, 2004;Treede et al., 1998). However, as will be discussed later it is likely that plasticity 
in the spinal cord plays a role in the interpretation of A fibre input as painful. 
 
As well as being spontaneously active nerve cell neuromas also respond to a number of sensory 
inputs including mechanical, thermal and chemical stimuli (Blumberg and Janig, 1984;Devor, 
2006;Campbell and Meyer, 2006). Cross excitation exists driven both by the general excitability 
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of ectopic discharge sites and the disruption of neuronal isolation caused by degradation of glial 
ensheathment (Devor, 1991). So called ‘ephaptic crosstalk’ occurs via direct electrical coupling 
of axons such that activity in another sensory or motor fibre results in the concurrent firing of a 
neighbouring neuron (Rasminsky, 1980;Seltzer and Devor, 1979;Devor, 1991). Activity in 
adjacent  axons can also result in action potential generation in a non-synchronised manner 
termed ‘crossed after discharge’ (Devor, 1991). 
 
The majority of insults resulting in neuropathic pain will not result in the transection of all the 
axons in a nerve fibre. This leaves open the possibility that intact neurons may be playing a part 
in driving neuropathic pain. This hypothesis is supported by the clinical efficacy of topical 
lidocaine patches applied to the painful dermatome in conditions such as PHN (Jensen and 
Finnerup, 2007). Spontaneous activity has been reported in uninjured small fibre unmyelinated 
afferents, likely representing nociceptors, in rodent and primate models of peripheral neuropathic 
pain (Ali et al., 1999;Djouhri et al., 2006;Wu et al., 2001). Intact afferents of a myelinated and 
unmyelinated nature show spontaneous activity as demonstrated by investigating activity in the 
L4 DRG neurons in the L5 SNL model (Wu et al., 2002;Boucher et al., 2000).  
 
Following an insult to the somatosensory system afferent fibres may become sensitive to 
catecholeamines resulting in crosstalk with the sympathetic nervous system (Birklein, 2005). The 
coupling of the sympathetic and sensory system may result in so called sympathetically 
maintained pain (SMP). SMP is thought to be a major factor in Complex Regional Pain 
Syndrome which can in some cases be relieved by sympathetic blockade (Campbell and Meyer, 
2006;Gibbs et al., 2008). A study investigating adrenergic sensitivity of neurons in a primate 
model of neuropathic pain suggests that this form of sensitisation occurs primarily in intact 
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nociceptors (Ali et al., 1999). However, results from a rat study suggest that a similar 
sensitisation process also occurs in damaged neurons (Chen et al., 1996). 
 
Sensitisation to sensory inputs which may contribute to hyperalgesia has been reported (Shim et 
al., 2005). Up regulation of RNA for the heat transducing channel TRPV1, which may account 
for increased sensitivity to thermal stimuli, has been reported in the cell bodies of uninjured 
axons in a model of partial nerve injury (Hudson et al., 2001). The level of NGF, which regulates 
TRPV1 expression (Xing et al., 2009), is increased in the dermatome of intact L4 neurones in the 
L5 SNL model and may drive increased TRVP1 expression (Campbell and Meyer, 2006). A 
similar sensitisation mechanism may be responsible for the increased cold sensitivity of L4 DRG 
neurons in the L5 SNL model with the TRPA1 channel responsible in this case (Katsura et al., 
2006;Diogenes et al., 2007).   
 
The levels of another growth factor, brain derived neurotrophic factor (BDNF), are also increased 
in the L4 DRG following injury to the L5 spinal nerve and may contribute to neuropathic pain as 
indicated by a decrease in thermal hypersensitivity following intrathecal application of an anti-
BDNF antibody (Fukuoka et al., 2001). Other factors related to nociception shown to be up-
regulated in uninjured afferents include CGRP and P2X3 (Fukuoka et al., 1998;Tsuzuki et al., 
2001). Intact afferents have also been show to develop increased sensitivity to TNFα which is 
known to be released by activated Schwann cells following injury (Schafers et al., 2003;Campana, 
2007). 
 
The chemical environment of a nociceptor affects its function. Under conditions of tissue injury a 
large number of inflammatory agents are released resulting in a state of hypersensitivity local to 
the wound. Some features of neuropathic pain (i.e. hyperalgesia and allodynia) resemble a 
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prolonged pathological manifestation of inflammation. Following axotomy denervated Schwann 
cells attract macrophages by releasing the pro-inflammatory cytokine monocyte chemoattractant  
protein-1 (MCP-1) (Tofaris et al., 2002). Mice lacking the MCP-1 receptor CCR2 fail to develop 
mechanical hyperalgesia after partial sciatic nerve ligation indicating a role for inflammatory 
mediators in the development in  neuropathic pain (Abbadie et al., 2003). Genetic manipulations 
leading to a decrease in the activity of the inflammatory mediator IL-1β have been demonstrated 
to reduce nerve injury induced hypersensitivity most likely due a reduction in ectopic activity 
(Wolf et al., 2006). Nerve injury also leads to activation of T-cells the absence of which 
attenuates hyperalgesia (Moalem et al., 2004). The increase in TNFα sensitivity displayed by 
intact injury associated neurons has already been mentioned. Sequestering or inhibition of this 
pro-inflammatory cytokine previous to induction of a peripheral neuropathy attenuated 
hypersensitivity although it has no effect once nerve damage is established (Sommer et al., 
2001;Schafers et al., 2003). Inflammatory mechanisms of neuropathic pain are investigated in 
detail by Moalem and Tracey in their 2006 review (Moalem and Tracey, 2006). 
 
1.4.2 Spinal Mechanisms: 
 
Spinal mechanisms of neuropathic pain range from increased activity of projection neurons and 
decreased inhibitory tone to structural changes in afferent input. In all cases, however, they result 
in a change in the nature or intensity of pain related information reaching supraspinal centres 
where the perception of pain is manifest. In the following subsection some of the major changes 
to spinal nociceptive processing will be summarised. 
 
One of the most studied and best understood spinal mechanisms of neuropathic pain is central 
sensitisation a process through which spinal neurons exhibit an increased reaction to nociceptive 
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input or misinterpret non-nociceptive input. As previously stated neuropathic pain shares some 
similarities with inflammatory pain; central sensitisation is a case in point, in that inflammatory 
secondary hyperalgesia relies upon the sensitisation of spinal neurons. Inflammatory secondary 
hyperalgesia is partially maintained by primary afferent input and will rapidly diminish following 
peripheral blockade (LaMotte et al., 1991). A similar reliance on ongoing input may be required 
for the maintenance of neuropathy related central sensitisation (Campbell and Meyer, 2006) 
However, as detailed above the multifarious sources of spontaneous activity make this difficult to 
confirm.  
 
Sensitisation of spinal neurons may be maintained by the same group of neurons that result in 
their abnormal firing, so called homosynaptic sensitisation (Campbell and Meyer, 2006). One 
example of homosynaptic sensitisation is “wind-up” a short term phenomenon caused by low 
frequency input from intact nociceptors (Ji et al., 2003). In the case of heterosynaptic 
mechanisms one set of afferents condition the spinal neuron while a separate set activate it 
(Campbell and Meyer, 2006). In this case conditioning by nociceptive input may prime spinal 
neurons leading to reactivity upon non-nociceptive Aβ input, revealing a possible mechanism for 
allodynia (Simone et al., 1991). Taking into account the abnormal firing patterns of injured Aβ 
afferents such heterosynaptic interactions also provide a possible explanation for some of the 
spontaneous pain events, such as painful paroxysms, evident in neuropathic pain syndromes 
(Truini et al., 2009). Evidence of putative heterosynaptic sensitisation has been demonstrated in 
neuropathic pain associated with a number of pathological syndromes including traumatic nerve 
injury and carpel tunnel syndrome (Campbell et al., 1988;Ji et al., 2003;Truini et al., 2009). 
 
Increased excitatory transmitter release from primary afferent fibres is one important mechanism 
by which central sensitisation may occur. Neurotransmitter release from nerve terminals is 
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initiated following Ca2+ influx through voltage gated Ca2+ channels. The alpha-2-delta subunit of 
these channels has been shown to be up-regulated following nerve injury (Li et al., 2004). Indeed 
the blockade of this channel subunit is the likely mechanism of therapeutic action for gabapentin 
in neuropathic pain (Bian et al., 2006;Freynhagen et al., 2005). Another nerve injury induced 
change which may result in increased excitatory transmitter release is a reduction in the 
expression of inhibitory presynaptic µ-opioid receptors (Kohno et al., 2005). As previously 
mention Aβ fibres expressing SP may be contributing to increased excitatory transmitter release 
(Noguchi et al., 1994). 
 
Postsynaptic strengthening events such as increased trafficking of AMPA receptors to the cell 
surface may occur following nerve injury, indeed increased expression of AMPA receptors has 
been reported in the superficial dorsal horn following L5 SNL (Harris et al., 1996). Up-regulation 
of dorsal horn AMPA and NMDA receptors has also been reported in the dorsal horn in a rat 
model of diabetes (Tomiyama et al., 2005). Ca2+ entry through NMDA receptors, as well as entry 
through GluR2 negative AMPA receptors, may underlie dorsal horn long term potentiation (Gu, 
1996; Ji et al., 2003). NMDA currents are likely to have a key role in central sensitisation as 
demonstrated by the abolition of secondary hyperalgesia to formalin in a conditional NR-1 
knockout (South et al., 2003). Further, both AMPA and NMDA antagonists attenuate nerve 
injury induced hypersensitivity in a rat model of neuropathic pain (Yoshimura and Yonehara, 
2006). 
 
Decreased inhibitory tone in the dorsal horn can also contribute to central sensitisation by making 
spinal neurons more likely to fire. The decreased expression of presynaptic µ-opioid receptors 
following nerve injury mentioned previously is also mirrored on postsynaptic cells (Kohno et al., 
2005). Nerve injury induced changes in potassium chloride transporter KCC2 expression may 
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lead to a phenotypic switch in the activity of GABA receptors in lamina I of the dorsal horn. The 
reduction in KCC2 activity results in a shift in the anion gradient resulting in activation of GABA 
receptors having an excitatory rather than inhibitory effect. Indeed local blockage or knockdown 
of KCC2 in lamina I results in neuropathic pain-like hypersensitivity in intact rats (Coull et al., 
2003). A more fundamental loss of inhibitory tone through nerve injury induced apoptosis of 
inhibitory interneurons has been reported (Moore et al., 2002). Blockade of this process by 
inhibition of caspase activity has been shown to attenuate neuropathy-related hypersensitivity 
(Scholz, 2005). The possibility that a spinal cell death related mechanism contributes to 
neuropathic pain has huge clinical significance as it implies that blockade of peripheral input will 
not be sufficient to reduced spinal sensitisation. Thus, the efficacy of purely peripheral therapies 
is brought into question (Campbell and Meyer, 2006).  
 
As previously mentioned, processing of nociceptive information in the spinal cord is influenced 
by modulatory brain stem neurons which project to the spinal cord. These neurons have both 
facilitatory and inhibitory effects on dorsal horn activity. It may be that chronic pain is in part 
driven by a shift in balance towards descending facilitation caused by persistent nociceptive input 
(Ren and Dubner, 2002). The RVM, with its populations of nociceptive responsive ON and OFF 
cells, has been implicated in the maintenance of neuropathic pain. Both anaesthetic blockade of 
the RVM and specific ablation of µ-opioid positive cells in this area attenuates nerve injury 
induced hypersensitivity (Burgess et al., 2002;Porreca et al., 2001) . There is strong evidence that 
this descending facilitatory effect is dependent on the serotonergic modulation of primary afferent 
inputs via presynaptic 5-HT3 receptors (Suzuki et al., 2004).  
 
As well as the neuronal mechanisms detailed above it has recently become clear that glial 
interactions within the spinal cord are important for the development of neuropathic pain. One 
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particularly important cell type are the spinal microglia (Scholz and Woolf, 2007;Tsuda et al., 
2005). In their so called quiescent state microglia constantly monitor the extracellular 
environment,  reacting to injury by altering their cell structure into a macrophage-like phenotype 
and releasing various inflammatory mediators (Tsuda et al., 2005). Following various forms of 
peripheral nerve insult microglia become activated in a large area of spinal cord surrounding the 
central terminals of injured afferents (Scholz and Woolf, 2007;Tsuda et al., 2005). Blockade of 
microglial activation using the selective inhibitor minocycline has been shown to attenuate 
hypersensitivity in rat models of neuropathic pain (Ledeboer, 2005;Raghavendra et al., 2003). 
Various routes by which microglia may affect pain sensitivity have been suggested including 
through the release of chemical mediators which alter neuronal function, involvement in neuronal 
cell death, and phagocytosis (Tsuda et al., 2005). Blockade of the ATP sensitive microglial 
receptor P2X4 attenuates neuropathic pain. Perhaps one of the strongest pieces of evidence for a 
key role of activated microglia in neuropathic pain is the induction of a neuropathic pain like 
phenotype in normal mice following the intrathecal injection of  P2X4 activated microglia (Tsuda, 
2003). 
 
1.4.3 Supraspinal Mechanisms: 
 
The recent increase in the number of imaging studies in the field of pain research has lead to 
further understanding of supraspinal mechanisms of pain processing. When studying the putative 
supraspinal pathologies concomitant with neuropathic pain syndromes a number of difficulties 
and confounds exist. The heterogeneity of symptoms, sensory changes, pharmacological 
therapies and disease aetiologies need to be taken into account during study design. Technical 
difficulties also exist, for example the difficulty in obtaining a stable baseline for fMRI studies 
makes its use in the measurement of spontaneous pain problematic (Seifert and Maihofner, 2009). 
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Nevertheless imaging studies are steadily adding to the understanding of the supraspinal 
processing of neuropathic pain. 
 
Positron emission tomography (PET) studies of patients with spontaneous pain have revealed a 
decrease in regional cerebral blood flow (rCBF) in the thalamus contralateral to their sight of 
injury (Hsieh et al., 1995). As previously stated this area is one of the major inputs of ascending 
nociceptive activity. This somewhat surprising result may be explained by the neurodegeneration 
triggered by pathological levels of excitation, inhibition of excessive inputs or a possible 
decoupling of CBF from neuronal activity (Seifert and Maihofner, 2009;Iadarola et al., 1995). A 
neurosurgical study using single unit recording techniques demonstrated abnormal activity and 
functional reorganisation in the ventral thalamus of a patient with below level spinal injury-
associated pain (Lenz et al., 1987). Abnormal activity and functional reorganisation in the 
thalamus has also been demonstrated in rat models of neuropathy (Guilbaud et al., 
1990;Bruggemann et al., 2001).   
 
Blood flow in the amygdala, as measured by fMRI, was increased during incidents of 
spontaneous pain in a study on patients with PHN. Amygdaloid activity was reduced following 2 
weeks, but not 6 hours, of treatment with lidocaine patches. A time course which agreed with the 
reductions in pain scores collected using the Neuropathic Pain Inventory (Geha et al., 2007). 
Animal studies have revealed numerous physiological changes in the amygdala concomitant to 
peripheral nerve injury. NMDA-independent synaptic strengthening has been reported in CeA in 
a rat model of neuropathic pain (Ikeda et al., 2007). Alterations in opioidergic function within the 
amygdala alongside anxiety-like behaviour have been reported in mice following partial sciatic 
nerve ligation (Narita et al., 2006a). Direct injection of the antidepressant/analgesic paroxetine 
into the basolateral amygdala reversed neuropathy related anxiety-like behaviour in a rat version 
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of the same neuropathic pain model (Matsuzawa-Yanagida et al., 2008). The administration of 
the GABA-A agonist muscimol into the amygdala reverses neuropathy induced mechanical 
hypersensitivity in rats. It also altered neuropathy related escape-avoidance behaviour, thought to 
reflect the affective component of pain. However, similar results obtained with the antagonist 
bicuculline in this test confuse the picture of how GABA-A receptor activity in the amygdala 
relates to the affective aspects of neuropathic pain (Pedersen et al., 2007). In a recent study using 
rats, the spared nerve injury model was associated with increased depression-like behaviour 
alongside increased amygdala volume due to an increase in cell proliferation (Goncalves et al., 
2008). Results from the above human and animal studies hint at a highly complex series of 
changes within the amygdala following peripheral nerve injury which may be important in the 
affective aspects of neuropathic pain. 
 
Patients with ongoing pain also showed increased rCBF to the right posterior ACC, an area 
proposed to be involved in the affective aspects of pain. This putative increase in neuronal 
activity occurred regardless of the location of the peripheral nerve insult (Hsieh et al., 1995). 
Three studies investigating evoked pain in neuropathic pain conditions showed no activation in 
the ACC (Witting et al., 2006;Peyron et al., 1998;Ducreux et al., 2006). It has been suggested that 
the lack of activation could be due to methodological problems (Seifert and Maihofner, 2009). 
This possibility is supported by other studies investigating mechanical allodynia in neuropathic 
pain which show increased activity in the ACC (Schweinhardt et al., 2006;Becerra et al., 
2006;Peyron et al., 2004). As well as by the light brush induced activation of the LTP related 
marker Erk found in the ACC in a rat model of single digit amputation (Wei and Zhuo, 2008). 
Amplified pre and postsynaptic excitatory transmission in an ACC slice preparation following 
peripheral nerve injury adds strength to the putative existence of neuropathy induced LTP in this 
area (Xu et al., 2008). Further, the serotonin-noradrenaline reuptake inhibitor milnacipran, which 
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attenuated hypersensitivity in rats with chronic constriction injury, also reduced cFOS expression 
in the ACC (Takeda et al., 2009).  
 
The insula has been implicated in both the sensory discriminative and affective motivational 
aspects of pain. rCBF in the insula was increased bilaterally in a PET study of patients with 
ongoing neuropathic pain (Hsieh et al., 1995). Imaging studies have also implicated the insula in 
dynamic allodynia (Witting et al., 2006;Peyron et al., 1998;Ducreux et al., 2006;Schweinhardt et 
al., 2006;Becerra et al., 2006) as well as cold allodynia/hyperalgesia (Becerra et al., 
2006;Ducreux et al., 2006). Altered processing of sensory information in the insula of rats with 
nerve injuries has also been demonstrated. Following chronic constriction injury to the 
infraorbital nerve light stoking of the relevant dermatome results in upregulation of pErk-1/2 in 
neuronal cells of the insula (Alvarez et al., 2009). 
 
Imaging studies have implicated the PFC in ongoing pain of a neuropathic origin (Hsieh et al., 
1995) as well as in cold hyperalgesia and mechanical allodynia (Ducreux et al., 2006;Becerra et 
al., 2006). PFC hyperactivity has also been demonstrated in patients with sympathetically 
maintained pain (Apkarian et al., 2001). As previously stated the PFC is involved in affective 
aspects of pain processing. Anatomical reorganisation and changes in NMDA related excitatory 
synaptic currents in the PFC follow spared nerve injury in rats (Metz et al., 2009). The role of 
NMDA in neuropathy induced changes in the PFC is further underlined by the reversal of spared 
nerve injury induced hypersensitivity following direct infusion of the NMDA partial antagonist 
D-cycloserine into the area (Millecamps et al., 2007). It has been suggested that chronic pain 
results in decreased PFC volume (Apkarian et al., 2004). Increased synaptic strength combined 
with higher levels of activity may offer a mechanism for cell loss in this area due to excitotoxicity.  
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1.5 Affective Co-morbidities in Neuropathic Pain 
 
As detailed above, the supraspinal pain matrix contains a number of nuclei involved in emotional 
and cognitive function and evidence is emerging of plasticity in these structures associated with 
chronic pain conditions (Ikeda et al., 2007;Metz et al., 2009). As such it is unsurprising that 
patients with chronic painful conditions suffer from a severe affective burden. A recent fMRI 
study revealed differences in the activity patterns caused by acute and chronic pain in emotional 
centres of the brain. Activation of the medial prefrontal cortex (mPFC), an area known to be 
important in pain affect, increased in line with the intensity of spontaneous chronic back pain 
suggesting a strong link between spontaneous chronic back pain and negative affect. However, no 
such correlation was seen during the application of acute noxious thermal stimuli in the same 
subjects (Baliki et al., 2006).  
 
The importance of controlling affective aspects of pain in order to improve the well being of 
chronic pain patients is underlined by the inclusion of  emotional functioning as one of the 
IMMPACT core recommended outcome measures in clinical trials of analgesic drugs (Dworkin 
et al., 2005).  The burden of negative affect associated with persistent pain combined with the 
disruption of normal work and social activities often associated with ongoing medical problems 
can have a profound effect on a patient’s quality of life (Craig, 2006). Patients dealing with 
chronic pain alongside co-morbid psychiatric conditions such as depression experience greater 
interference of pain, greater pain intensity and more maladaptive coping strategies than those 
without co-morbid conditions (Herr et al., 1993;Weickgenant et al., 1993). In a comparative study 
pain clinic patients with lower back pain or PHN showed similar levels of cognitive and mood 
effects suggesting a similar burden due to pain chronicity despite differing aetiologies (Daniel et 
al., 2008). PHN patients also had increased symptoms of major depression, somatisation disorder 
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and a trend towards increased generalised anxiety disorder when compared with peripheral 
vestibular disease a condition resulting in vertigo, a chronic adverse but non-painful symptom 
(Clark et al., 2000). This suggests that chronic pain differs in its affective burden compared to 
other chronic adverse conditions, a fact perhaps not surprising given the nature of the nuclei 
involved in the pain matrix.  
 
Although the impact of chronic neuropathic pain on emotional functioning is a well recognised 
phenomenon it still represents a neglected area of research. An investigation into the impact of 
neuropathic pain due to a nerve or root lesion on quality of life revealed a negative effect on all 
dimensions measured (Fig. 1.5 A) and similar results were obtained in a Spanish study into health 
based quality of life in patients with neuropathic pain or mixed pain syndromes (Meyer-Rosberg 
et al., 2001;Galvez et al., 2007). Meyer-Rosberg and colleagues showed a high incidence of sleep 
disturbance in neuropathic pain sufferers, this result is backed up by a later study into sleep 
problems which also demonstrated a link between sleep disturbance, pain intensity, anxiety and 
depression (Rejas et al., 2007;Meyer-Rosberg et al., 2001;Gore et al., 2005). A number of studies 
have also highlighted the detrimental effect that chronic neuropathic pain has on patient’s ability 
to work (Tolle et al., 2006;Gore et al., 2006;McDermott et al., 2006).  The presence of affective 
co-morbidities also increases the burden on the healthcare system, in a cross-sectional study 
investigating painful diabetic neuropathy 43% of patients reported using prescription drugs to 
combat affective co-morbidities, such as anxiety, sleep disturbances or depression, in addition to 
analgesic therapies (Tolle et al., 2006). Investigations into health related quality of life have 
demonstrated that the measurement of affective dysfunction is sensitive to analgesic therapies and 
can be used to effectively discriminate between efficacious and non-efficacious interventions 
(Rejas et al., 2007;Otto et al., 2007;Deshpande et al., 2006). The above data indicate that the 
affective burden of neuropathic pain is of equal importance from a patient well being perspective 
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to the sensory/discriminative aspects and needs to be considered in future laboratory based 
studies as well as in the clinic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 A: Behavioural co-morbidities of a moderate to very severe nature reported by a 
group of 126 patients suffering from neuropathic pain due to a peripheral nerve or root 
lesion. Adapted from (Meyer-Rosberg et al., 2001) 
 
1.6 Animal Models of Neuropathic Pain  
 
1.6.1 Early In Vivo Pain Models: 
 
In the following section the development and utility of animal models of neuropathic pain will be 
discussed. Early animal experiments investigating pain perception and physiology focussed on 
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acute pain and utilised the application of noxious stimuli, usually to extremities, commonly with 
limb withdrawal as the outcome measure. Common acute pain tests include the tail flick, 
Hargreaves radiant heat test (Galbraith et al., 1993), hot plate and von Frey paradigms. The 
combination of these tests with physiological and pharmacological interventions and assays lead 
to many early breakthroughs in pain research and a number remain in use as assays of 
hypersensitivity in animal models of chronic pain and in the phenotyping of knockout mice 
(Mogil, 2009;Mogil et al., 2006;Le Bars et al., 2001).  
 
The next step for in vivo pain research was the development of models of inflammatory pain. 
These commonly involve the intradermal injection of substances such as formalin or Freund’s 
adjuvant into the hind limb. Following injection behavioural responses such as limb placement 
and licking/biting behaviours are observed and scored (Le Bars et al., 2001).  
 
1.6.2 In vivo Models of Neuropathic Pain:  
 
A number of models of traumatic peripheral neuropathy were developed in the late 80’s and early 
90’s. However, the first model replicating a form of neuropathic pain was developed 10 years 
earlier by Pat Wall (Wall et al., 1979). Wall and colleagues used various insults, including 
transection, ligation and crush injuries, to the sciatic and saphenous nerves, which innervate the 
hind paw, of both rats and mice. These insults led to varying degrees of hind paw mutilation 
(autotomy) which was suggested to be a result of pain coming from the denervated area, similar 
to the condition of anaesthesia dolorosa seen in some patients with neuropathic pain. There are 
ethical concerns surrounding the use of autotomy as well as disagreement as to whether it truly 
results from pain in the denervated limb, as will be discussed in detail in later sections (Rodin and 
Kruger, 1984;Kauppila, 1998;Mogil, 2009). As a result the majority of modern investigations into 
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neuropathic pain use models of partial nerve injury which are less likely to cause self mutilation 
and are also a more common cause of neuropathic pain than complete transection (Mogil, 2009).  
 
The first raft of these partial damage models used surgical interventions to cause nerve trauma. 
These included loose ligation of the nerve, cutting, partial tight ligation, spinal nerve damage, 
ischemia and freezing (Bennett and Xie, 1988;DeLeo et al., 1994;Kim and Chung, 1992;Seltzer 
et al., 1990;Seltzer, 1995). A huge amount has been learnt about putative mechanisms of 
neuropathic pain from these surgical models and they have been shown to have good reverse 
validity with current clinically efficacious drugs often reversing the hypersensitivity induced by 
nerve damage (Mogil, 2009;Rice et al., 2008;Whiteside et al., 2008). However, patients with pain 
resulting from peripheral nerve trauma make up a relatively small proportion of the neuropathic 
pain demographic (Hall et al., 2006;Attal et al., 2008). Traumatic models have frequently been 
shown to be lacking in forward validity in the development of new analgesic therapies (Mogil, 
2009). This may be partially due to the fact that according to a recent meta-analysis of 
randomised clinical trials (RCT) only 19 out of 174 were conducted in patients with peripheral 
nerve injuries (Finnerup et al., 2010;Finnerup et al., 2005). 
 
With these facts in mind a drive toward more clinically relevant models of painful neuropathy has 
been gathering strength. One such example is the rat model of varicella zoster  associated 
neuropathy which attempts to replicate features of post herpetic neuralgia (PHN). PHN is a 
common cause of neuropathic pain and is likely to increase in prevalence alongside an aging 
population (Fleetwood-Walker et al., 1999;Rowbotham and Fields, 1996;Hasnie et al., 
2007a;Hempenstall et al., 2005). The rodent latent varicella zoster virus infection model shares a 
number of the features seen in PHN offering an opportunity to better understand the 
pathophysiology of PHN as well as screen for clinically efficacious drugs in a manner more 
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closely allied to human clinical trials (Hempenstall et al., 2005;Hasnie et al., 2007a;Fleetwood-
Walker et al., 1999;Garry et al., 2005). A number of similar models mimicking other neuropathic 
pain related diseases, such as HIV and diabetes, exist allowing the elucidation of putative disease 
specific mechanisms and therapies in order to improve future patient well being (Wallace et al., 
2007a;Wallace et al., 2007b;Tomiyama et al., 2005). 
 
1.7 Behavioural Outcome Measures in Rodent Models of Neuropathic Pain 
 
1.7.1 Introduction: 
 
Alongside the refinement of animal models of neuropathic pain, the improvement of outcome 
measures for the assessment of putative chronic pain represents an area with great potential for 
increasing the effectiveness of preclinical drug screens. It is common for studies into neuropathic 
pain to use hypersensitivity of reflex withdrawal of the hind limb, evoked by various stimuli, as 
the primary, if not soul, outcome measure (Mogil and Crager, 2004). These reflex withdrawal 
outcome measures are thought to represent indices of allodynia and hyperalgesia (Woolf and 
Mannion, 1999;Jensen and Baron, 2003;Mogil and Crager, 2004;Mogil, 2009). However, such 
stimulus evoked pain in humans may not correlate with analgesic efficacy and drugs tend to 
target ongoing and spontaneous pain (Eisenach et al., 2003;Dworkin et al., 2005). If there is a 
disparity between what clinicians and basic scientists are measuring it is, perhaps, unsurprising 
that compounds with promising analgesic effects in the laboratory are proving ineffective when 
moved into the clinic (An et al., 1998;Rice, 2010;Rice et al., 2008;Mogil, 2009;Hill, 2000). 
Further, as neuropathic pain has a multifaceted impact on patient quality of life the expansion in 
outcome measures in an attempt to measure this global effect can only be sensible development 
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(Rice, 2010;Rice et al., 2008;Mogil and Crager, 2004;Gore et al., 2006;McDermott et al., 
2006;Meyer-Rosberg et al., 2001). 
 
1.7.2 Spontaneous Pain Outcome Measures: 
  
Attempts to measure spontaneous or ongoing pain in animal models of neuropathic pain have 
been present within the literature for as long as such models have existed (Wall et al., 1979). 
Indeed, autotomy, the self mutilation of a denervated paw, which was taken to be an indicator of 
anaesthesia dolorosa, was the major outcome measure used in many early studies of neuropathic 
pain (Wall et al, 1979; Abad et al., 1989; Coderre et al., 1984; Russell et al., 1986). Excessive 
grooming is extensively used as a measure of pain in models of spinal cord injury-related 
neuropathic pain and is thought to be driven by similar mechanisms to autotomy (Brewer et al., 
1998; Yezierski et al., 1998; Yezierski et al., 2004; Yu et al., 2005; Abraham et al., 2001). The 
behaviour shares some features with human spinal cord injury related pain in that it has delayed 
onset and dermatomal distribution similar to the site of injury (Yezierski et al., 1998). A great 
deal of controversy exists as to whether autotomy does in fact represent a sign of chronic pain or 
is merely a rodent response to a denervated limb (Rodin and Kruger, 1984;Kauppila, 1998). It 
may be argued, due to the animal welfare implications of an outcome measure based on self 
mutilation, that it is a moot point as to whether this behaviour is related to pain or not. 
Nevertheless, despite the existence of many animal models which cause hypersensitivity without 
concurrent autotomy this outcome measure is still used in a surprising number of recent studies 
(Marcol et al., 2007; Devor et al., 2007; Coffeen et al., 2008; Persson et al., 2009; Zhang et al, 
2008; Kotulska et al., 2006; Pellicer et al., 2007; Tyner et al, 2007; Wolf et al., 2006).  
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Other, more subtle, attempts have been made at measuring spontaneous/ongoing pain in rodent 
models of neuropathic pain. Many studies investigating sciatic nerve related neuropathies base 
their observations on a behavioural scoring system created by Attal and colleagues, which rates 
severity of pain through changes in foot position (Attal et al., 1990; Paulson et al., 2002; Daemen 
et al., 2008; Van Remoortere et al., 2007; Chattopadhyay et al., 2007). Others have used 
observations based on foot lifting, weight bearing and grooming (Weissman-Fogel et al., 2008; 
Gutierrez et al., 2008; Jin et al., 2008; Ooi et al., 2006; Massie et al., 2005). Measures based on 
paw position have specificity problems as animals are likely, in fact, avoiding pain evoked caused 
by contact with the ground. Further, these measures often require highly trained observers and 
may have problems of subjectivity (Mogil and Crager, 2004). Studies into less common 
neuropathy models have also investigated possible measures of spontaneous pain, for example 
following chronic constriction of the infraorbital nerve, a model of trigeminal neuralgia, rats 
show an increase in spontaneous blinking behaviour (Vit et al., 2008). 
 
1.7.3 Affective Outcome Measures: 
 
In line with the subject of this thesis the focus of this subsection will be on measures of behaviour 
that are designed to assess affective co-morbidities in rodent models of neuropathic pain. In a 
reflection of the human literature the two co-morbidities that have received the most attention are 
those reflecting depressive or anxious behaviour. This is likely, to an extent, to be due to the 
abundance of well validated and simple rodent behavioural models available to assess aspects of 
depression and anxiety-like behaviour which were primarily developed for the pre-clinical 
evaluation of novel anxiolytic and antidepressant drugs (Cryan and Holmes, 2005;Lister, 
1990;Willner, 1990). It should be noted, however, that other behavioural co-morbidities, such as 
sleep disturbance, appear to be more common within the clinical population (Meyer-Rosberg et 
89 
 
al., 2001). However, as the majority of the work herein concerns rodent tests of anxiety and 
depression-like behaviour these paradigms will be concentrated upon. In order to obtain an 
appropriate sample of papers a literature search of Medline was carried out using the following 
terms: anxiety/depression/behaviour/affective AND chronic pain/neuropathy/neuropathic. The 
search was limited to papers in English working with animals and a hand search of the 
bibliographies of the retrieved papers was carried out to identify any studies which may have 
been missed.  
 
Before going on to discuss the results of the literature review it is useful to carry out a short 
examination of the development and utility of the tests and models used to assess affect-related 
behaviour in rodents. Behavioural paradigms can largely be split into two categories, conditioned 
test/models which rely on repeated exposure of an animal to a stimulus or environment in order to 
elicit a learned response and unconditioned tests/models which examine the spontaneous 
behaviour of the animal. The majority of the tests and models used thus far in pain research were 
originally developed as screens for psychoactive drugs before having their use adapted and 
extended into measuring features of pathological conditions (Willner, 1990;Lister, 1990;Carobrez 
and Bertoglio, 2005). Classically the validity of these models has relied to a large extent on the 
ability to distinguish between active and non-active compounds (Willner, 1990;Prut and Belzung, 
2003). The validity of a model or test is often broken down into three categories: face validity, 
construct validity and predictive validity. Review of the literature reveals some variation as to 
how these criteria are defined and their meaning may be altered depending on whether they are 
applied to a behavioural outcome, such as the elevated plus maze anxiety model, or an animal 
model, such as the L5 SNT model of neuropathic pain (Table 1.7.3 A) (Willner, 1990;Walf and 
Frye, 2007).  
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Table 1.7.3 A: Table showing definitions of different types of validity in animals models and 
behavioural outcome measures (Rice, 2010). 
 Animal Model Behavioural Outcome 
Face Validity Symptomatic resemblance 
to clinical condition 
Does a test appear likely to 
measure the desired trait 
for the desired subject (e.g. 
rodents). 
Predictive Validity Ability to detect 
efficacious and non-
efficacious drugs 
Ability to detect 
efficacious and non-
efficacious drugs 
Construct Validity Theoretical rational of the 
model with the reference 
to clinical features 
How does the outcome fit 
the underlying behavioural 
theory/construct.  
 
It is perhaps easiest to understand these concepts in reference to a particular test or model, for 
example the open field. The open field is a behavioural test and model of anxiety in which a 
rodent is allowed to freely explore an open arena. The major anxiety-related outcome measure is 
defined by entries, movement or time spent in a zone within the centre of the arena (Lister, 
1990;Britton and Britton, 1981;Prut and Belzung, 2003).  Face validity refers to whether a test 
looks as if it will measure the desired trait, i.e. taken at face value does this test appear 
appropriate. The face validity of the open field test derives from the knowledge that, for rodents, 
predation is more likely in open areas and thus these areas would be likely to induce anxiety. The 
predictive validity of behavioural outcome measures, in general, refers to the ability of a model to 
correctly identify pharmacological agents. In the case of the open field, utility in identifying 
anxiogenic and anxiolytic agents is well established (Prut and Belzung, 2003). Construct validity 
refers to the theoretical concept underlying the model or test, and as such often incorporates 
aspects of face and predicative validity. The construct validity of the open field relies upon the 
confound between a rodent’s natural proclivity to explore open spaces and the desire to avoid 
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open spaces where predation is more likely. An increase in anxiety would, therefore, be manifest 
in the open field as a decrease in entries, time spent or exploration in the central area of the arena 
(Lister, 1990). 
 
The importance of another form of validity, namely ethological validity, is emphasised by a 
number of researchers within the field of behavioural neuroscience (Calatayud et al., 
2004;Blanchard et al., 1993;Rodgers, 1997;Rodgers et al., 1997). Ethology refers to the 
systematic study of animal behaviour. Ethological validity relies on a test or model using natural 
stimuli and measuring spontaneous behaviour, such as in the open field, rather than conditioned 
and/or unnatural stimuli such as in the shock probe test (Treit, 1990;Lister, 1990). The fact that a 
test is described as ethologically valid should not be confused with the use of an ethological 
analysis of behaviour in that test (Lister, 1990;Rodgers et al., 1997). The proper ethological 
analysis of a particular model or test is extremely time and resource intensive and results cannot 
necessarily be equated between laboratories (Calatayud et al., 2004;Roy et al., 2001;Wall and 
Messier, 2000;Rodgers et al., 1997). As such, it is likely to be out of the reach of the majority of 
pain focused laboratories. However, the importance of a global understanding of animal 
behaviour cannot be overstated, particularly when investigating pathology as multifaceted as 
chronic pain. In cases where resources allow, an ethological approach to the study pain behaviour 
in rodents may result in the identification of novel outcome measures and improve the assessment 
of potential analgesic therapies (Rodgers et al., 1997;Calatayud et al., 2004;Wall and Messier, 
2000). 
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1.7.4 Anxiety Tests and Models: 
 
Eighteen papers were identified which used behavioural paradigms in an attempt to model the 
increased levels of anxiety reported by some neuropathic pain suffers (Table 1.7.4 A) (Norman et 
al., 2010;Goncalves et al., 2008;Benbouzid et al., 2008a;Hasnie et al., 2007a;Hasnie et al., 
2007b;Kontinen et al., 1999;Leite-Almeida et al., 2009;Suzuki et al., 2007;Seminowicz et al., 
2009;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 
2008;Roeska et al., 2008;Narita et al., 2006a;Matsuzawa-Yanagida et al., 2008;Narita et al., 
2006b;Baastrup et al., 2010). Mixed results were obtained with some papers reporting the 
presence of neuropathy-related anxiety-like behaviour (Hasnie et al., 2007a;Wallace et al., 
2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 2008;Narita et al., 2006a;Narita 
et al., 2006b;Matsuzawa-Yanagida et al., 2008;Roeska et al., 2008;Seminowicz et al., 
2009;Suzuki et al., 2007;Benbouzid et al., 2008a;Leite-Almeida et al., 2009;Baastrup et al., 2010) 
while others showed no alteration in anxiety-like behaviour (Norman et al., 2010; Leite-Almeida 
et al., 2009; Roeska et al., 2008; Hasnie et al., 2007; Kontinen et al., 1999; Goncalves et al., 
2008). All the current studies used exploratory tests of anxiety which are viewed as ethologically 
valid and have been pharmacologically validated in numerous separate studies (Goncalves et al., 
2008;Benbouzid et al., 2008a;Hasnie et al., 2007a;Hasnie et al., 2007b;Kontinen et al., 
1999;Leite-Almeida et al., 2009;Suzuki et al., 2007;Seminowicz et al., 2009;Wallace et al., 
2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 2008;Roeska et al., 2008;Narita 
et al., 2006a;Matsuzawa-Yanagida et al., 2008;Narita et al., 2006b;Prut and Belzung, 2003;Lister, 
1990;Dawson and Tricklebank, 1995;Baastrup et al., 2010). The putative confound of 
neuropathy-induced movement dysfunction in exploration based models will be discussed in 
detail in later chapters (See Chapter 3). However, it is worth noting here that a number of papers 
used independent measures of locomotion in order to discount this as a confounding factor 
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(Kontinen et al., 1999;Roeska et al., 2008;Benbouzid et al., 2008a). One study also used the 
marble burying test alongside the exploration based elevated plus maze (Benbouzid et al., 2008a). 
However, despite being sensitive to some anxiolytic drugs this test has largely be discredited as 
an appropriate measure of anxiety (Deacon, 2006b).  
 
Anxiety-like behaviour does not appear to be species specific and has been observed in both 
mouse (Benbouzid et al., 2008a;Matsuzawa-Yanagida et al., 2008;Narita et al., 2006a;Narita et 
al., 2006b;Suzuki et al., 2007) and rat (Baastrup et al., 2010;Hasnie et al., 2007a;Wallace et al., 
2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 2008;Leite-Almeida et al., 
2009;Roeska et al., 2008) models of neuropathy. Altered exploratory behaviour within anxiety 
tests has been consistently demonstrated in Wistar rats (Roeska et al., 2008;Hasnie et al., 
2007a;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 2008), 
results using other strains have, however, been less robust (Leite-Almeida et al., 2009;Goncalves 
et al., 2008;Kontinen et al., 1999;Seminowicz et al., 2009). It would be interesting to explore 
whether consistent strain differences in anxiety-like behaviour are present. Comparison of highly 
susceptible and highly resistant strains could reveal the existence of genetic predispositions 
towards the development of affective co-morbidities which could then be investigated within the 
human population. Evidence of gene derived variation in the perception of persistent pain is 
emerging (Tegeder et al., 2006;Tegeder et al., 2008). Similar evidence as to whether such 
variation extends to the risk of developing co-morbidities likely remains some way off. However, 
it may offer an explanation for the strength of the relationship between pain and certain forms of 
affective dysfunction (Goldenberg, 2009;Bair et al., 2003).  
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Table 1.7.4 A: Summary of studies investigating anxiety-like behaviour in rodent models of 
neuropathic pain. Continued over page. 
Author Species Strain Models Tests Outcomes Behavioural 
Change 
Analgesic 
Sensitivity 
Separate 
Locomotor 
Test 
Baastrup et 
al., 2010 Rat (F) 
Sprague- 
Dawley 
Spinal Cord 
Contusion EPM 
 
 
 
Open arm duration. 
 
 
 
↓ 
Pregabalin 
Morphine 
Midazolam 
-  -  - 
↓ 
Benbouzid 
et al., 2008 
Mouse 
(M) C57Bl/6J 
Sciatic 
Nerve Cuff 
EPM 
 
Marble 
Burying 
%time open arms. 
Total arm entries. 
 
Marbles buried 
↓ 
↔ 
 
↑ 
Not tested ↔ 
Goncalves 
et al., 2008 Rat (M) 
 
 
Wistar-
Han 
 
 
 
SNI 
 
EPM 
 
OF 
Open arm duration. 
Closed arm duration. 
 
Inner zone duration. 
Outer zone duration. 
Rearing Duration. 
Number of rears.  
↔ 
↔ 
 
↔ 
↔ 
↔ 
↔
 
 
 
 
Not tested 
Not Tested 
Hasnie et 
al., 2007 
Neurosci 
Rat (M) Wistar 
VZV 
L5 SNT 
PSNI 
 
OF 
 
Inner zone entries. 
Inners zone duration. 
Distance moved. 
 
↓ ↓ ↔ 
↓ ↓ ↔ 
↔ ↓ ↓ 
Gabapentin 
-  +  Not tested 
-  + Not tested 
↔ ↔Not tested 
Not tested 
Hasnie et 
al. 2007 Br 
J Anaesth 
 
 
Mouse 
(M) 
 
C57Bl/6J 
 
PSNI 
OF 
 
 
 
EPM 
%time inner zone. 
Inner zone entries. 
Distance moved. 
 
Open arm duration. 
Open arm frequency. 
Closed arm duration. 
Closed arm frequency. 
Centre duration. 
Centre frequency 
Distance moved. 
↔ 
↔ 
↔ 
 
↔ 
P14↑ 
↓ 
↔ 
↔ 
↔ 
P28↑ 
Not tested Not tested 
Kontinen 
et al., 1999 Rat (M) 
Sprague-
Dawley L5-6 SNL 
OF 
 
 
 
 
EPM 
 
 
 
 
L/D 
Locomotion. 
Grooming. 
Rearing. 
Faeces. 
 
Open arm entries. 
Closed arm entries. 
%time closed arms. 
Faeces. 
 
Entries dark. 
Entries light. 
Time dark. 
Total locomotion. 
Locomotion dark. 
Faeces. 
↔ 
↔ 
↔ 
↔ 
 
↔ 
↔ 
↔ 
↔ 
 
↔ 
↔ 
↔ 
↔ 
↔ 
↔ 
Not tested ↔ 
Abbreviations: VZV-varicella zoster virus; L5 SNT- L5 spinal nerve transection; PSNI-partial sciatic nerve injury; 
L5-6 SNL-L5-6 spinal nerve ligation; SNI-spared nerve injury; HAART-highly active antiretroviral therapy; EPM-
elevated plus maze; OF-open field; L/D- light/dark preference; M-male; F-female; s.c. subcutaneous; i.c. intracranial. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
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Table 1.7.4 A: Summary of studies investigating anxiety-like behaviour in rodent models of 
neuropathic pain. Continued over page. 
Author Species Strain Models Tests Outcomes Behavioural 
Change 
Analgesic 
Sensitivity 
Separate 
Locomotor 
Test
Leite-Almeida 
et al., 2009 Rat (M) 
Wistar-
Han 
 
Young 
Mid 
Old 
SNI 
OF 
 
 
 
EPM 
Inner zone duration. 
Rearing. 
Distance moved. 
 
% time in open arms. 
Risk assessment. 
Closed arm entries. 
↓   ↓   ↓ 
↓  ↔  ↓ 
↔ ↓   ↓ 
 
↓  ↔  ↓ 
↓  ↔ ↔ 
↔ ↔ ↔ 
Not tested Not tested 
Matsuzawa-
Yanagida et al., 
2008 
 
Mouse 
(M) 
 
 
 
 
 
Rat (M) 
 
 
C57Bl/6J 
 
 
 
 
 
 
Sprague-
Dawley 
PSNI 
 
 
 
 
L/D 
 
EPM 
 
 
 
 
EPM 
 
 
 
 
Time light. 
 
%time open arms. 
% entries open arms. 
Closed arm entries. 
 
 
%time open arms. 
% entries open arms. 
Closed arm entries. 
 
 
 
 
↓ 
 
↓ 
↔ 
↔ 
 
 
↓ 
↓ 
↔ 
Imipramine 
Milnacipram 
Paroxetine 
 
+  + + 
 
+  + + (s.c.) 
↔  ↔ ↔(s.c.) 
↔ ↔ ↔(s.c.) 
 
 
+(i.c.) 
+(i.c.) 
↔ (i.c.) 
Not tested 
Narita et al., 
2006 (J 
Neurochem) 
Mouse 
(M) C57Bl/6J PSNI 
L/D 
 
EPM 
Time in light. 
 
%time open arms 
↓ 
 
↓ 
Not tested Not tested 
Narita et al., 
2006 
(Neuropsycho-
pharmacology) 
Mouse 
(M) C57Bl/6J PSNI 
L/D 
 
EPM 
Time light 
 
% time open arms. 
Open arm entries. 
Closed arm entries. 
↓ 
 
↓ 
↔ 
↔ 
Not Tested Not tested 
Norman et al., 
2010 
Mouse 
(M) 
 
C57/BL6 
 
SNI 
 
OF 
 
Inner zone duration. 
 
↔ 
 
Not Tested 
 
Not Tested 
Roeeska et al., 
2007 Rat (M) Wistar 
CCI 
 
PSNI 
 
 
 
 
EPM 
 
 
 
 
Time open arms 
 
Entries open arms. 
 
 
 
 
↓  ↔ 
 
↓  ↔ 
CCI Only 
Midazolam 
Morphine 
Gabapentin 
+  +  + 
 
+  +  + 
↔ 
 
↔ 
Abbreviations: VZV-varicella zoster virus; L5 SNT- L5 spinal nerve transection; PSNI-partial sciatic nerve injury; 
L5-6 SNL-L5-6 spinal nerve ligation; SNI-spared nerve injury; HAART-highly active antiretroviral therapy; EPM-
elevated plus maze; OF-open field; L/D- light/dark preference; M-male; F-female; s.c. subcutaneous; i.c. intracranial. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
 
 
 
 
 
 
 
 
96 
 
Table 1.7.4 A: Summary of studies investigating anxiety-like behaviour in rodent models of 
neuropathic pain.  
Author Species Strain Models Tests Outcomes Behavioural 
Change 
Analgesic 
Sensitivity 
Separate 
Locomotor 
Test 
Seminowicz 
et al., 2009 Rats (M) 
Long-
Evans SNI 
OF 
 
 
 
EPM 
Time inner zone. 
Rears. 
Distance moved. 
 
Time open arms. 
Time closed arms. 
Time centre. 
Closed arm exits. 
Rears. 
↔ 
↓ 
↓ 
 
↔ 
↔ 
↔ 
↔ 
↓ 
Not tested Not tested 
Suzuki et al., 
2007 
Mouse 
(M) 
C57Bl/
6J L5 SNL 
OF 
 
 
L/D 
 
 
EPM 
Time in inner zone. 
Distance moved. 
 
% time in light. 
Entries to light. 
 
% time in open arms. 
% entries to open 
arms. 
Total arm entries. 
↓ 
↔ 
 
↓ 
↓ 
 
↓ 
 
↓ 
↔ 
Not tested Not tested 
Wallace et al., 
2007 (Pain) Rat (M) Wistar 
HIV 
(gp120) 
OF Time in inner zone. 
Inner zone entries. 
Distance Moved. 
↓ 
↓ 
↔ 
Not tested Not tested 
Wallace et al., 
2007 (Brain) Rat (M) Wistar 
HAART 
(ddc) 
 
HIV+ 
HAART 
(gp120 + 
ddc) 
 
 
OF 
 
 
Time in inner zone. 
Entries to inner zone. 
Distance moved. 
 
 
↓  ↓ 
↓  ↓ 
↔ ↔ 
 
Not tested Not tested 
Wallace et al., 
2007 (Br J 
Pharmacol.) 
Rat (M) Wistar PSNI 
 
OF 
 
Time in inner zone. 
Entries to inner zone. 
Distance moved. 
 
↓ 
↓ 
↔ 
L-29 
+ 
+ 
↔ 
Not tested 
Wallace et al., 
2008 Rat (M) Wistar 
HIV 
(gp120) 
 
 
 
OF 
 
 
 
Time in inner zone. 
Entries to inner zone. 
Distance moved. 
 
 
 
↓ 
↓ 
↔ 
Gabapentin 
Morphine 
Diazepam 
+  + + 
+  + + 
↔  ↔ ↔ 
Not tested 
Abbreviations: VZV-varicella zoster virus; L5 SNT- L5 spinal nerve transection; PSNI-partial sciatic nerve injury; 
L5-6 SNL-L5-6 spinal nerve ligation; SNI-spared nerve injury; HAART-highly active antiretroviral therapy; EPM-
elevated plus maze; OF-open field; L/D- light/dark preference; M-male; F-female; s.c. subcutaneous; i.c. intracranial. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
 
The majority of studies investigating neuropathy related anxiety-like behaviour have utilised 
models of traumatic peripheral neuropathy, however, it has also been demonstrated in models 
designed to replicate neuropathies of more clinically relevant aetiologies such as HIV or varicella 
zoster related neuropathies (Hasnie et al., 2007a;Wallace et al., 2007a;Wallace et al., 2007b). 
Although the majority of studies have utilised models of peripheral neuropathy using male rats, a 
recent study has demonstrated the presence of anxiety-like behaviour in a model of central 
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neuropathic pain using female rats (Baastrup et al., 2010). One study indicates that affective 
dysfunction may vary with the age of the animal. Young and old animals, but not mid aged 
animals displayed anxiety-like behaviour in the elevated plus maze following spared nerve injury 
(Leite-Almeida et al., 2009). However, no studies appear to exist into the relationship between 
age and co-morbid anxiety in neuropathic pain patients.  
 
Expression of anxiety-like behaviour appears to be dependent on the duration of neuropathy. A 
number of studies report no change in behaviour at the one week time point, despite the presence 
of hind limb hypersensitivity, but an increase in anxiety-like behaviour at between 15 and 30 days 
(Suzuki et al., 2007;Matsuzawa-Yanagida et al., 2008;Narita et al., 2006b). This lag in the 
development of affective dysfunction may be indicative that affective co-morbidities are a feature 
of nervous system plasticity driven by long term nociceptive input. Indeed, changes to the 
structure and function of supraspinal nuclei involved in the expression of anxiety, such as the 
amygdala and PFC, have been reported in animal models of neuropathic pain (Ikeda et al., 
2007;Millecamps et al., 2007;Goncalves et al., 2008). These nuclei have also been implicated in 
the pathology of neuropathic pain in humans (Geha et al., 2007;Hsieh et al., 1995;Ducreux et al., 
2006).  
 
The use of behavioural measures affords researchers the opportunity to investigate physiological 
changes that may drive neuropathy-related affective dysfunction. In their 2006 paper in the 
Journal of Neurochemistry Narita and colleagues demonstrated a down regulation of δ-opioid 
receptor activity in the mouse cortex concomitant to increased anxiety-like behaviour in the 
light/dark and elevated plus maze tests (Narita et al., 2006b). Further, antagonism of δ-opioid 
receptors in the cingulate cortex, an area known to be important in neuropathic pain (Hsieh et al., 
1995;Peyron et al., 2004;Schweinhardt et al., 2006;Becerra et al., 2006;Xu et al., 2008;Takeda et 
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al., 2009), was found to increase anxiety-like behaviour in naive animals. Astrogliosis associated 
with the down regulation of δ-opioid receptors was also observed in the cingulate cortex. Further, 
injection of both astrocyte activated medium and activated astrocytes into the cingulate cortex 
resulted in the expression of anxiety-like behaviour, suggesting that glial activity has a role in 
driving this behaviour (Narita et al., 2006b). The same group have also implicated opioidergic 
plasticity in the amygdala in the expression of neuropathy-related anxiety-like behaviour (Narita 
et al., 2006a). Partial sciatic nerve ligation was shown to result in reduced neuronal excitation in 
response to intra-amygdalal injection of δ and µ opioid receptor agonists. Furthermore, injection 
of the respective antagonists into the amygdala of naive animals resulted in increased anxiety like 
behaviour. These results provide strong evidence suggesting reduced opioidergic activity may be 
driving neuropathy-related anxiety-like behaviour. However, the attenuation of neuropathy-
related anxiety-like behaviour, through the manipulation of the opioidergic transmission, would 
be required before a definitive conclusion can be drawn (Narita et al., 2006b;Narita et al., 2006a).  
 
In a recent paper, which combined MRI and behavioural testing, the authors report a temporal 
relationship between a reduction in the volume of the prefrontal and retrosplenial cortices and 
anxiety-like behaviour following spared nerve injury (Seminowicz et al., 2009). Similar 
reductions in prefrontal cortex volume have been reported in patients with chronic lower back 
pain and complex regional pain syndrome (Apkarian et al., 2004;Geha et al., 2008). The authors 
suggest a possible causal link between the reported anxiety-like behaviour and these 
neuroanatomical changes. It should be noted, however, that behaviour did not become manifest 
until significantly later in this study than in comparable investigations. Further, the main anxiety 
outcome measure used, closed arm exits, is not commonly used as an indicator of anxiety in the 
elevated plus maze (Wall and Messier, 2001;Wall and Messier, 2000;Calatayud et al., 2004;Walf 
and Frye, 2007). It is likely that this measure would be significantly associated with locomotion 
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and the reduction may be reflecting the effect of long term neuropathy on movement rather than 
anxiety.  
 
The use of anxiety-like paradigms has also provided evidence for the parallel processing of 
different aspect of the pain experience in separate supraspinal nuclei (Matsuzawa-Yanagida et al., 
2008). Following sciatic nerve ligation, injection of the serotonin reuptake inhibitor paroxetine, 
an effective analgesic agent for neuropathic pain (Sindrup et al., 1990), into both the basolateral 
amygdala and the cingulate cortex resulted in attenuation of neuropathy related anxiety-like 
behaviour in rats. Hind limb hypersensitivity was, however, unaffected. Conversely injection of 
paroxetine into the S1 region attenuated hypersensitivity without altering anxiety-like behaviour. 
This paper also provides evidence for a supraspinally derived mechanism of action for 
antidepressant analgesia, which had been majorly thought to rely on their effects on spinal 
serotonin and noradrenergic systems (Sindrup et al., 2005).  
 
Interestingly, the inhibition of spinal microgliosis has been shown to prevent the expression of 
anxiety-like behaviour, alongside hind limb hypersensitivity, in a rat model of combined viral and 
toxic neuropathy. Evidence suggests that this effect is limited to models of neuropathy that are 
associated with a high level of microgliosis in the spinal cord (Wallace et al., 2007b). It may 
seem counterintuitive that an intervention directed solely at the spinal level can inhibit 
supraspinally derived behaviour such as anxiety. However, it may be that microgliosis is driving 
increased dorsal horn excitatory activity that is in turn resulting in increased ascending drive to 
supraspinal centres involved in anxiety (Tsuda et al., 2005;Braz et al., 2005;Neugebauer et al., 
2004). 
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The ultimate goal of studies into neuropathic pain is to provide novel and more effective 
analgesic treatments for patients. A number of the studies herein have investigated the effects of 
clinically efficacious drugs on neuropathy-related anxiety-like behaviour, and thus the potential 
usefulness of anxiety paradigms as screens for novel analgesics. In a mouse model chronic, but 
not acute, treatment with imipramine, paroxetine and milnacipran, reversed neuropathy related 
anxiety-like behaviour as well as hind limb hypersensitivity (Sindrup et al., 2005;Matsuzawa-
Yanagida et al., 2008). Both gabapentin and morphine have been to shown to reverse anxiety-like 
behaviour in a number of different neuropathy models and in various exploratory tests of anxiety 
(Hasnie et al., 2007a;Wallace et al., 2008;Roeska et al., 2008). It should be noted that all of the 
above analgesic compounds have also been shown to be have anxiolytic activity in studies which 
do not involve models of neuropathic pain (Ettinger and Argoff, 2007;Singh et al., 1996;Pande et 
al., 1999;Koks et al., 1999;Bantsiele et al., 2009;Duxon et al., 2000;Cruz et al., 1994). Further, 
neuropathy-related anxiety-like behaviour is also reversed by non-analgesic anxiolytic 
compounds (Wallace et al., 2008;Roeska et al., 2008). Although this confirms that animals with 
peripheral neuropathies are indeed showing increased anxiety, rather than reduced exploration 
due to locomotor dysfunction, it also highlights the fact that anxiety tests may produce false 
positives when screening for analgesics and should only be used as part of a battery of 
behavioural outcome measures. In the single study investigating a model of  central neuropathic 
pain anxiety-like behaviour was not revered by the analgesics pregabalin and morphine, or the 
anxiolytic midazolam. It should be noted however that in this model a significant reduction in the 
distance moved was detected in spinal cord injured animals and the reduction in time spent in the 
open arms of the elevated plus maze may reflect this rather than anxiety (Baastrup et al., 2010).   
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1.7.5 Depression Tests: 
 
Nine appropriate papers were identified which used tests of depression-like behaviour in rodent 
models of neuropathic pain  (Table 1.7.5 A) (Leite-Almeida et al., 2009;Hasnie et al., 
2007b;Goncalves et al, 2008;Benbouzid et al., 2008a;Hu et al., 2010;Suzuki et al., 2007;Zeng et 
al., 2008;Wang et al., 2009;Norman et al., 2010;Hu et al., 2009). An increase in depression-like 
behaviour was reported in the majority of these studies (Leite-Almeida et al., 2009;Hu et al., 
2009;Hu et al., 2010;Goncalves et al., 2008;Norman et al., 2010;Suzuki et al., 2007). However, a 
number of investigations failed to show any increase in depression-like behaviour in animal 
models of neuropathic pain (Zeng et al., 2008;Leite-Almeida et al., 2009;Hasnie et al., 
2007b;Benbouzid et al., 2008a). The forced swim test (Leite-Almeida et al., 2009;Goncalves et al, 
2008;Hu et al., 2010;Suzuki et al., 2007;Wang et al., 2009;Norman et al., 2010;Hu et al., 2009) 
and tail suspension test (Hasnie et al., 2007b;Benbouzid et al., 2008a), or analogous rat horizontal 
suspension test (Zeng et al., 2008), were used to assess the level of depression-like behaviour 
following peripheral neuropathy.  
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Table 1.7.5 A: Summary of studies investigation the effect of neuropathy on forced swim 
test behaviour.  
Author Species Strain Model Test Outcomes Behavioural Change 
Analgesic 
Sensitivity 
Benbouzid et 
al., 2008 Mouse (M) C57Bl/6J 
Sciatic 
Nerve Cuff 
Tail 
Suspension Immobility ↔ Not tested 
Gonclaves et 
al., 2008 Rat (M) Wistar-Han SNI FST Activity ↓ Not tested 
Hasnie et al., 
2007 Mouse (M) C57Bl/6J PSNI 
Tail 
Suspension Immobility ↔ Not tested 
Hu et al., 2009 Rat (M) Wistar CCI FST 
 
 
Immobility 
Swimming 
Climbing 
 
 
↑ 
↔ 
↓ 
Desipramine 
GW4058833 
↓↓ 
↔↔ 
↑↑ 
Hu et al., 2010 Rat (M) Sprague-Dawley L5 SNL FST 
 
 
Immobility 
 
 
↑ 
Amitriptyline 
Lornoxicam 
↓↔ 
Leite-Almeida 
et al., 2009 
 
Rat(M, three 
ages) 
Wistar-Han 
Young 
Mid 
Old 
SNI FST 
Immobility 
(latency) 
 
Immobility 
(duration) 
↔  ↔  ↔ 
 
 
↔   ↑   ↔ 
Not tested 
Norman et al., 
2010 Mouse (M) C57/BL6 SNI FST Immobility ↑ Not tested 
Suzuki et al., 
2007 Mouse (M) C57/BL6 L5 SNL FST Immobility 
P2 ↔ 
P7↔ 
P15↑ 
P30↑ 
P56↑ 
Not tested 
Zeng et al., 
2008 Rat(M) 
Wistar 
 
Wistar-Kyoto 
CCI FST Immobility P3 ↔ ↑ P7 ↔ ↑ Not tested 
Abbreviations: CCI-chronic constriction injury; SNI- spared nerve injury; L5 SNL- L5 spinal nerve ligation; P-days 
post surgery; FST-forced swim test; M-male. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
 
In the forced swim test an animal is placed within an inescapable container filled with water, the 
amount of time spent immobile, i.e. not attempting escape, is taken as an indicator of depressive 
behaviour (Willner, 1990;Cryan et al., 2005b;Cryan et al., 2002). In rats a pre-test session 24 
hours before the test is required in order to obtain stable pharmacologically sensitive immobility 
behaviour, while in mice a single test session is sufficient (Cryan et al., 2002). The validity of the 
forced swim test will be discussed at length in later chapters (See Chapter 4). Briefly, it is based 
on putative ‘hopelessness’, often termed behavioural despair, derived from exposure to an 
inescapable stressor (Willner, 1990).  It is a test rather than a model of depression, unless used 
repeatedly as a chronic stressor (Kalueff et al., 2007). The strong predictive validity of the forced 
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swim test, particularly in its modified form which includes scoring active escape behaviours as 
well as immobility, alongside its sensitivity to a large number of stressors which cause depression 
in humans adds weight to its utility as a test of depression-like behaviour (Cryan and Mombereau, 
2004;Cryan et al., 2005b). The mouse tail suspension test and rat horizontal suspension test are 
based on a similar principle to the forced swim test in that they involve inescapable situations and 
use duration of immobility as an index of depression (Willner, 1990;Cryan and Holmes, 2005). 
There are, however, important differences between the two tests including an increased 
sensitivity for antidepressants in the tail suspension test as well as possible advantages for this 
test in screening appropriate mouse knockout models of depression (Cryan et al., 2005a). It is 
interesting to note that neither of the studies that used the tail suspension test showed any increase 
in depression-like behaviour following peripheral nerve injury (Hasnie et al., 2007b;Benbouzid et 
al., 2008a). There is evidence that behaviour in the forced swim and tail suspension tests are 
driven by different biological substrates and it may be that peripheral neuropathy impacts 
differently on these tests (Cryan et al., 2005a;Renard et al., 2003). However, it should be noted 
that both these negative studies used C57Bl/6 mice which are generally thought to be unsuitable 
for use in the tail suspension test due to their proclivity for tail climbing (Cryan et al., 
2005a;Mayorga and Lucki, 2001).  
 
In common with anxiety, neuropathy-related depression-like behaviour appears to be expressed in 
both mouse (Norman et al., 2010;Suzuki et al., 2007) and rat models (Zeng et al., 
2008;Goncalves et al., 2008;Hu et al., 2009;Hu et al., 2010;Leite-Almeida et al., 2009). 
Neuropathy-related depression-like behaviour has been demonstrated in a range of rat strains 
(Zeng et al., 2008;Leite-Almeida et al., 2009;Goncalves et al., 2008;Hu et al., 2009;Hu et al., 
2010). There is evidence, however, that rat strains which are prone to depression-like behaviour 
show a more rapid development of co-morbid depression-like behaviour suggesting a possible 
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increase in susceptibility (Zeng et al., 2008).  All of the studies carried out so far have used 
models of neuropathic pain with a traumatic or mixed traumatic/inflammatory aetiology; the 
logical next step would be to extend this work into more clinically relevant models. There is 
evidence that mid aged rats are more prone to neuropathy-related depression-like behaviour than 
young or old animals (Leite-Almeida et al., 2009). Unfortunately, there is a paucity of data 
concerning the effect of age on the incidence of co-morbid depression in neuropathic pain 
patients.   
 
In a time course study in mice, depression-like behaviour emerged 15 days after induction of 
neuropathy and stayed stable for up to 8 weeks, suggesting that depression-like behaviour may be 
dependent on duration of neuropathy (Suzuki et al., 2007). In a 2008 study by Zeng and 
colleagues rats showed a much earlier onset at only three days post surgery (Zeng et al., 2008). 
The animals used were, however, from the Wistar Kyoto strain which is prone to depressive 
behaviour (Pare and Redei, 1993). Interestingly, these animals also showed a higher level of hind 
limb hypersensitivity than Wistar rats. Similarly chronic exposure to stress, which is a well 
established model of depression (Willner, 1990;Willner, 1997), resulted in increased hind limb 
hypersensitivity and forced swim test immobility following spared nerve injury compared to non-
stressed rats with peripheral neuropathies (Leite-Almeida et al., 2009). These studies offer 
evidence that the bi-directional relationship between pain and depression that exists in humans 
may also be present in rodent models of neuropathic pain (Bair et al., 2003). In the study by Zeng 
and colleagues Wistar rats did not show any neuropathy-induced depression-like behaviour. 
However, the study was ended after 7 days and other studies have demonstrated depression-like 
behaviour in this strain at later time points (Hu et al., 2009;Zeng et al., 2008). It may be that if the 
duration of neuropathy had been longer, as it was in the other positive rat studies (Hu et al., 
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2009;Hu et al., 2010;Goncalves et al., 2008;Leite-Almeida et al., 2009), a significant increase in 
depression-like behaviour would have emerged. 
 
Neurogenesis induced hypertrophy of the amygdala is present in the spared nerve injury model 
two months after induction of neuropathy, and is associated with depression-like behaviour. The 
time required for such neuroanatomical changes may underlie the apparent association between 
duration of neuropathy and expression of depression-like behaviour (Goncalves et al., 2008). 
Indeed, increased amygdalal volume has been detected in individuals with major depression 
using MRI and appears to be associated with the early stages of depressive illness (Frodl et al., 
2002;Frodl et al., 2003). It is suggested that this increase is caused by prolonged activation of the 
amygdala (Frodl et al., 2002). It is likely that persistent nociceptive input associated with 
peripheral neuropathy is driving the increase in amygdala volume reported, and thus may also 
underlie the increased depression-like behaviour (Goncalves et al., 2008;Braz et al., 
2005;Neugebauer et al., 2004). 
 
The hippocampus, and more specifically neurogenesis in this area, is important in the 
pathophysiology of depression (Fuchs et al., 2004). Hu and colleagues report a neuropathy 
associated decrease in BDNF mRNA expression in the hippocampus, alongside increased 
immobility in the forced swim test, following L5 spinal nerve transection (Hu et al., 2010). 
BDNF has a key role in hippocampal neurogenesis (Chan et al., 2008;Rossi et al., 2006). 
Persistent inflammatory pain has previously been shown to deplete hippocampal BDNF and 
disrupt neurogenesis (Duric and McCarson, 2005;Duric and McCarson, 2006). Therefore, 
putative neuropathy associated pain may be driving a decrease in hippocampal BDNF levels and 
thereby be contributing to reduced neurogenesis and depression-like behaviour (Hu et al., 2010).  
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An increase in IL-1β mRNA associated with depression-like behaviour was reported in the mouse 
prefrontal cortex following spared nerve injury (Norman et al., 2010). The prefrontal cortex is 
another important area in the pathophysiology of depression (Koenigs and Grafman, 2009). 
Intracerebroventricular administration of an IL-1β antagonist prevented the expression of 
depression-like behaviour in mice following spared nerve injury (Norman et al., 2010). A strong 
association between cytokines and depression is suggested within the literature (Anisman et al., 
2002). Interestingly, attenuation of L5 SNT-induced mechanical and thermal hypersensitivity, by 
chronic administration of the antidepressant mirtazapine, was also associated with a reduction in 
neuroinflammatory markers (Zhu et al., 2009). While, levels of the proinflammatory cytokine IL-
4 are elevated in patients with painful neuropathies as compared to those without pain (Uceyler et 
al., 2007). Thus, neuroinflammation may represent at least part of the mechanism for the 
bidirectional relationship between depression and pain (Gambassi, 2009). The ACC is known to 
be important in the pathology of neuropathic pain and appears to show changes in depressive 
illnesses (Hsieh et al., 1995;Becerra et al., 2006;Peyron et al., 2004;Schweinhardt et al., 
2006;Wei and Zhuo, 2008;Xu et al., 2008;Drevets et al., 2008). Zeng and colleagues showed that 
the injection of melatonin into the ACC reversed neuropathy induced depression-like behaviour 
and hypersensitivity in Wistar Kyoto rats suggesting a possible link between pain and depression-
like behaviour in this area (Zeng et al., 2008).  
 
Data concerning the utility of depression-like behaviour as an outcome measure to detect 
clinically useful analgesics is so far sparse and mixed in its conclusions (Hu et al., 2009;Hu et al., 
2010). In a 2009 study published in Pain, Hu and colleagues report the reversal of chronic 
constriction injury associated depression-like behaviour, alongside reversal of hind limb 
hypersensitivity, by the CB-2 receptor agonist GW405833. Interestingly, GW405833 had no 
effect on the behaviour of sham operated rats suggesting it was ameliorating depression-like 
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behaviour through blockade of putative neuropathy-induced nociception (Hu et al., 2009). 
Although GW405833’s efficacy in reversing hypersensitivity in animals models of neuropathic 
pain has been previously established there have yet to be any trails demonstrating its efficacy in 
human patients (Valenzano et al., 2005;Whiteside et al., 2005). Further, the non-analgesic 
antidepressant desipramine attenuated the neuropathy associated increased in immobility within 
the forced swim test (Hu et al., 2009). Although this result does confirm that the increased 
immobility is related to depression-like behaviour, rather than any putative neuropathy induced 
movement dysfunction, it also highlights the probability of detecting false positives when 
screening for analgesics. As with anxiety paradigms depression tests should be used as part of a 
battery of behavioural tests in preclinical studies.  
 
Another recent study demonstrated that amitriptyline, an antidepressant with analgesic activity in 
neuropathic pain conditions (Sindrup et al., 2005), reversed neuropathy associated depression-
like behaviour following L5-spinal nerve ligation in rats, as well as attenuating hind limb 
hypersensitivity. Amitriptyline also reversed the neuropathy-associated reduction in hippocampal 
BDNF mRNA reported in this study. Lornoxicam was shown to reverse hind limb 
hypersensitivity, but had no effect on forced swim immobility or the level of BDNF mRNA in the 
hippocampus (Hu et al., 2010). It should be noted that although lornoxicam is well established as 
a postoperative analgesic there is little data concerning its efficacy in neuropathic pain (Rawal et 
al., 2010;Herrmann and Geertsen, 2009;Baron and Binder, 2004).  Thus, the lack of effect in the 
forced swim test may reflect inadequate analgesia. 
 
It is important to mention one inconsistency in the above study as compared to the other rat 
forced swim studies herein (Hu et al., 2010). The authors of this paper utilised the mouse rather 
than rat forced swim test paradigm i.e. no pre-test swimming session was employed. Studies have 
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revealed that, in rats, a pre-test session is required in order for the forced swim test to properly 
screen for antidepressant activity (Borsini et al., 1989;Cryan and Mombereau, 2004), indeed in 
the aforementioned study amitriptyline had no effect on immobility time in sham operated rats 
(Hu et al., 2010). An interesting debate may be had as to whether neuropathy itself is acting as a 
chronic pre-test stressor in this study, much like the pre-test swim in the orthodox rat paradigm. 
Indeed, a paradigm involving chronic mild stress has been used as a model for depression in 
rodents for many years (Willner, 1990;Willner, 1997). Rats exposed to this paradigm have also 
been reported to show increased immobility within the forced swim test (Bielajew et al., 2003).  
 
It is notable that, in the 2009 study by Hu and colleagues both chronic constriction injury and 
sham animals responded to the antidepressant desipramine (Hu et al., 2009). This is to be 
expected, as the rat forced swim test was originally developed as a screen for antidepressant 
activity in naïve animals. However, it does suggest that in this case, and presumably in the other 
positive studies previously discussed herein, the difference between sham and neuropathic groups 
is one of degree of depression-like behaviour. Whereas, in the aforementioned paper utilising the 
mouse paradigm, as indicated by the lack of antidepressant efficacy in the sham group, the 
difference is in the presence or absence of depression-like behaviour. Thus, this testing paradigm 
may offer and alternative route for the study of depression itself as well as its link to chronic pain.  
 
1.7.6 Conclusion: 
 
The data reviewed herein underlines the usefulness of affect-related outcome measures in 
increasing knowledge of the underlying pathophysiology of neuropathic pain, as well as their 
utility as screening tools in the search for novel analgesics. Such outcome measures may be 
instrumental in indentifying the specific neurotransmitter systems behind putative activity related 
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changes suggested by human imaging studies. Future studies using multiple behavioural tests 
should form an integral part of  research into neuropathic pain.  
 
1.8 Statement of hypothesis: 
 
It is clear that neuropathic pain remains a major area of unmet clinical need. The improvement of 
preclinical studies, both through the use of more clinically relevant animal models and the 
expansion of outcome measures, is required to improve the likelihood of creating novel therapies. 
The following  thesis with investigate the hypothesis that the presence of affect-related 
behavioural co-morbidities in rat models of neuropathic pain offers a potential route for the 
expansion of preclinical outcome measures.  
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Effect of Cage Mate Status on Open Field Behaviour 
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2.1 Introduction: 
 
The development of multiple animal models of peripheral neuropathic pain over the last 20 years 
and subsequent amassing of mechanistic data has not, as has already been touched on, been 
followed by a concomitant improvement in the range of therapeutic options for patients (Rice and 
Hill, 2006;Dworkin et al., 2007). In order to address this discrepancy basic scientists have begun 
to refine their models and outcome measures, in order to better reflect the clinical situation 
(Mogil and Crager, 2004;Mogil, 2009) (See sections 1.6 and 1.7). With the same goal in mind a 
drive towards bringing animals experiment in line with clinical trials in terms of the use of bias 
reduction techniques is gathering force.   
 
The refinement of outcome measures has lead to the use of complex operant and non-operant 
behavioural paradigms, designed to detect behavioural co-morbidities such as anxiety and 
depression, in many pain research laboratories (See section 1.7 for review). Reducing variability 
in the testing environment is a key step toward gaining useful behavioural data. As laboratory 
animals spend the majority of their time in their home cages, it is also important to consider the 
impact of this environment on animal behaviour. Factors within the animal holding room such as 
noise, light intensity, temperature/humidity and vibration, can profoundly affect the physiology 
and behaviour of laboratory animals (Jain and Baldwin, 2003). Manipulations of an animal’s 
home cage environment have also been shown to affect behaviour. For example, single housing 
causes increased susceptibility to stress in female rats, resulting in an increased anhedonic 
response in the chronic mild stress model of depression (Baker and Bielajew, 2007). The 
deleterious effect of single housing combined with chronic mild stress is enough to result in 
disruption of the oestrus cycle, an effect not seen in group housed animals exposed to the same 
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stressful stimuli (Baker and Bielajew, 2007;Baker et al., 2006). Such social isolation has also 
been shown to result in learning and memory deficits (Schrijver et al., 2004;Schrijver et al., 2002).  
 
The physical as well as social environment of the cage can impact on animal behaviour and 
physiology. Rats housed in an enriched environmental have lower levels of the stress hormones 
adrenocorticotropic hormone and corticosterone (Belz et al., 2003) and show decreased adrenal 
reaction to car odour (Roy et al., 2001). Animals from enriched environments also show greater 
aptitude in learning and memory paradigms than non-enriched animals (Schrijver et al., 
2004;Schrijver et al., 2002). Interestingly, although both social isolation and lack of 
environmental enrichment cause learning and memory deficits, these deficits are dissociable 
using behavioural paradigms that assess different forms of memory (Schrijver et al., 
2004;Schrijver et al., 2002). A neural substrate for improved learning and memory abilities in 
animals from enriched environment has been posited by Kempermann and colleagues who 
showed increased granule cell numbers in the dentate gyrus of enriched mice which is likely 
linked to increased neurogenesis (Kempermann et al., 1997;Brown et al., 2003). Thus, it is clear 
that changes in housing conditions can have profound effects on behaviour and physiology 
(Wurbel, 2001). 
 
Recent studies have suggested that home cage social and environmental conditions can impact on 
behaviour in animal models of neuropathic pain (Robinson et al., 2004). Further, a recently 
published paper by Langford et al., showed that mice undergoing the acetic acid abdominal 
constriction (“writhing”) test exhibited increased pain related behaviour when receiving 
simultaneous injections alongside a cage mate. However no such increase was observed when 
mice received simultaneous injections alongside a non-cage mate. In addition the increased pain 
behaviours were shown to emerge only after 14 days of animals being housed together, 
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suggesting that a particular level of familiarity was required (Langford et al., 2006).  The authors 
suggest that these alterations in pain behaviour are driven by an empathy related mechanism, a 
suggestion given weight by the cage mate specific nature of the effect. 
 
Randomisation of treatment is an important part of the aforementioned drive towards bias 
reduction (Macleod et al., 2008). However, full randomisation would require the mixing of 
animals with peripheral neuropathies with those without. If, as these recent studies suggest, cage 
mate status and home cage environment can affect behaviour, mixed housing may result in the 
masking of behaviour differences between groups. In order to clarify whether it was feasible to 
carry out random treatment allocation in studies of neuropathy-related affective dysfunction a 
study was conducted into open field behaviour in naïve and L5 spinal nerve transected (L5 SNT) 
rats housed in mixed and segregated groups. 
 
Hypothesis: 
 
Differences in cage mate status will affect open field anxiety-like behaviour resulting in masking 
of clear behavioural phenotypes within groups. 
 
2.2 Methods: 
 
As in other sections detailed methods are reported in Appendix 1 alongside extended method 
forms from Rice et al., 2008 detailing excluded animals etc. (Rice et al., 2008).  
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2.2.1 Animals: 
 
Detailed information can be found in appendix 1. Briefly, male Wistar rats weighing 180-220g 
were obtained from B & K Universal Limited and habituated for at least 3 days before the 
commencement of any experiments. Rats were housed in groups of 2 in individually ventilated 
cages and maintained on a twelve hour light-dark cycle. 
 
2.2.2 Exclusion Criteria: 
 
Animals which did not display a 30% reduction in ipsilateral paw withdrawal threshold following 
L5 SNT were excluded from the neuropathy group. Because of the nature of the experiment 
exclusion of one animal due to lack of hind limb hypersensitivity necessitated the exclusion of its 
cage mate. Details of excluded animals are displayed in the extended methods form in appendix 1. 
 
2.2.3 Randomisation: 
 
Animals were assigned to treatments by picking numbers out of a hat. 
 
2.2.4 Housing test: 
 
In order to assess the effect of housing conditions on L5 SNT induced behaviour animals were 
housed in three combinations: naïve animals housed with naïve (Naïve segregated); L5 SNT 
housed with L5 SNT (L5 SNT segregated) and naïve animals housed with L5 SNT animals 
(Naïve mixed and L5 SNT mixed). 
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2.2.5 Open field test: 
 
The apparatus consisted of a walled square Perspex arena (100x100x40cm) (Fig. 2.2.5 A) within 
a floor to ceiling isolation chamber. Rats were placed in turn into the middle of the arena  and 
spontaneous locomotor activity recorded for 15 min under low level lighting conditions (4 lux, 
measured in the centre of the arena) using an infrared camera (Sanyo VCB 3372). Video data 
were analyzed using Noldus EthoVision XT software (Tracksys Ltd., Nottingham, UK). The 
following outcome measures were examined: frequency of entries to the inner zone (40x40 cm) 
and total distance moved (cm). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.5 A: Schematic diagram of open field apparatus. 
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2.2.6 L5 SNT  surgery: 
 
A detailed method for L5 SNT surgery can be found in appendix 1. Briefly, rats were deeply 
anaesthetised with isoflurane. The L6 transverse spinous process was exposed by blunt dissection. 
Hemi-laminectomy was undertaken in order to expose the L4 and 5 spinal nerves. The L5 spinal 
nerve was identified, ligated and transected 1-2mm distal to the ligature. 
 
2.2.7 von Frey Sensory Testing: 
 
All von Frey sensory testing was carried out by a blinded observer, unaware to which group 
animals were allocated. A detailed method of von Frey testing can be found in appendix 1. 
Briefly, animals were placed within individual Plexiglas testing chambers for two 1 hour 
habituation sessions, on separate days, prior to testing. Baseline paw withdrawal threshold was 
determined for each animal using a calibrated force transducer device. The transducer was 
applied to the mid-plantar surface of each hind paw in turn at a steady rate until an active limb 
withdrawal response was observed. Mean paw withdrawal threshold was calculated from a set of 
5 applications to each limb. Baseline measurements were taken on two separate occasions, at 
least 24 hours apart, in order to reduce any variability caused by the rat’s exposure to a novel 
testing method. The average results obtained were taken to represent true baselines. Post 
operative testing was carried out on day 14. 
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2.2.8 Statistical Analysis: 
 
Differences between baseline and post surgery hind limb withdrawal were investigated using the 
Student’s t-test (SigmaStat version 3.5). Differences between groups in open field behaviour were 
assessed using one way ANOVA Holm-Sidak method (SigmaStat version 3.5). The presence of 
interactions between the effects of housing and neuropathy status were investigated using two 
way ANOVA (SigmaStat version 3.5) 
 
2.3 Results: 
 
2.3.1 Effect of mixed housing on the behaviour of naïve and L5 SNT rats. 
 
Transection of the L5 spinal nerve resulted in a marked decrease in ipsilateral paw withdrawal 
threshold at 14 days post-surgery; indicating the presence of a neuropathy induced mechanical 
hypersensitivity. (Mann-Whitney Rank Sum Test, p<0.001) (Fig 2.3.1 A). No differences were 
found between baseline and post-surgery withdrawal threshold in the contralateral limb, or in the 
response of either limb in the naïve groups (Fig 2.3.1 A). 
 
L5 SNT animals housed alongside naïve animals made fewer entries to the inner zone of the open 
field than naïve animals housed in segregated groups, suggesting the presence of anxiety-like 
behaviour in this group (One Way ANOVA Holm-Sidak, p=0.013) (Fig. 2.3.1 B). Frequency of 
entries did not differ between other groups (Fig. 2.3.1 B). There was no significant interaction 
between neuropathy status and housing, however, both mixed housing and L5 SNT independently 
reduced entries to the inner zone (Two Way ANOVA). Post-hoc all pairwise multiple 
comparisons (Holm-Sidak method) revealed both surgery (p=0.007) status and housing (p=0.04) 
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significantly reduced entries to the inner zone (Fig. 2.3.1 C). Taken together these results suggest 
that both mixed housing and L5 SNT had an anxiogenic effect across groups. 
 
Both L5 SNT and naïve animals from mixed housing moved a significantly shorter distance than 
naïve animals housed in segregated housing, as did segregated L5 SNT animals (One Way 
ANOVA Holm-Sidak, p<0.001) (Fig. 2.3.1 D). This may be indicative of a neuropathy induced 
movement dysfunction. L5 SNT animals from both mixed and segregated housing also moved a 
shorter distance than naïve animals from mixed housing (Fig. 2.3.1 D) (One Way ANOVA 
Holm-Sidak, p<0.001). There was no significant interaction between neuropathy status and 
housing (p= 0.172). However, both mixed housing (p=0.003) and L5 SNT (p<0.001) independently 
reduced distance moved in the open field (Fig. 2.3.1 E) (Two Way ANOVA, Holm-Sidak 
method). L5 SNT may be reducing distance moved though a neuropathy induced motor deficit. 
The source of the housing related effect is less easy to elucidate and will be discussed below. 
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2.4 Discussion: 
 
Cage mate status did not appear to affect the extent of hind limb hypersensitivity caused by L5 
SNT (Fig. 2.3.1 A). It should be noted that the data examined was restricted to animals that 
passed the 30% hind limb were included within the statistical analysis, however inclusion of the 
excluded animals did not result in  the appearance of a difference in hypersensitivity between 
groups (data not shown). It may appear unsurprising that hind limb withdrawal is not affected by 
social modulation. However, small changes to rats home cage environment, such as the choice of 
bedding material or food, have been shown to be crucial for the expression of neuropathy induced 
hypersensitivity (Shir et al., 1998;Robinson et al., 2004). Indeed, mixed housing of rats bred to 
express high and low levels of autotomy behaviour overrides the predisposition towards this 
putative pain related behaviour (Raber and Devor, 2002). 
 
No differences in the open field anxiety-related outcome measure, frequency of entries to the 
inner zone, was detected between naïve and L5 SNT animals housed in segregated groups (Fig. 
2.3.1 B). This is somewhat surprising as L5 SNT induced anxiety has been consistently 
demonstrated in the open field in this laboratory (Hasnie et al., 2007a). It may be that reducing 
the stocking density from four to two has affected the animal’s behaviour. Male rats are known to 
exhibit increased levels of corticosterone in crowded conditions (Brown and Grunberg, 1995) and 
stress hormones have been shown to exacerbated neuropathy related hind limb hypersensitivity 
(Alexander et al., 2009). Whether glucocorticoids are similarly related to the expression anxiety-
like behaviour in rodent models of neuropathic pain remains to be elucidated. However, a 
stocking density induced reduction in glucocorticoids represents one feasible explanation for the 
lack of a clear difference in anxiety-related behaviour between segregated naïve and L5 SNT 
groups. It should be noted, however, that a strong trend towards a decrease in the number of 
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entries to the inner zone was observed in segregated L5 SNT rats as compared to segregated 
naive animals. It would be advisable to increase n numbers before making a firm conclusion 
about the relationship between these two groups.   
 
Mixed housed L5 SNT and naïve groups show a similar difference in mean frequency of entries 
to that seen between the segregated naïve and L5 SNT groups (Fig. 2.3.1 B). However, both 
groups show a statistically insignificant trend towards decreased entries when compared to their 
segregated conspecifics, suggesting a possible increase in anxiety caused by mixed housing. This 
housing related anxiogenic effect is confirmed by the results of the two way ANOVA (Fig 2.3.1 
C). Indeed, the fact that a significant difference in entries exists between the SNT mixed group 
and naïve segregated group suggests that this group is expressing a more anxious phenotype than 
the segregated SNT rats (Fig. 2.3.1 B). It is tempting to speculate that this apparent increase in 
anxiety-like behaviour may be brought on by a change in home cage social dynamics. A decrease 
in home cage social interaction has been observed in a mouse model of neuropathic pain 
(Benbouzid et al., 2008a). It may be that a similar decrease in social interaction by L5 SNT rats is 
resulting in these animals adopting a subordinate role in the home cage hierarchy. Reduced 
dominance behaviour has been reported in a subpopulation of animals following chronic 
constriction injury (Monassi et al., 2003). Interestingly, social status has been shown to modulate 
pain behaviour in rodents (Gioiosa et al., 2009). Social defeat may also result in the expression of 
an anxiety-like phenotype within the elevated plus maze (Pich et al., 1993;Heinrichs et al., 1992). 
However, data from mice shows no difference in the anixiety-like behaviour of subordinate and 
dominant animals from stable social hierarchies (Vekovishcheva et al., 2000). A detailed analysis 
of agonistic encounters within animal’s home cages would be required in order to confirm this 
social defeat-related anxiety hypothesis. The corresponding trend towards a reduction in entries 
to the inner zone by mixed housed naïve animals (Fig. 2.3.1 B), although not significant, may 
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represent a similar empathy driven modulation of behaviour as that seen by Langford and 
colleagues in a study into cage mate pain behaviour in mice (Langford et al., 2006).  
 
L5 SNT rats from both housing conditions moved significantly less than the segregated and 
mixed naïve groups (Fig. 2.3.1 D). A L5 SNT induced reduction in distance moved within the 
open field has been reported previously (Hasnie et al., 2007a). Further, a similar reduction is 
reported in the light dark preference test study detailed herein (See Chapter 3). Determining, 
whether this reduction represents neuropathy induced locomotor dysfunction or an anxiety-
related reduction in exploration would require an independent assessment of locomotion in a non-
anxiogenic environment (Merlo and Samanin, 1989;Roeska et al., 2007;Roeska et al., 
2008;Kontinen et al., 1999;Suzuki et al., 2007). Intriguingly, naive rats housed alongside L5 SNT 
animals also showed a reduction in distance moved (Fig 2.3.1 D). Once again it would be useful 
to have an independent measure of locomotion in order to contextualise this behavioural change. 
Further, the two way ANOVA confirmed that mixed housing resulted in a reduction in movement 
that was independent of neuropathy status (Fig 2.3.1 E) It may be that L5 SNT animals are less 
active within their home cages and that naïve animals housed alongside them also adopt a less 
active behavioural phenotype. Alternatively, the reduction may represent a subtle increase in 
anxiety-like behaviour which is not detected by a reduction in entries to the inner zone. A 
combination of these two factors impacting both mixed housed naive animals may also account 
for the reduced movement seen in the mixed housed group as a whole. In either case, however, it 
is clear that mixed housing is affecting the behaviour of both naive and L5 SNT animals within 
the open field test. 
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Conclusion: 
 
Mixed housing appears to subtly affect open field behaviour in both naïve and L5 SNT animals. 
Although differences in the main anxiety measure compared to segregated conspecifics were not 
detected, enough evidence for an impact of behaviour is present to suggest that mixed housing 
should be avoided in behavioural studies using neuropathic pain models. 
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Chapter 3 
 
 
 
Assessment of Anxiety-like Behaviour in a Rat Model 
of Peripheral Neuropathy using a Dark/Light 
Preference Test 
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3.1 Introduction: 
 
Research into co-morbid pain and anxiety has become a rapidly expanding field of research over 
the last 15-20 years (Asmundson and Katz, 2009). Anxiety is characterised by hyper vigilance 
and worry directed towards potential future threat which, unlike in the related emotion fear, is 
unspecified in nature. It results in a diffuse state of distress characterised by negative affect and 
negative future orientated thoughts (Bishop, 2007;Asmundson and Katz, 2009;Rhudy and 
Meagher, 2000;Ford and Finn, 2008).  Although anxiety is a common emotion, which everyone 
experiences to a greater or lesser extent, it is associated with a spectrum of clinical disorders 
including post-traumatic stress disorder and panic disorder.  
 
There appears to be a link between these so-called anxiety disorders and pain (Asmundson and 
Katz, 2009). For example, the incidence of chronic pain in individuals suffering from anxiety 
disorders appears to be higher than that seen in the general population (Otis et al., 
2003;McWilliams et al., 2003). The majority of work investigating the relationship between 
chronic pain and anxiety disorders has been carried out on patients with post-traumatic stress 
disorder (Asmundson and Katz, 2009).  In these cases, as well as an increase in the incidence of 
chronic pain, a relationship between symptom severity, pain-related disability and pain scores 
appears to exist (Beckham et al., 1997).  
 
Two theoretical frame works explaining the relationship between pain and anxiety disorders have 
gathered strength amongst researchers in the field  (Asmundson and Katz, 2009). The mutual 
maintenance model postulates that aspects of each condition, which may be physiological, 
cognitive and affective in nature, impact upon and exacerbate the concurrent condition 
(Asmundson and Katz, 2009;Sharp and Harvey, 2001). The other major theory is the shared 
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vulnerability model. This model suggests that pre-existing factors, which may be driven by 
genetics, lead to a patients being more susceptible to both chronic pain and post-traumatic stress 
disorder. These two theories should not be viewed in isolation or be seen as mutually exclusive 
(Asmundson and Katz, 2009). The shared architecture of neural systems subserving pain and 
anxiety provides a physiological framework for both these theories whereby dysfunction by one 
condition, in a nucleus involved with both can either maintain or increase vulnerability to the 
other (Davidson, 2002;Bishop, 2007;Tracey, 2005). 
 
Various studies have demonstrated the reduction in quality of life resulting from chronic pain 
(Craig, 2006;Daniel et al., 2008;Meyer-Rosberg et al., 2001;Clark et al., 2000;Galvez et al., 
2007;Tolle et al., 2006;Deshpande et al., 2006;Rejas et al., 2007;Otto et al., 2007). The affective 
burden of pain is one of the major factors that impacts of patient quality of life (See Section 1.5). 
A comparative study has shown that post-herpetic neuralgia carries a similar affective burden to 
chronic lower back pain, suggesting a similar impact on quality of life despite differing 
aetiologies (Daniel et al., 2008). Comparison of post-herpetic neuralgia with a non-painful 
somatic condition, namely peripheral vestibular disease, suggests that painful conditions result in 
a greater degree of affective dysfunction (Clark et al., 2000).  
 
Despite the inclusion of anxiety or anxiety disorders within the outcome measures of a number of 
studies investigating the impact of neuropathic pain on quality of life, there is a paucity of studies 
which have the investigation of neuropathy-related anxiety at their centre (Clark et al., 
2000;Daniel et al., 2008;Meyer-Rosberg et al., 2001;Tolle et al., 2006;Deshpande et al., 
2006;Gore et al., 2005). In one such quality of life survey 35% of patients with diabetic 
peripheral neuropathy reported moderate to very severe disturbance due to anxiety, this result is 
comparable with a study on neuropathies of mixed aetiology where approximately 28% of 
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patients reported moderate to very severe disturbance (Gore et al., 2005;Meyer-Rosberg et al., 
2001). In the diabetic neuropathy study, which used a heterogeneous population, higher levels of 
pain intensity were associated with higher levels of anxiety. Further, physician-reported anxiety 
disorders ran at approximately 27% in this group (Gore et al., 2005). In a similarly diverse and 
representative sample of chronic pain patients, in this case with arthritis related pain, 35% of 
participants presented with an anxiety disorder over the previous 12 months (McWilliams et al., 
2003). These levels of prevalence appear to show an increased incidence of anxiety disorders in 
chronic pain patients when compared to levels seen in the general population, which run at 
around 18% over the same 12 month period in the United States (Kessler and Wang, 2008).  
 
A number of drugs efficacious in the treatment of neuropathic pain have an anxiolytic profile and 
are also used in the treatment of anxiety disorders. Pregabalin, for example, has anxiolytic effects 
in both operant and non-operant rat anxiety paradigms and in an animal model of post-traumatic 
stress disorder (Field et al., 2001;Zohar et al., 2008). Further, it has been shown to be efficacious 
in the treatment of generalised anxiety disorder (Feltner et al., 2003;Pande et al., 2003;Pohl et al., 
2005). The related compound gabapentin has also been shown to have anxiolytic effects in 
animal anxiety paradigms and in human anxiety disorders (Ettinger and Argoff, 2007;Singh et al., 
1996;Pande et al., 1999). Paroxetine, a selective serotonin reuptake inhibitor, inhibits neuropathy 
driven anxiety-like behaviour and hind limb hypersensitivity in a mouse model of neuropathic 
pain (Matsuzawa-Yanagida et al., 2008). Interestingly the anxiolytic and analgesic-like actions of 
paroxetine were shown to be derived from its actions on different brain areas, involved in 
processing of affective/motivational and sensory/discriminative aspects of pain respectively 
(Matsuzawa-Yanagida et al., 2008). Similarly, abundant binding sites for pregabalin have been 
detected in areas involved in pain affect, as well areas involved in earlier stage nociceptive 
processing such as the spinal cord (Bian et al., 2006).  
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When it comes to experimental studies of pain and anxiety the differing nature of fear and anxiety, 
which has been touched on briefly, is extremely important. In fear conditioning studies which 
link a non-noxious environmental stimulus with a fear producing stimulus, such as foot shock, 
subsequent exposure to the non-noxious stimulus produces analgesia (Butler and Finn, 2009). 
Conversely, animals placed in situations likely to produce anxiety rather than fear, such as a 
novel environment, exhibit hyperalgesia (Vidal and Jacob, 1986). Fear related hypoalgesia has 
been demonstrated experimentally with human subjects (Ford and Finn, 2008;Willer et al., 
1981;Rhudy and Meagher, 2003;Rhudy and Meagher, 2000). Similarly, increased reactivity to 
painful stimuli following experimental induction of anxiety has been shown in groups of healthy 
volunteers (Rhudy and Meagher, 2000;Carter et al., 2002). 
 
The opposing effects of fear and anxiety can be most easily understood from an evolutionary 
perspective. Fear is a directed target-orientated emotion, linked to a current and particular 
stimulus such as a predator (Asmundson and Katz, 2009;Rhudy and Meagher, 2000;Ford and 
Finn, 2008). It is a key component in the fight/flight response and is characterised by a desire to 
escape (Ford and Finn, 2008;Rhudy and Meagher, 2000). As such from an evolutionary point of 
view there is an inherent logic to a transient analgesia which facilitates escape despite possible 
injury. Unlike fear, anxiety is diffuse and future orientated, and is characterised by negative affect 
and anticipation of future threat (Asmundson and Katz, 2009;Rhudy and Meagher, 2000;). 
Anxiety leads to increased environmental and somatic awareness and thus facilitates the detection 
of any threat that may develop (Rhudy and Meagher, 2000). Hyperalgesia is likely to form part of 
this increased somatic awareness by improving the likelihood of detecting a potentially noxious 
stimulus.  
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Controversy exists as to whether the different modulatory effects of fear and anxiety are 
qualitative or quantitative in nature. The qualitative argument contends that separate 
neuroanatomical systems subserve anxiety and fear; while the quantitative argument is based on 
the assertion that the same neural circuit underlies both systems and the level of activation 
determines whether the response elicited is fear/analgesia (intense activation) or 
anxiety/hyperalgesia (moderate activation) (Rhudy and Meagher, 2000). Evidence in support of 
both these theories has been obtained from animal models (Davis et al., 1997;Meagher et al., 
2001b).    
 
Animal models of anxiety have developed and changed over the 80 years since Hall introduced 
the open field test as a test of ‘emotionality’ in rats, however, exploratory models remain one of 
the best characterised and simplest of the many now in use (Hall, 1934;Lister, 1990;Kalueff et al., 
2007).  Exploratory models rely on the confound between a rodent’s natural proclivity to explore 
novel environments and anxiety produced by potential threats within these environs. The majority 
of these tests exploit the potential threat implicit in open, brightly light or exposed spaces and use 
changes in spatiotemporal variables relating to ‘safe’ and ‘unsafe’ areas of the test apparatus as 
their main anxiety-related outcome measures (Lister, 1990;Kalueff et al., 2007). Exploratory 
models based on this principal include the open field test, the light/dark or dark/light test and the 
elevated plus maze. Although these paradigms do represent models of anxiety, i.e. they induce 
anxiety, they can also be used as tests of how physiological or pharmacological manipulations 
affect anxiety-like behaviour (Kalueff et al., 2007). 
 
The light/dark preference model is a widely used exploratory model of anxiety-like behaviour in 
rodents. First developed as a test for benzodiazepine activity in mice the test allows free 
movement of an animal within a box partitioned into a large brightly lit and a small dimly lit area 
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(Crawley, 1981;Crawley and Goodwin, 1980). Benzodiazepines have been shown to increase 
movement and shuttles between the light and dark areas independent of increased locomotor 
activity (Crawley and Goodwin, 1980). Modified versions of the test with equally sized chambers 
and altered outcome measures such as time spent in the light chamber have since been 
characterised (Costall et al., 1987;Belzung et al., 1987;Lister, 1990). Similar 
anxiolytic/anxiogenic sensitive behaviour has since been characterised in the light/dark 
preference test for rats (Timothy et al., 1999;Merlo and Samanin, 1989).  
 
Preliminary results from our laboratory using a manually scored dark/light preference test 
demonstrate that rats with trauma-induced, chemokine-induced, drug-induced and combined 
chemokine/drug-induced hypersensitivity spent significantly more time in the dark chamber. The 
test is termed dark/light rather than light/dark as the animals begin the test in the dark chamber. 
The results obtained from this study add weight to the hypothesis that rats displaying 
hypersensitivity due to peripheral nerve damage exhibit a behavioural phenotype resembling that 
of animals treated with anxiogenic drugs.  
 
The following section details the use of a modified dark/light preference test which allows for 
automated tracking of rat movement. The behaviour of L5 SNT rats was investigated using this 
test in order to confirm the presence of putative neuropathy-related anxiety-like behaviour.  
 
Hypothesis: 
 
Animals displaying ipsilateral hind limb hypersensitivity due to transection of the L5 spinal nerve 
(L5 SNT) will also display a concomitant increase in anxiety-like behaviour in the dark/light 
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preference test. Further, this increase in anxiety-like behaviour will be sensitive to amelioration 
by drugs clinically efficacious in the treatment of neuropathic pain. 
 
3.2 Methods: 
 
As in other sections, detailed methods are reported in Appendix 1 alongside extended method 
forms from Rice et al., 2008 detailing excluded animals etc. (Rice et al., 2008).  
 
3.2.1 Animals: 
 
Detailed information can be found in appendix 1. Briefly, male Wistar rats weighing 180-220g 
were obtained from B & K Universal Limited and habituated for at least 3 days before the 
commencement of any experiments. Rats were housed in groups of 4-5 in individually ventilated 
cages and maintained on a twelve hour light-dark cycle. 
 
3.2.2 Exclusion Criteria: 
 
Animals which did not display a 30% reduction in ipsilateral paw withdrawal threshold following 
L5 SNT were excluded from the neuropathy group. In addition, animals which displayed a 30% 
reduction in ipsilateral paw withdrawal threshold following sham surgery were excluded from the 
sham group.  
 
3.2.3 Randomisation: 
 
Animals were assigned to treatments in cage groups by picking numbers out of a hat. 
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3.2.4 Dark/light preference test: 
 
The apparatus consisted of two square Perspex chambers (45x45x45cm) connected by a door 
(12x12x10cm) housed within a floor-to-ceiling isolation chamber designed to deaden sound. The 
section of Perspex containing the door was constructed from infrared permeable Perspex to allow 
continuous tracking of the animal. The dark chamber (5 lux) was covered by a removable lid of 
infrared permeable Perspex, while the light chamber was lit by adjustable LED track lighting to a 
level of 24 lux (measured in the centre of the chamber) (Fig 3.2.4 A).  
 
Animals were introduced to the dark chamber for a 5 minute period of habituation, to reduce 
anxiety related to handling, before being allowed access to the light chamber. Activity was then 
recorded for 30 min using an infrared video camera (Sanyo VCB 3372) linked to a computer with 
video capture software. Video data were analyzed using Noldus EthoVision XT software 
(Tracksys Lmt., UK).  
 
 
Figure 3.2.4 A: Schematic details of dark light preference apparatus.  
 
 
 
Light Chamber Dark Chamber45cm
45 cm
24lx 5lx
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3.2.5 Protocol Validation: 
 
In order to confirm the pharmacological validity of the test in our hands, the effects of yohimbine 
on time spent within the dark chamber of the dark/light preference test was investigated. 
Yohimbine (Sigma-Aldrich) was dissolved in dH2O and administered by i.p. injection with a 23g 
needle at a dose of 2.5mg/kg and a dilution of 1ml/kg. Control animals received an injection of 
dH2O vehicle at 1ml/kg. Injections were carried out 40 minutes previous to the test.  The 
following outcome measures were used: time spent in dark chamber (s); frequency of entries to 
the light chamber; latency to enter the light chamber (s) and distance moved (cm). 
 
3.2.6 L5 SNT behaviour in the dark/light preference test: 
 
The effect of L5 SNT surgery as compared to sham surgery in the dark/light preference test was 
investigated at between 15 and 17 days post-surgery. Outcome measures used were as those 
above.  
 
 3.2.7 Effect of acute gabapentin on L5 SNT/sham behaviour in the dark/light preference test:  
 
L5 SNT and sham rats were randomly assigned to either gabapentin or vehicle groups. Animals 
received intraperitoneal injections using 23g needles of gabapentin 30mg/kg in 1ml/kg saline or 
vehicle at 1ml/kg 40 minutes before entry into the dark/light test. Rats were placed in Plexiglas 
boxes following injections. Only outcome measures showing significant perturbation by L5 SNT 
were investigated in this experiment. 
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3.2.8 L5 SNT and sham surgery: 
 
A detailed method for L5 SNT and sham surgery can be found in appendix 1. Briefly, rats were 
deeply anaesthetised with isoflurane. The L6 transverse spinous process was exposed by blunt 
dissection. Hemi-laminectomy was undertaken in order to expose the L4 and 5 spinal nerves. The 
L5 spinal nerve was identified, ligated and transected 1-2mm distal to the ligature. In sham 
animals, an identical procedure was performed except hemi-laminectomy, ligation and 
transection were not executed. 
 
3.2.9 von Frey Sensory Testing: 
 
All von Frey sensory testing was carried out by a blinded observer, unaware to which group 
animals were allocated. A detailed method of von Frey testing can be found in appendix 1. 
Briefly, animals were placed within individual Plexiglas testing chambers for two 1 hour 
habituation sessions, on separate days, prior to testing. Baseline paw withdrawal threshold was 
determined for each animal using a calibrated force transducer device. The transducer was 
applied to the mid-plantar surface of each hind paw in turn at a steady rate until an active limb 
withdrawal response was observed. Mean paw withdrawal threshold was calculated from a set of 
5 applications to each limb. Baseline measurements were taken on two separate occasions, at 
least 24 hours apart, in order to reduce any variability caused by the rat’s exposure to a novel 
testing method. The average results obtained were taken to represent true baselines. Post 
operative testing was carried out on day 14. 
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3.2.10  Statistical Analysis: 
 
For the pharmacological validation with yohimbine, as well as for the comparison of L5 SNT and 
sham operated animals, differences in behaviour between groups were investigated using 
Student’s t-test (SigmaStat version 3.5). In cases where data was not normally distributed Mann-
Whitney Rank Sum test (SigmaStat version 3.5) was used to detect differences between groups. 
The presence of correlations between dark/light test behaviours and the extent of ipsilateral hind 
limb hypersensitivity following L5 SNT were investigated using Pearson’s Correlation 
(SigmaStat version 3.5). 
 
For the investigation into the efficacy of gabapentin in the dark/light preference test differences 
between groups were investigated using One Way ANOVA (SigmaStat version 3.5). In cases 
where data was not normally distributed Kruskal-Wallis One Way Analysis of Variance on Ranks 
was performed (SigmaStat version 3.5).   
 
3.3 Results 
 
3.3.1 Effect of acute yohimbine on behaviour in the light dark box: 
 
Rats spent less time in the dark chamber (Student’s t-test, p<0.001) (Fig 3.3.1 A) and entered the 
light chamber less frequently (Student’s t-test, p<0.001) (Fig. 3.3.1B) following administration of 
yohimbine as compared to rats which received vehicle injections. Yohimbine administration also 
increased the latency to enter the light chamber as compared to vehicle (Mann-Whitney Rank 
Sum, p=0.004) (Fig 3.3.1 C). These results likely reflect an increase in anxiety-like behaviour due 
to yohimbine injection. Rats also moved less within the dark/light preference test following 
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intraperitoneal injection of yohimbine than vehicle injected controls (Student’s t-test, p<0.001) 
(Fig 3.3.1 D). It is unlikely that this reduction in distance moved is due to sedation as yohimbine 
does not have a sedative effect at the dose administered. Rather, it is likely due to an anxiety-
related reduction in exploratory behaviour. 
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3.3.2 Effect of L5 SNT on behaviour in the dark/light preference test: 
 
Transection of the L5 spinal nerve resulted in a marked reduction in ipsilateral paw withdrawal 
threshold to punctuate mechanical stimuli 14 days post surgery (Student’s t-test, p<0.001). 
Indicating the presence of a neuropathy induced mechanical hypersensitivity. No alterations in 
paw withdrawal threshold were detected on the contralateral side of L5 SNT rats or bilaterally in 
sham operated controls (Fig. 3.3.2 A).  
 
L5 SNT rats displaying a 30% reduction in ipsilateral hind limb withdrawal threshold spent 
significantly more time in the dark than sham operated controls (Student’s t-test, p=0.035) (Fig. 
3.3.2B). The frequency of entries into the light chamber was also reduced in hypersensitive 
animals (Student’s t-test, p=0.048) (Fig. 3.3.2D). Indication the presence of a neuropathy induced 
increase in anxiety-like behaviour in L5 SNT animal. L5 SNT surgery did not affect animals 
latency to enter the light chamber (Fig. 3.3.2F). This difference in behavioural phenotype, as 
compared to yohimbine injected animals, may be indicative of a lower level of anxiety in L5 SNT 
animals. 
 
Rats in the L5 SNT group also moved a shorter distance in the dark/light preference test than 
sham operated controls (Student’s t-test, p=0.002) (Fig. 3.3.2 G). As in previous chapters, this is 
likely due to a neuropathy induced movement deficit.  
 
No correlation was found between time spent in the dark chamber, frequency of light entries or 
distance moved and hind limb hypersensitivity following L5 SNT (Fig. 3.3.2 C, E, H).  
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3.3.3 Effect of acute gabapentin on L5 SNT behaviour in the dark/light preference test: 
 
Transection of the L5 spinal nerve resulted in a marked reduction in ipsilateral paw withdrawal 
threshold to punctuate mechanical stimuli at 14 days post-surgery (L5 SNT vehicle group- 
Student’s t-test, p<0.001; L5 SNT Gabapentin group- Mann Whitney Rank Sum Test, p<0.001). 
Indicating the presence of neuropathy induced mechanical hypersensitivity. No alterations in paw 
withdrawal threshold were detected on the contralateral side of L5 SNT rats or bilaterally in sham 
operated controls (Fig. 3.3.3 A). 
 
No difference in time spent in the dark chamber, or in frequency of entries to the light chamber of 
the dark/light preference test were detected between L5 SNT and sham operated animals 
following administration of  vehicle or gabapentin (Fig. 3.3.3 B+C).  This may be due to anxiety 
related to drug administration resulting in a ceiling effect. No difference in distance moved within 
the paradigm was found between any of the groups tested (Fig. 3.3.3 D). An anxiety induced 
reduction in distance moved, related to drug administration, in sham animals may be masking the 
differences in distance moved found previously between L5 SNT and sham animals. 
Alternatively, gabapentin may be having an unexpected sedative effect. 
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3.4 Discussion: 
 
When setting up any new behavioural paradigm, even one used extensively in other laboratories, 
it is important, where possible, to validate the outcome measures using appropriate 
pharmacological agents. The primary outcome measure, time spent in the dark, and secondary 
outcome measure, frequency of entries to the light chamber, were validated pharmacologically 
using the anxiogenic compound yohimbine (Fig. 3.3.1 A+B). Yohimbine is an α2-adrenoceptor 
antagonist which has well established anxiogenic effects in humans and in animal anxiety tests, 
including in the rat light/dark preference paradigm (Pellow et al., 1985;Charney et al., 
1983;Merlo and Samanin, 1989;Tanaka et al., 2000). Yohimbine also caused a marked increase 
in latency to enter the light chamber (Fig. 3.3.1 C). Rats displaying a 30% reduction in ipsilateral 
paw withdrawal threshold two weeks after L5 SNT show an increase in anxiety-like behaviour in 
the dark/light preference test, as measured by time spent in the light and frequency of entries to 
the dark (Fig. 3.3.2 B+D). There was, however, no corresponding increase in latency to enter the 
light chamber in L5 SNT animals (Fig 3.3.2 F).  
 
Yohimbine also caused a marked reduction in the distance moved within the dark/light preference 
test (Fig 3.3.1 D). The dose of yohimbine used herein has previously been shown to cause 
hyperactivity rather than hypoactivity, when assessed using activity monitoring cages, and to 
reduce exploratory activity in a dark/light preference test (Merlo and Samanin, 1989). Thus, the 
reduction in distance moved following administration of yohimbine is unlikely to be due to 
sedation. Rather, it would appear to be due to an anxiety-induced reduction in exploratory activity. 
Animals within the L5 SNT group also moved significantly less than the sham operated controls 
within the dark/light preference test however it is debatable whether this reduction in exploratory 
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activity is due to neuropathy related movement problems or whether it represents an anxiety-like 
behaviour (Fig 3.3.2 G). 
 
These data are in agreement with an increasing body of literature demonstrating the presence of 
anxiety-like behaviour in rodent models of neuropathic pain (See Section 1.7.4) (Matsuzawa-
Yanagida et al., 2008;Suzuki et al., 2007;Seminowicz et al., 2009;Leite-Almeida et al., 
2009;Narita et al., 2006a;Narita et al., 2006b;Wallace et al., 2007a;Wallace et al., 2007b;Wallace 
et al., 2007c;Wallace et al., 2008;Hasnie et al., 2007a;Roeska et al., 2007;Roeska et al., 
2008;Benbouzid et al., 2008a;Baastrup et al., 2010). Anxiety-like behaviour has been 
demonstrated in a number of different behavioural paradigms including the open field (Wallace et 
al., 2008;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 2007c;Hasnie et al., 
2007a;Suzuki et al., 2007;Seminowicz et al., 2009), elevated plus maze (Suzuki et al., 
2007;Leite-Almeida et al., 2009;Seminowicz et al., 2009;Matsuzawa-Yanagida et al., 2008;Narita 
et al., 2006a;Narita et al., 2006b;Benbouzid et al., 2008a;Roeska et al., 2007;Roeska et al., 
2008;Baastrup et al., 2010), light/dark test (Suzuki et al., 2007;Matsuzawa-Yanagida et al., 
2008;Narita et al., 2006a;Narita et al., 2006b) and the marble burying test (Benbouzid et al., 
2008a). The behaviour appears consistent in neuropathic pain models of various aetiologies 
including traumatic (Hasnie et al., 2007a;Leite-Almeida et al., 2009;Matsuzawa-Yanagida et al., 
2008;Narita et al., 2006a;Narita et al., 2006b;Roeska et al., 2007;Roeska et al., 2008;Seminowicz 
et al., 2009;Suzuki et al., 2007;Wallace et al., 2007c), constriction/inflammation of a peripheral 
nerve (Benbouzid et al., 2008b;Roeska et al., 2008), viral (Wallace et al., 2007a;Hasnie et al., 
2007a), spinal cord damage (Baastrup et al., 2010) and toxic neuropathies as well as those of a 
mixed aetiology (Wallace et al., 2007b). Some studies have, however, failed to show any 
association between specific models of neuropathic pain and anxiety-like behaviour in rodents 
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(Kontinen et al., 1999;Hasnie et al., 2007b;Hasnie et al., 2007a;Roeska et al., 2008). See table 3.4 
A for a summary of neuropathy related anxiety studies in rodents. 
 
Table 3.4 A: Summary of studies investigating anxiety-like behaviour in rodent models of 
neuropathic pain. Continued over page. 
Author Species Strain Models Tests Outcomes Behavioural 
Change 
Analgesic 
Sensitivity 
Separate 
Locomotor 
Test 
Baastrup et 
al., 2010 Rat (F) 
Sprague- 
Dawley 
Spinal Cord 
Contusion EPM 
 
 
 
Open arm duration. 
 
 
 
↓ 
Pregabalin 
Morphine 
Midazolam 
-  -  - 
↓ 
Benbouzid et 
al., 2008 
Mouse 
(M) C57Bl/6J 
Sciatic 
Nerve Cuff 
EPM 
 
Marble 
Burying 
%time open arms. 
Total arm entries. 
 
Marbles buried 
↓ 
↔ 
 
↑ 
Not tested ↔ 
Goncalves et 
al., 2008 Rat (M) 
 
 
Wistar-
Han 
 
 
 
SNI 
 
EPM 
 
OF 
Open arm duration. 
Closed arm duration. 
 
Inner zone duration. 
Outer zone duration. 
Rearing Duration. 
Number of rears.  
↔ 
↔ 
 
↔ 
↔ 
↔ 
↔
 
 
 
Not tested Not Tested 
Hasnie et al., 
2007 
Neuroscience 
Rat (M) Wistar 
VZV 
L5 SNT 
PSNI 
 
OF 
 
Inner zone entries. 
Inners zone duration. 
Distance moved. 
 
↓ ↓ ↔ 
↓ ↓ ↔ 
↔ ↓ ↓ 
Gabapentin 
-  +  Not tested 
-  + Not tested 
↔ ↔Not tested 
Not tested 
Hasnie et al. 
2007 Br J 
Anaesth  
Mouse 
(M) C57Bl/6J PSNI 
OF 
 
 
 
EPM 
%time inner zone. 
Inner zone entries. 
Distance moved. 
 
Open arm duration. 
Open arm frequency. 
Closed arm duration. 
Closed arm frequency. 
Centre duration. 
Centre frequency 
Distance moved. 
↔ 
↔ 
↔ 
 
↔ 
P14↑ 
↓ 
↔ 
↔ 
↔ 
P28↑ 
Not tested Not tested 
Kontinen et 
al., 1999 Rat (M) 
Sprague-
Dawley L5-6 SNL 
OF 
 
 
 
 
EPM 
 
 
 
 
L/D 
Locomotion. 
Grooming. 
Rearing. 
Faeces. 
 
Open arm entries. 
Closed arm entries. 
%time closed arms. 
Faeces. 
 
Entries dark. 
Entries light. 
Time dark. 
Total locomotion. 
Locomotion dark. 
Faeces. 
↔ 
↔ 
↔ 
↔ 
 
↔ 
↔ 
↔ 
↔ 
 
↔ 
↔ 
↔ 
↔ 
↔ 
↔ 
Not tested ↔ 
Abbreviations: CCI- chronic constriction injury; VZV-varicella zoster virus; L5 SNT- L5 spinal nerve transection; 
PSNI-partial sciatic nerve injury; L5-6 SNL-L5-6 spinal nerve ligation; SNI-spared nerve injury; HAART-highly 
active antiretroviral therapy; EPM-elevated plus maze; OF-open field; L/D- light/dark preference; M-male; F-female. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
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Table 3.4 A: Summary of studies investigating anxiety-like behaviour in rodent models of 
neuropathic pain. Continued over page. 
Author Species Strain Models Tests Outcomes Behavioural 
Change 
Analgesic 
Sensitivity 
Separate 
Locomotor 
Test
Leite-Almeida 
et al., 2009 Rat (M) 
Wistar-
Han 
 
Young 
Mid 
Old 
SNI 
OF 
 
 
 
EPM 
Inner zone duration. 
Rearing. 
Distance moved. 
 
% time in open arms. 
Risk assessment. 
Closed arm entries. 
↓   ↓   ↓ 
↓  ↔  ↓ 
↔ ↓   ↓ 
 
↓  ↔  ↓ 
↓  ↔ ↔ 
↔ ↔ ↔ 
Not tested Not tested 
Matsuzawa-
Yanagida et 
al., 2008 
 
Mouse 
(M) 
 
 
 
 
 
Rat (M) 
 
 
C57Bl/6J 
 
 
 
 
 
 
Sprague-
Dawley 
PSNI 
 
 
 
 
L/D 
 
EPM 
 
 
 
 
EPM 
 
 
 
 
Time light. 
 
%time open arms. 
% entries open arms. 
Closed arm entries. 
 
 
%time open arms. 
% entries open arms. 
Closed arm entries. 
 
 
 
 
↓ 
 
↓ 
↔ 
↔ 
 
 
↓ 
↓ 
↔ 
Imipramine 
Milnacipram 
Paroxetine 
 
+  + + 
 
+  + + (s.c.) 
↔  ↔ ↔(s.c.) 
↔ ↔ ↔(s.c.) 
 
 
+(i.c.) 
+(i.c.) 
+(i.c.) 
Not tested 
Narita et al., 
2006 (J 
Neurochem) 
Mouse 
(M) C57Bl/6J PSNI 
L/D 
 
EPM 
Time in light. 
 
%time open arms 
↓ 
 
↓ 
Not tested Not tested 
Narita et al., 
2006 
(Neuropsycho-
pharmacology) 
Mouse 
(M) C57Bl/6J PSNI 
L/D 
 
EPM 
Time light 
 
% time open arms. 
Open arm entries. 
Closed arm entries. 
↓ 
 
↓ 
↔ 
↔ 
Not Tested Not tested 
Norman et al., 
2010 
Mouse 
(M) 
 
C57/BL6 
 
SNI 
 
OF 
 
Inner zone duration. 
 
↔ 
 
Not Tested 
 
Not Tested 
Roeeska et al., 
2007 Rat (M) Wistar 
CCI 
 
PSNI 
 
 
 
 
EPM 
 
 
 
 
Time open arms 
 
Entries open arms. 
 
 
 
 
↓  ↔ 
 
↓  ↔ 
CCI Only 
Midazolam 
Morphine 
Gabapentin 
+  +  + 
 
+  +  + 
↔ 
 
↔ 
Abbreviations: CCI- chronic constriction injury; VZV-varicella zoster virus; L5 SNT- L5 spinal nerve transection; 
PSNI-partial sciatic nerve injury; L5-6 SNL-L5-6 spinal nerve ligation; SNI-spared nerve injury; HAART-highly 
active antiretroviral therapy; EPM-elevated plus maze; OF-open field; L/D- light/dark preference; M-male; F-female. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
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Table 3.4 A: Summary of studies investigating anxiety-like behaviour in rodent models of 
neuropathic pain.  
Author Species Strain Models Tests Outcomes Behavioural 
Change 
Analgesic 
Sensitivity 
Separate 
Locomotor 
Test 
Seminowicz 
et al., 2009 Rats (M) 
Long-
Evans SNI 
OF 
 
 
 
EPM 
Time inner zone. 
Rears. 
Distance moved. 
 
Time open arms. 
Time closed arms. 
Time centre. 
Closed arm exits. 
Rears. 
↔ 
↓ 
↓ 
 
↔ 
↔ 
↔ 
↔ 
↓ 
Not tested Not tested 
Suzuki et al., 
2007 
Mouse 
(M) C57Bl/6J L5 SNL 
OF 
 
 
D/L 
 
 
EPM 
Time in inner zone. 
Distance moved. 
 
% time in light. 
Entries to light. 
 
% time in open arms. 
% entries to open 
arms. 
Total arm entries. 
↓ 
↔ 
 
↓ 
↓ 
 
↓ 
 
↓ 
↔ 
Not tested Not tested 
Wallace et 
al., 2007 
(Pain) 
Rat (M) Wistar HIV (gp120) 
OF Time in inner zone. 
Inner zone entries. 
Distance Moved. 
↓ 
↓ 
↔ 
Not tested Not tested 
Wallace et 
al., 2007 
(Brain) 
Rat (M) Wistar 
HAART 
(ddc) 
 
HIV+ 
HAART 
(gp120+d
dc) 
 
 
OF 
 
 
Time in inner zone. 
Entries to inner zone. 
Distance moved. 
 
 
↓  ↓ 
↓  ↓ 
↔ ↔ 
 
Not tested Not tested 
Wallace et 
al., 2007 (Br 
J Pharmacol.) 
Rat (M) Wistar PSNI 
 
OF 
 
Time in inner zone. 
Entries to inner zone. 
Distance moved. 
 
↓ 
↓ 
↔ 
L-29 
+ 
+ 
↔ 
Not tested 
Wallace et 
al., 2008 Rat (M) Wistar 
HIV 
(gp120) 
 
 
 
OF 
 
 
 
Time in inner zone. 
Entries to inner zone. 
Distance moved. 
 
 
 
↓ 
↓ 
↔ 
Gabapentin 
Morphine 
Diazepam 
+  + + 
+  + + 
↔  ↔ ↔ 
Not tested 
Abbreviations: CCI- chronic constriction injury; VZV-varicella zoster virus; L5 SNT- L5 spinal nerve transection; 
PSNI-partial sciatic nerve injury; L5-6 SNL-L5-6 spinal nerve ligation; SNI-spared nerve injury; HAART-highly 
active antiretroviral therapy; EPM-elevated plus maze; OF-open field; L/D- light/dark preference; M-male; F-female. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
 
With the exception of the marble burying test used by Benbouzid and colleagues all the anxiety 
models so far employed, including the test used herein, have been exploration based (Matsuzawa-
Yanagida et al., 2008;Suzuki et al., 2007;Seminowicz et al., 2009;Leite-Almeida et al., 
2009;Narita et al., 2006a;Narita et al., 2006b;Matsuzawa-Yanagida et al., 2008;Wallace et al., 
2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 2008;Hasnie et al., 
2007a;Roeska et al., 2007;Roeska et al., 2008;Benbouzid et al., 2008a;Baastrup et al., 2010). This 
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type of anxiety paradigm relies on the conflict between a rodent’s desire to explore novel 
environments and the putative anxiety caused by open spaces and/or bright light. One drawback 
in the use of such paradigms to study anxiety-like behaviour in rodent models of neuropathic pain 
lies in the possibility that neuropathy induced movement dysfunction, rather than increased 
anxiety, may underlie reductions in exploration. Indeed, as previously stated a reduction in 
distance moved was observed in L5 SNT animals as compared to sham operated controls in this 
study (Fig. 3.3.2 G).  
 
A number of papers have reported similar reductions in distance moved following induction of 
peripheral neuropathy (Hasnie et al., 2007a;Leite-Almeida et al., 2009;Seminowicz et al., 2009). 
Conversely, anxiety-like behaviour within exploratory models has been demonstrated in the 
absence of any reduction in total distance moved (Hasnie et al., 2007a;Leite-Almeida et al., 
2009;Suzuki et al., 2007;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 
2007c;Wallace et al., 2008). In order to circumvent the possible confounding effects of reduced 
locomotion future studies investigating neuropathy induced anxiety-like behaviour within this 
laboratory should include an independent monitor of activity levels, such as an automated activity 
box. This would allow the independent measurement of activity levels in neuropathic animals and 
reveal any neuropathy-induced reduction in movement. Indeed, a number of studies into 
neuropathic-pain related anxiety have already taken this step (Kontinen et al., 1999;Suzuki et al., 
2007;Roeska et al., 2008;Roeska et al., 2007;Baastrup et al., 2010). 
 
The lack of any correlation between the extent of hind limb hypersensitivity and any of the 
anxiety-related behaviours in the dark/light preference test suggests that they are being driven by 
different mechanisms/physiological substrates (Fig. 3.3.2 C, E +H). Results from a study 
investigating the effects of stereotactic injections of paroxetine in a rat model of peripheral 
neuropathy add weight to this explanation. In this study reversal of hypersensitivity and anxiety-
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like behaviour was achieved through injection into brain areas involved in the 
sensory/discriminative and affective/motivational aspects of pain respectively (Matsuzawa-
Yanagida et al., 2008). It may be that this behaviour is related directly to ongoing or spontaneous 
pain, indeed this appears to be the case in humans (Gore et al., 2005), however, the lack of well 
validated measures of these phenomena in animal models make this impossible to confirm. This 
lack of correlation is in contrast with a study investigating open field behaviour in a varicella 
zoster related neuropathy model, as well as the L5 SNT model used herein, where hind limb 
hypersensitivity correlated with entries to the anxiogenic inner zone (Hasnie et al., 2007a). 
Despite both being exploratory anxiety tests it is likely that the precise driving factors behind 
activity in the open field and dark/light test differ (Belzung and Le Pape, 1994) and may underlie 
these conflicting results.  
 
 Data from some of the studies published so far suggests that the expression of anxiety-like 
behaviour in animal models of neuropathic pain is dependent on the duration of the neuropathy. 
Three studies from the same laboratory showed that, following partial sciatic nerve ligation, mice 
behaved normally in the light/dark and elevated plus maze at 1 week but by 4 weeks had 
developed an anxiety-like phenotype (Matsuzawa-Yanagida et al., 2008;Narita et al., 
2006a;Narita et al., 2006b). The authors suggest that the increased anxiety-like behaviour is 
related to altered opioidergic function in the amygdala and increased astrocyte activity in the 
cingulate cortex driven by down regulation of δ-opioid receptor function (Narita et al., 
2006a;Narita et al., 2006b). Both these areas have roles in anxiety and have been implicated in 
human imaging studies of neuropathic pain as well studies using rodent models (Ikeda et al., 
2007;Devinsky et al., 1995;Hsieh et al., 1995;Takeda et al., 2009;Davidson, 2002;Geha et al., 
2007).  In another mouse study anxiety like behaviour was manifest between 7 and 15 days after 
ligation of the L5 spinal nerve (Suzuki et al., 2007). This is in good agreement with the data 
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herein, although as no other earlier time points were studied no assumptions can be made about 
the onset of anxiety-like behaviour in this model.  
 
It is important to note that caution should be taken when interpreting results from studies where 
animals have been repeatedly tested in exploratory paradigms as novelty is an important factor in 
rodent behaviour in these tests (Lister, 1990). For example, in the elevated plus maze repeated 
test exposure results in less activity in the open arms and reduced sensitivity to anxiolytic drugs 
(Holmes et al., 2001;Espejo, 1997). Even with this caveat in mind, however, the time course data 
from these studies is likely valid as it is compared to sham groups which were also subject to 
repeated tests. Indeed, in the study by Matsuzawa-Yanagida and colleagues no apparent change 
in light/dark test behaviour was observed after repeated testing in the sham group (Matsuzawa-
Yanagida et al., 2008). 
 
Now that the presence of anxiety-like behaviours in rodent models of neuropathic pain has been 
established there is likely to be a drive towards the standardisation of anxiety tests between 
laboratories. The logic behind the standardisation of behavioural tests is self evident in that it will 
improve the comparability of data obtained in different laboratories and from different 
neuropathic pain models. However, the move towards standardisation should not, if possible, 
result in a reduction in the variety of anxiety tests used (Kalueff et al., 2007). It may seem 
wasteful in terms of both time and resources to test the same behaviour using multiple paradigms, 
however, principal component analysis of a number of anxiety tests carried out in the same 
laboratory has shown that specific anxiety-related outcome measures do not correlate easily with 
one another between tests (Belzung and Le Pape, 1994). This suggests that these tests may be 
measuring different aspects of the animal’s anxiety response and thus may be sensitive to 
different aspects of putative neuropathy-related affective dysfunction.  
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No differences in the primary measure of anxiety, time spent in the dark (Fig. 3.3.3 B), or the 
secondary measure, frequency of entries to the light chamber (Fig. 3.3.3 C), were found between 
groups following gabapentin or vehicle treatment. It is likely that this change in behaviour 
compared to the previous dark light preference results is due to an increase in anxiety caused by 
the intraperitoneal injection and 40 minutes of isolation previous to testing. It may be that this 
increase is causing a ceiling effect, and is thus responsible for masking the differences in state 
anxiety observed in animals which did not receive injections before testing. The fact that all 
animals within this experiment, whether injected with gabapentin or vehicle, show a lower 
number of entries to the light chamber than non-injected animals adds weight to the theory of an 
injection induced increase in anxiety (Fig. 3.3.2 D + 3.3.2 C). Gabapentin treatment did not cause 
a significant reduction in anxiety-like behaviour in L5 SNT rats when compared to the vehicle 
treated group, although a trend towards a decrease in the time spent in the dark was present (Fig. 
3.3.3 B).  
 
Gabapentin was chosen as an appropriate analgesic to validate the dark/light preference test due 
to its well established clinical efficacy, as well as the wealth of data indicating its ability to 
reverse hypersensitivity in various animal models of neuropathic pain (An et al., 1998;Hasnie et 
al., 2007a;Rice and Maton, 2001;Wallace et al., 2007b;Garry et al., 2005;Dworkin et al., 2007). 
The protocol used for the gabapentin experiment was based on studies carried out in this 
laboratory where gabapentin was shown to successfully ameliorate anxiety-like behaviour in the 
open field in a number of models of neuropathy including L5 SNT (Wallace et al., 2008;Hasnie et 
al., 2007a) . It should, however, be noted that reversal of anxiety-like behaviour did not occur in 
all models tested (Hasnie et al., 2007a). Other studies, utilising the elevated plus maze and mouse 
light/dark preference test, have also used similar protocols to successfully reverse neuropathy 
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associated anxiety-like behaviour with clinically efficacious analgesics (Roeska et al., 
2008;Matsuzawa-Yanagida et al., 2008). It may be that this version of the dark/light preference 
test is simply not suitable for the screening of putative analgesic drugs and is as such of limited 
use in the field of chronic pain research.  
 
However, if anxiety caused by the acute injection is indeed perturbing the proper measurement of 
pain-related anxiety, switching from an acute dosing regimen to a chronic one may overcome this 
issue. Such a change would also result in a closer resemblance to the clinical situation, where 
patients receive chronic rather than acute drug treatments. In the case of gabapentin, due both to 
pharmacokinetics and dose titration, it generally takes around two weeks for patients to reach a 
therapeutic dose (Dworkin et al., 2007). Similarly, in a recent study Benbouzid and colleagues 
demonstrated that in a mouse model of neuropathic pain, the initial effect of gabapentin on paw 
withdrawal threshold was no longer present after two hours. However, following three days of 
twice daily injections the amelioration of neuropathy induced hypersensitivity persisted overnight. 
(Benbouzid et al., 2008b). Using a similar protocol would better reflect the effect of ‘analgesia’ 
on anxiety-like behaviour, due to the long term reversal of hypersensitivity and putative ongoing 
pain. Further, it would allow the efficacy of the analgesic to be confirmed by von Frey testing at a 
time point which would not likely affect behaviour within the dark/light preference paradigm, 
such as the day before testing. As well as negating the need for an injection immediately 
preceding behavioural testing, the protocol would allow animals to stay in their home cages up 
until the moment of testing thereby reducing stress. It should be noted that repeated injections 
would also likely be stressful for the animal and ideally these should be carried out by someone 
other than the experimenter who handles the animal before the anxiety test.  
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All of the drugs so far used to reverse neuropathy-related anxiety-like behaviour in rodents are 
anxiolytic in their own right (Ettinger and Argoff, 2007;Singh et al., 1996;Pande et al., 
1999;Koks et al., 1999;Bantsiele et al., 2009;Duxon et al., 2000;Cruz et al., 1994). Further, in one 
study neuropathy related anxiety-like behaviour was shown to be sensitive to non-analgesic 
anxiolytics (Wallace et al., 2008). These data underline the fact that, in order to protect against 
false positive results, neuropathy-related anxiety-like behaviour should form part of a battery of 
outcome measures used to assess the efficacy of novel pharmaceutical compounds. 
 
Conclusion: 
 
Although L5 SNT induced anxiety-like behaviour was observed in the rat dark/light preference 
test, this study was unable to demonstrate the sensitivity of the test to the analgesic drug 
gabapentin. Refinement of the protocol to incorporate chronic drug treatment may improve the 
paradigm’s efficacy as a drug screen and would also improve its comparability to the clinic.  The 
ability to assess outcome measures in future tests of anxiety-like behaviour would be improved 
by the inclusion of an independent monitor of locomotion.  
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Chapter 4 
 
 
 
Assessment of Depression-like Behaviour in a Rat 
Model of Peripheral Neuropathy Using a Forced Swim 
Test 
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4.1 Introduction: 
 
The World Health Organisation defines depression as “a common mental disorder that presents 
with depressed mood, loss of interest or pleasure (anhedonia), feelings of guilt or low self-worth, 
disturbed sleep or appetite, low energy and poor concentration.” (2010b).  It is a complex 
disorder with a wide range of symptoms none of which are either essential or definitive for 
diagnosis (Willner, 1990). A recent meta-analysis of data comprising over 150,000 subjects from 
28 countries rated major depression as the most common mental disorder in Europe, with a 
median prevalence within the 12 months before screening of 6.9% in the adult population 
(Wittchen and Jacobi, 2005). 
 
It is now well accepted within the medical community that a link exists between pain and 
depressive symptoms.  Incidence of co-morbid depression in pain clinics runs at between 40 and 
60%, significantly higher than the general population (Bair et al., 2003;McWilliams et al., 2004). 
A 2001 study reported that roughly 30% of patients with chronic neuropathic pain had suffered 
moderate to very severe discomfort due to depressive symptoms in the seven days previous to 
questioning (Meyer-Rosberg et al., 2001). Despite a lack of high quality studies, evidence from a 
recent review of the literature suggests that the link between pain and depression is bi-directional 
and multifaceted (Bair et al., 2003). Medically unexplained pain is a common, though often 
neglected, symptom of depression (Bair et al., 2003;Katon et al., 2001). Further, just as 
symptoms of depression predict future episodes of pain (Croft et al., 1995;Von et al., 
1993;Carroll et al., 2004); multiple symptoms of pain are associated with an increased likelihood 
of co-morbid depression (Von et al., 1988;Kroenke and Price, 1993;Bair et al., 2003). In addition, 
there is a bi-directional relationship between symptom severity and the likelihood of co-morbidity 
(Carroll et al., 2000;Carroll et al., 2004). Resolution or improvement of painful symptoms also 
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appears to be associated with a reduction in measures of depression, when compared to scores in 
those whose painful symptoms have not improved (Bair et al., 2003). Further, the experimental 
induction of a depression-like state has been shown to reduce tolerance and increase intensity in a 
pressure pain test (Carter et al., 2002). 
 
Theories postulated to explain the relationship between pain and depression can be broadly 
viewed as fitting into three categories: firstly that depression is a direct result of physical pain; 
secondly that painful episodes are a somatic manifestation of the psychological dysfunction; and 
finally that the two conditions share pathophysiological features influenced by genetic, 
environmental and developmental factors (Goldenberg, 2009). The recent focus on supraspinal 
plasticity in chronic pain syndromes is likely to increase the weight of evidence favouring this 
later theory.  
 
A number of drugs useful in the treatment of depression have been shown to be analgesic 
clinically, and to attenuate pain-like behaviours in animals. Indeed, tricyclic antidepressants 
(TCAs) are one of the major classes of drug used in the treatment of neuropathic pain (Sindrup et 
al., 2005). In a recent systematic review of analgesic therapies for post-herpetic neuralgia, TCAs 
had among the lowest number needed to treat of any of the commonly prescribed drugs (Finnerup 
et al., 2010). Studies using animal models have revealed a number of peripheral and spinal 
mechanisms, which likely contribute to the analgesic quality of antidepressants (Sindrup et al., 
2005).  
 
With regard to neuropathic pain, the efficacy of antidepressant drugs is thought to rely largely on 
their effect of the noradrenergic and serotonergic systems, which are critically important for the 
modulation of nociceptive processing (Sindrup et al., 2005;Ren and Dubner, 2002;Burgess et al., 
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2002;Porreca et al., 2001;Blier and Abbott, 2001;Viisanen and Pertovaara, 2007). The varying 
efficacy of TCAs, selective serotonin reuptake inhibitors and serotonin/noradrenaline reuptake 
inhibitors suggests that duel action on both neurotransmitter systems is most efficacious (Sindrup 
et al., 2005). Other mechanisms of action are also likely to contribute to analgesia including Na+ 
channel blockade, NMDA receptor antagonism and potentially Ca2+ channel blockade (Eisenach 
and Gebhart, 1995;Sindrup et al., 2005;Wang et al., 2004;Brau et al., 2001;Lavoie et al., 1997). 
An opioid receptor dependant effect downstream of β2 adrenoceptors has also been proposed 
(Benbouzid et al., 2008b). Recently a non-neuronal mechanisms for antidepressant induced 
analgesia, via the blockade of the microglial P2X4 receptor (Nagata et al., 2009), which is thought 
to be important in neuropathic pain (Tsuda et al., 2005) has been proposed.  
 
Current theories of antidepressant analgesia suggest that pain relief is an independent 
phenomenon from the amelioration of depressed mood. However, the strong data suggesting a 
link between mood and pain suggests that such a relationship should not be excluded entirely 
(Sindrup et al., 2005). Indeed, supraspinal modes of action which may be related to pain relief are 
beginning to be elucidated, some of which are directed towards brain nuclei important in the 
pathology of depression such as the amygdala and hippocampus (Zhu et al., 2009;Matsuzawa-
Yanagida et al., 2008;Fuchs et al., 2004;Frodl et al., 2002;Frodl et al., 2003;Takeda et al., 2009).  
 
In order to study the neurophysiological substrate of depression a number of animal models of 
depression or depression-like symptoms have been developed over the years. Ability to detect the 
activity of antidepressant drugs is generally taken to be a prerequisite for a valid animal model of 
depression. It should not, however, be seen as sufficient (Willner, 1990). Models can be roughly 
split into three categories: stress models, involving the priming of the animal with a stressful 
situation which leads to depression-like behaviour; separation models, involving the isolation of 
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the animal during a critical stage of neonatal development and brain damage models (Willner, 
1990). The complexity of depression as a syndrome, and the resulting difficulties in animal 
modelling, has lead many researchers to relate single phenotypic differences in models to single 
symptoms of depression. Indeed many of the models previously termed models of depression 
have been reinterpreted with this in mind. (Cryan and Mombereau, 2004). 
 
The aforementioned link between chronic pain and depression has lead to the investigation of 
depression-like behaviour in animal models of chronic neuropathic pain (Leite-Almeida et al., 
2009;Hu et al., 2009;Hu et al., 2010;Goncalves et al., 2008;Kontinen et al., 1999;Suzuki et al., 
2007;Norman et al., 2010;Zeng et al., 2008). The link between improved pain symptoms and 
reduced depressive symptoms seen clinically suggests that depression-like behaviours may offer 
a reliable outcome measure to study the efficacy of novel therapeutic interventions (Bair et al., 
2003). One of the most widely used paradigms in depression research is the forced swim test 
(Willner, 1990). In the forced swim test rodents are placed within a confined inescapable 
container containing water. Following a brief period characterised by vigorous attempts to escape 
the animal becomes passive. Rats which undergo an initial pre-test session within the forced 
swim test adopt this passive immobile state more rapidly and for a longer duration upon a second 
exposure to the test. The developers of the test theorised that this more rapid onset represented 
hopelessness and termed the state ‘behavioural despair’ (Willner, 1990;Porsolt et al., 1978).  
 
The majority of previous studies into depression-like behaviour in animal models of neuropathic 
pain have concentrated on the forced swim test as a core outcome measure (Leite-Almeida et al., 
2009;Hu et al., 2009;Hu et al., 2010;Goncalves et al., 2008;Kontinen et al., 1999;Suzuki et al., 
2007;Norman et al., 2010;Zeng et al., 2008). As multicentre research models, such as the 
Innovative Medicines Initiative (2010a), proliferate the importance of standardising affective 
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outcome measures across laboratories and in different animal models is likely to increase. 
Therefore, the current study was undertaken in an attempt replicate depression-like behaviour in 
the forced swim test in the L5 spinal nerve transection (L5 SNT) model of neuropathic pain, 
which is well characterised within this laboratory. 
 
Hypothesis: 
 
L5 SNT, resulting in prolonged ipsilateral hind limb hypersensitivity, will induce depression-like 
behaviour, characterised by increased time spent immobile within the forced swim test. 
 
4.2 Methods: 
 
As in other sections methods are reported in Appendix 1 using the extended methods form from 
Rice et al., 2008 (Rice et al., 2008).  
 
4.2.1 Animals: 
 
Detailed information can be found in appendix 1. Briefly, male Wistar rats weighing 180-220g 
were obtained from B & K Universal Limited and habituated for at least 3 days before the 
commencement of any experiments. Rats were housed in groups of 4-5 in individually ventilated 
cages and maintained on a twelve hour light-dark cycle. 
 
4.2.2 Exclusion Criteria: 
 
Animals which did not display a 30% reduction in ipsilateral paw withdrawal threshold following 
L5 SNT were excluded from the neuropathy group. In addition, animals which displayed a 30% 
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reduction in ipsilateral paw withdrawal threshold following sham surgery were excluded from the 
sham group. Animals were also excluded if they caught the side of the chamber or if the animal 
managed to escape the chamber during the test. Details of excluded animals are displayed in the 
extended methods form in appendix 1. 
 
4.2.3 Randomisation: 
 
Animals were assigned to treatments in cage groups by picking numbers out of a hat. 
 
4 .2.4 Modified Forced-Swim Test: 
 
A modified protocol, based on the original test developed by Porsolt (Porsolt et al., 1978), was 
used to assess depression-like behaviour in male Wistar rats. A detailed protocol can be found in 
(Detke et al., 1995). Briefly, animals were placed in a clear circular container, 19cm in diameter, 
filled to a depth of 28cm with 25°C water. Animals underwent a 15 minute pre-test session 
followed 24 hours later rats by a second 5 minute test session. Sessions were recorded using an 
infrared video camera (Sanyo VCB 3372) placed at the side of the chamber, linked to a computer 
with video capture software. Following each session animals were dried with a paper towel and 
placed in a heated plexiglass box in order to dry out. The water was replaced after every session. 
 
4.2.5 Protocol Optimization: 
In order to optimise the protocol preliminary investigations were run under different light 
intensities. Tests were carried out at 4lux and 60lux and the total time spent immobile timed 
using a stopwatch.  
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4.2.6 Protocol Validation: 
 
In order to confirm the pharmacological validity of the test in our hands, the effects of 
amitriptyline on behaviour within the forced swim test were investigated. Amitriptyline HCl 
(Sigma-Aldrich) was dissolved in saline and administered by i.p. injection with a 23g needle at a 
dose of 10mg/kg and a dilution of 1ml/kg. Control animals received an injection of saline vehicle 
at 1ml/kg. Injections were carried out immediately following the 15 minute pre-test session and 
then again at 19h and 1h before the 5 minute test session. Behaviours were scored using a method 
developed by Detke et al (See section 4.2.10). (Detke et al., 1995). 
 
4.2.7 L5 SNT and sham surgery: 
 
A detailed method for L5 SNT and sham surgery can be found in appendix 1. Briefly, rats were 
deeply anaesthetised with isoflurane. The L6 transverse spinous process was exposed by blunt 
dissection. Hemi-laminectomy was undertaken in order to expose the L4 and 5 spinal nerves. The 
L5 spinal nerve was identified, ligated and transected 1-2mm distal to the ligature. In sham 
animals, an identical procedure was performed except hemi-laminectomy, ligation and 
transection were not executed. 
 
4.2.8 von Frey Sensory Testing: 
 
All von Frey sensory testing was carried out by a blinded observer, unaware to which group 
animals were allocated. A detailed method of von Frey testing can be found in appendix 1. 
Briefly, animals were placed within individual Plexiglass testing chambers for two 1 hour 
habituation sessions, on separate days, prior to testing. Baseline paw withdrawal threshold was 
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determined for each animal using a calibrated force transducer device. The transducer was 
applied to the mid-plantar surface of each hind paw in turn at a steady rate until an active limb 
withdrawal response was observed. Mean paw withdrawal threshold was calculated from a set of 
5 applications to each limb. Baseline measurements were taken on two separate occasions, at 
least 24 hours apart, in order to reduce any variability caused by the rat’s exposure to a novel 
testing method. The average results obtained were taken to represent true baselines. Testing was 
carried out at post-operative day 14 for the 2 week time point and post-operative day 21 for the 3 
week time point. 
 
4.2.9 L5 SNT Forced-Swim: 
 
Investigations into forced swim behaviour in L5 SNT and sham rats was carried out at 2 (post-
operative days 15-18) and 3 (post-operative days 23-26) weeks post surgery, in order to 
investigate the effect neuropathy behaviour on depression-like behaviour. Behavioural scoring 
methods are detailed below.  
 
4.2.10 Forced Swim Test Analysis: 
 
All analysis of forced swim test videos was performed by blinded observers who were not aware 
to which group each animal was allocated. For Protocol Optimisation (Section 4.2.5) only time 
spent immobile was recorded throughout the 5 minute trial.  
 
In the case of both the 2 and 3 week time points total time spent engaged in three behaviours: 
climbing, swimming and immobility, was recorded manually with a stop watch.  
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• Climbing was defined as rapid vertical movements of the fore paws, usually combined 
with rapid movements of the hind limbs, generally along the side of the chamber; 
• Swimming was defined as behaviour involving prolonged and rapid movement of the tail. 
• Immobility was defined as absence of tail movement.  
 
In order to exclude movements involved in keeping stable in the water only behaviours 
undertaken for longer than 3 seconds were recorded.  This analytical method will henceforth be 
referred to as method 1. 
 
To further validate the results obtained in our forced swim test a second analysis technique 
developed by Detke et al was also employed to re-score the behaviour of animals at the 3 week 
time point (Detke et al., 1995). Behaviours were redefined in line with those used previously with 
this technique (Detke et al., 1995;Cryan et al., 2005b).  
 
• Climbing was defined as above.  
• Swimming was defined as directed movement, usually horizontal, throughout the chamber.  
• Immobility was defined as movements only directed towards keeping the animals head 
above water.  
 
The session was separated into 5 second periods and the behaviour within each period assigned to 
one of the above categories according to the dominant activity undertaken. This technique has 
previously been validated against simple timing of each behaviour with a stopwatch (Detke et al., 
1995). This second technique was also employed for the pharmacological validation of the forced 
swim test (Section 4.6.2). This analytical method with henceforth be referred to as method 2. 
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4.2.11 Statistical Analysis: 
 
Differences between baseline and post surgery hind limb withdrawal were investigated using the 
Student’s t-test (SigmaStat version 3.5). Differences between groups in immobility, climbing and 
swimming behaviour were compared using Student’s t-test (SigmaStat version 3.5). In cases 
where data was not normally distributed Mann-Whitney Rank Sum analysis (SigmaStat version 
3.5) was used to detect differences between groups. Correlations between forced swim test 
behaviours and ipsilateral hind limb hypersensitivity following L5 SNT were investigated using 
Pearson’s Correlation (SigmaStat version 3.5). In cases where data was not normally distributed 
Spearman’s Correlation (SigmaStat version 3.5) was used. 
 
4.3 Results: 
 
4.3.1 Effect of different light intensities on immobility time in the forced swim test: 
 
No difference in immobility time was detected between rats in the forced swim test at 4lux or 
60lux (Student’s t-test; p=0.979) (Fig 4.3.1 A).  However, the standard error of the mean (SEM) 
suggested a lower level of variability in the 60lux group. Therefore, the remainder of behavioural 
studies were undertaken at this light level. 
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Figure 4.3.1 A: Time spent immobile in the forced swim test in seconds at different light 
intensities, 4lx (n=6) and 60lx (n=6). MEAN±SEM time spent immobile in seconds.  
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4.3.2 Effect of chronic amitriptyline on behaviour in the forced swim test (Analysis method 2): 
 
Chronic administration of amitriptyline resulted in a decrease in immobility counts (Student’s t-
test; p=0.04) and an increase in climbing counts in the forced swim test (Mann-Whitney Rank 
Sum Test; p=0.009). Swimming behaviour was not altered by amitriptyline administration 
(Mann-Whitney Rank Sum Test; p=0.174) (Fig 4.3.2 A). Thus, confirming antidepressant effects 
of amitriptyline in this forced swim paradigm, and validating the behavioural scoring used herein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4
behaviou
climbing 
compariso
 
 
 
 
.3.2 A: E
r in the 
behaviours
n to saline
ffect of a
forced swi
 when sam
 *p>0.05, *
mitriptyli
m test. M
pled every
*p<0.01. 
ne (n=12)
EAN±SEM
 5 second
and salin
 counts f
s in the fo
e (n=12) 
or immobi
rced swim
administr
lity, swim
 test. Diffe
166
ation on 
ming and 
rences in 
 
167 
 
4.3.3 Effect of L5 SNT on rat forced swim test behaviour at 2 weeks post-surgery:  
 
Transection of the L5 spinal nerve resulted in a significant decrease in the ipsilateral paw 
withdrawal threshold to punctuate mechanical stimuli, as compared to baseline withdrawal 
threshold (Student’s t-test, p<0.001). Indicating the presence of a neuropathy induced mechanical 
hypersensitivity. No alterations in the ipsilateral paw withdrawal threshold were detected in the 
sham L5 SNT group, or in the contralateral paw of either of the groups tested (Fig 4.3.3 A). 
 
However, transection of the L5 spinal nerve did not result in altered immobility, swimming or 
climbing behaviour in the forced swim test as compared to sham operated animals (Student’s t-
test, p=0.822; 0.686 and 0.452 respectively) (Fig 4.3.3 B). Suggesting that peripheral neuropathy 
did not induce depression like behaviour at this time point. 
 
No correlation was found between hind limb hypersensitivity and any of the behaviours at this 
time point (Fig 4.3.3 C-E) (Pearson’s Correlation: Immobility r=0.548, p=0.203; Swimming r=-
0.486, p=0.269; Climbing r=-0.728, p=0.0634). 
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4.3.4 Effect of L5 SNT on rat forced swim test behaviour at 3 weeks post-surgery:  
  
Transection of the L5 spinal nerve resulted in a significant decrease in the ipsilateral paw 
withdrawal threshold to punctuate mechanical stimuli, as compared to baseline withdrawal 
threshold (Fig 4.3.4 A) (Mann-Whitney Rank Sum Test, p<0.001). Indicating the presence of a 
neuropathy induced mechanical hypersensitivity. No alterations in the ipsilateral paw withdrawal 
threshold were detected in the sham group, or in the contralateral paw of either of the groups 
tested (Fig. 4.3.4 A).    
 
As stated in the methods section, forced swim test videos were scored using two alternative 
methods. Analysis using method 1 did not reveal any significant differences in immobility, 
swimming or climbing behaviour in the forced swim test between L5 SNT rats and sham 
operated animals (Fig. 4.3.4 B) (Student’s t-test, p= 0.352; 0.104 and Mann-Whitney Rank Sum 
Test, p=0.406 respectively). Suggesting that neuropathy did not induce depression-like behaviour 
at this time point. A correlation between % reduction in ipsilateral hind limb withdrawal and 
climbing behaviour was, however, revealed (Fig 4.3.4 E) (Spearman’s Correlation; r=0.531, 
p=0.0397). Indicating that the reduction in climbing behaviour was likely related to the 
neuropathy induced mechanical hypersensitivity. However, no other correlations were found 
between the hind limb hypersensitivity and immobility (Fig 4.3.4 C) or swimming behaviour (Fig 
4.3.4 D) (Spearman’s Correlation; Immobility r=-0.310, p= 0.262; Swimming r= 0.0993, p= 
0.725). 
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Analysis of forced swim test videos using method 2, an analytical paradigm developed by Detke 
and Lucki (Detke et al., 1995), did not reveal any differences in behaviour between L5 SNT rats 
and sham operated controls (Fig 4.3.4 F) (Student’s t-test: Immobility, p= 0.702; Swimming, p= 
0.217; Climbing, p= 0.351). This confirmed that no neuropathy induced depression-like 
behaviour was present, and that the lack of effect could not be put down to the behavioural 
scoring regime used. However, this method of scoring did alter the ratio of immobility:swimming 
due to the inclusion of tail motility not leading to movement around the chamber in the 
immobility score. A correlation between % reduction in ipsilateral hind limb withdrawal and 
climbing behaviour was also revealed using this analytical method (Fig4.3.4 I) (Pearson’s 
Correlation; r=0.605, p=0.0170). Adding further weight to the likely connection between 
neuropathy induced hypersensitivity and reduced climbing behaviour. However, no other 
correlations were found between the hind limb hypersensitivity and immobility (Fig 4.3.4 G) or 
swimming behaviour (Fig 4.3.4 H) (Pearson’s Correlation; Immobility r=-0.318, p= 0.247; 
Swimming r=-0.0889, p=0.753). 
 
 
 
 
 
. 
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4.4 Discussion: 
 
The data herein indicates that there is no clear link between L5 SNT and depression-like 
behaviour in the forced swim test at either two (Fig 4.3.3 B) or three weeks (Fig 4.3.4 B and 4.3.4 
D) post-surgery. The reduction in immobility observed in the forced swim test following chronic 
i.p. administration of amitriptyline (Fig 4.3.2 A) indicates that the test was pharmacologically 
valid under the stated conditions and that immobility behaviour was being scored correctly. 
Amitriptyline is a balanced serotonin and noradrenaline reuptake inhibitor (Sindrup et al., 2005) 
and as such would be expected to increase both swimming and climbing behaviour (Cryan et al., 
2005b). However, these data revealed an increase in climbing behaviour, which is mediated by 
the noradrenergic activity of antidepressants, alone (Fig 4.3.2 A). It is probable that this 
inconsistency is due to the position from which videos were captured. Cryan and colleagues have 
indicated that more accurate scoring of swimming behaviour can be obtained from videos 
captured from a top down view point, rather than the side on aspect used herein (Cryan et al., 
2005b). Any further studies undertaken in this laboratory should take this into account. 
 
Before discussing these results in reference to the previous literature it is important to discuss the 
methodological approach used to obtain them. Of particular importance is an understanding of the 
forced swim test itself, and its strengths and weaknesses as a measure of depression-like 
behaviour. In this experiment the cylinder used was 45cm high and 19cm wide with a depth of 
water of approximately 28cm. Traditionally, a relatively shallow level of water, 15-18cm, was 
used (Cryan et al., 2005b). At this depth of water animals spend more time immobile than at 
greater depths, presumably because their hind paws can reach the bottom of the tank (Cryan et al., 
2005b). This is desirable as the test was originally developed to screen for antidepressant efficacy 
174 
 
and the outcome measure most often used to measured efficacy is decreased immobility (Willner, 
1990;Cryan et al., 2005b).  
 
As the purpose of this study was to detect an increase in depression-like behaviour, i.e. an 
increase in immobility, a lower baseline level of immobility was desirable. For this reason, the 
modification in water depth instituted by Detke and colleagues was adopted (Cryan et al., 
2005b;Detke et al., 1995;Detke and Lucki, 1996). The increased depth of water used results in a 
lower duration of immobility and would therefore increase the likelihood of detecting an increase 
in depression-like behaviour (Cryan et al., 2005b). In addition we adopted the alternative scoring 
method developed by Detke and colleges, which was designed to reveal the noradrenergic and 
serotonergic components of antidepressant activity, in the hope of revealing neuropathy driven 
alterations in neuropharmacology (Detke et al., 1995;Detke and Lucki, 1996;Cryan et al., 2005b). 
In this scoring regime climbing and swimming behaviour are scored alongside immobility as they 
have been shown to be driven by the noreprinephrinergic and serotonergic aspects of 
antidepressant pharmacology respectively (Cryan et al., 2005b;Detke et al., 1995;Detke and 
Lucki, 1996). 
 
The predictive (pharmacological) validity of the modified forced swim test has been well 
documented and the ability to distinguish between antidepressants with different mechanisms of 
action makes it unique amongst animal models of depression. It should be noted, however, that 
some false positives, such a psychomotor stimulants, do exist (Cryan et al., 2005b). Because of 
the possible confounding effects of neuropathy induced motor dysfunction it would be desirable 
to include an independent measure of locomotion in future studies.  
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The face validity of the forced swim test relies on the fact that immobility is related to a reduced 
proclivity towards sustained effort, giving up due to ‘behavioural despair’, rather than a general 
reduction in locomotion. This is thought to correspond to the fact that within a clinical setting 
depressed patients display the greatest level of psychomotor impairment in tests that require a 
prolonged effort (Cryan and Mombereau, 2004;Willner, 1990;Weingartner and Silberman, 1982). 
It should be noted that a great deal of controversy surrounds precisely what immobility within the 
forced swim test actually represents. Some argue that it represents and adaptive strategy designed 
to save energy, indeed it has been demonstrated that animals that show increased immobility 
early on are protected from sinking following prolonged exposure to the test (Nishimura et al., 
1988). As Cryan and Mombereau point out, however, the varied factors such as stress, alterations 
in sleep or food intake and genetic predisposition that both impact on human major depression 
and forced swim test immobility add weight to its use as a measure of depression-like behaviour 
(Cryan and Mombereau, 2004). The construct validity of the forced swim test is dependent on the 
inescapability of the chamber and the assertion that this leads to despair or hopelessness, which 
are common symptoms of depression, expressed as immobility. It has been argued that his same 
state can be induced in people by uncontrollable situations (Willner, 1990).  
 
Despite the above stated controversies the forced swim test’s strong predictive validity, and the 
fact that many environmental and developmental factors impact on both depression in humans 
and immobility in the forced swim test, make it an attractive test of depression. However, it 
would be useful to investigate putative depression-like behaviour in models of neuropathic pain 
using other paradigms, such as the sucrose preference test which models anhedonia (Vollmayr et 
al., 2004). 
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The data herein contrast with a number of studies which have demonstrated depression-like 
behaviour in the forced swim test in both rat (Leite-Almeida et al., 2009;Hu et al., 
2009;Goncalves et al., 2008;Zeng et al., 2008;Hu et al., 2010) and mouse (Norman et al., 
2010;Suzuki et al., 2007) models of neuropathic pain. This association has not, however, been 
shown consistently throughout all studies (Zeng et al., 2008;Leite-Almeida et al., 2009;Hasnie et 
al., 2007b;Benbouzid et al., 2008a). It is difficult to directly compare studies due to the different 
methodology, species and strains used (Table 4.4 A). However, some broad trends may be 
derived from the results.  
 
Table 4.4 A: Summary of studies investigating the effect of neuropathy on forced swim test 
behaviour.  
Author Species Strain Model Test Outcomes Behavioural Change 
Analgesic 
Sensitivity 
Gonclaves 
et al., 2008 Rat (M) Wistar-Han SNI FST Activity ↓ Not tested 
Hu et al., 
2009 Rat (M) Wistar CCI FST 
 
 
Immobility 
Swimming 
Climbing 
 
 
↑ 
↔ 
↓ 
Desipramine 
GW4058833 
↓↓ 
↔↔ 
↑↑ 
Hu et al., 
2010 Rat (M) 
Sprague-
Dawley L5 SNL FST 
 
 
Immobility 
 
 
↑ 
Amitriptyline 
Lornoxicam 
↓↔ 
Leite-
Almeida et 
al., 2009 
 
Rat(M, 
three ages) 
Wistar-Han 
Young 
Mid 
Old 
SNI FST 
Immobility (latency) 
 
 
Immobility (duraton) 
↔  ↔  ↔ 
 
 
↔   ↑   ↔ 
Not tested 
Norman et 
al., 2010 Mouse (M) C57/BL6 SNI FST Immobility ↑ Not tested 
Suzuki et 
al., 2007 Mouse (M) C57/BL6 L5 SNL FST Immobility 
P2 ↔ 
P7↔ 
P15↑ 
P30↑ 
P56↑ 
Not tested 
Zeng et al., 
2008 Rat(M) 
Wistar 
 
Wistar-
Kyoto 
CCI FST Immobility P3 ↔ ↑ P7 ↔ ↑ Not tested 
Abbreviations: CCI-chronic constriction injury; SNI- spared nerve injury; L5 SNL- L5 spinal nerve ligation; P-days 
post surgery; FST-forced swim test; M-male. 
Key: ↓ reduction; ↑ increase; ↔ no change; + amelioration of anxiety-like behaviour; - no change in anxiety-like 
behaviour. 
 
A time course study investigating the onset of depression-like behaviour in L5 spinal nerve 
ligated mice suggests that duration of neuropathy may be an important factor in altered forced 
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swim test behaviour (Suzuki et al., 2007). Comparison of forced swim test behaviour in Wistar 
rats with chronic constriction injury from two papers also suggests that depressive behaviour may 
be time dependant, although time of onset appears to vary depending on the rat strain (Zeng et al., 
2008;Hu et al., 2009). Similarly, comparing two studies investigating spared nerve injury induced 
depression-like behaviour in Wistar-Han rats shows differing results at different neuropathy 
durations (Goncalves et al., 2008;Leite-Almeida et al., 2009). Interestingly, the effect of 
neuropathy also appears to vary depending on the age of the animal, with only mid-aged (9 
month) animals showing neuropathy induced depression-like behaviour at 33 days post-spared 
nerve injury (Leite-Almeida et al., 2009). 
 
It may be that neuroanatomical changes with a slow onset are responsible for the induction of 
depression-like behaviour. Indeed, the presence of neurogenesis related hypertrophy in the 
amygdala of spared nerve injury rats displaying depression-like behaviour, concurs with this 
theory (Goncalves et al., 2008). Unfortunately, neither the time course nor the onset of this 
neuroplasticity was investigated thus it cannot be determined whether it was concurrent with the 
development of depression-like behaviour.  The data in the 3 week study (Fig 4.3.4B + 4.3.4D) 
are taken from a time points which are comparable with those in the positive chronic constriction 
injury study (Hu et al., 2009), although they are significantly lower in duration than the endpoint 
showing depression associated neurogenesis (Goncalves et al., 2008).  
 
It may be that depression-like behaviour in the L5 SNT model takes longer to develop than in the 
chronic constriction injury model, or that differences in the pathological phenotype mean that 
depressive behaviour is simply not induced. Although both these models involve partial damage 
to the sciatic nerve they do have a number of distinctions. Comparison of chronic constriction 
injury with spinal nerve ligation, upon which our model is based, showed differences in a number 
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of behavioural outcomes including more frequent paw lifting and a longer duration of 
hypersensitivity to von Frey hairs in the chronic constriction injury model (Dowdall et al., 2005). 
The frequency of paw lifting may be particularly important as this is thought to be an index of 
spontaneous pain (Djouhri et al., 2006). The presence of spontaneous or ongoing pain may be 
required for the expression of depression-like behaviour, as suggested by the amelioration of 
increased immobility by analgesic treatment in the chronic constriction injury model (Hu et al., 
2009). Although a direct comparison between the spinal nerve ligation and SNT models has not 
been made, the models share many similarities and spontaneous foot lifting has not been 
observed regularly in this laboratory. The absence of this behaviour should not be regarded as 
definitive proof that spontaneous or ongoing pain are absent in the L5 SNT model. However, the 
presence of a different behavioural phenotype may go some way towards explaining the lack of 
depression-like behaviour in this study. 
 
Work in a mouse model of neuropathic pain has shown that depression-like behaviour is linked to 
increased IL-1β mRNA expression in the frontal cortex and that intracerebroventricular 
administration of an IL-1β antagonist attenuated the neuropathy-induced increase in forced swim 
test immobility (Norman et al., 2010). Studies have demonstrated L5 SNT induced increases in 
inflammatory mediators, including IL-1β, in the rat brain, thus, it seems unlikely that these results 
are due to a lack of neuropathy induced neuroinflammation (Liu et al., 2007;Zhu et al., 2009).  
 
Rat strains with a predisposition towards depressive behaviour appear to be susceptible to a more 
rapid onset of depression-like behaviour following chronic constriction injury and, in addition, 
show increased ipsilateral hind limb hypersensitivity (Zeng et al., 2008). In another study using 
L5/6 spinal nerve ligation in Sprague-Dawley rats, however, level of pre-surgery depression-like 
behaviour was not predictive for post-surgery hypersensitivity (Kontinen et al., 1999). No 
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correlation between ipsilateral hind limb hypersensitivity following L5 SNT and time spent 
immobile in the forced swim test was detected at either time point assessed herein. Interestingly, 
a negative correlation between severity of hind limb hypersensitivity and time spent climbing was 
observed at three weeks using both methods of analysis (Fig 4.3.4C + 4.3.4E). The r2 value 
indicates that approximately a third of the variation in climbing behaviour can be explained by 
the extent of hind limb hypersensitivity (31.6% and 36.7% for timed and counted measures 
respectively). Rats use their hind limbs extensively during climbing and it is likely that the 
correlation simply reflects animals avoiding the discomfort associated with excessive movement 
of sensitised limbs. It is, however, possible that this correlation reflects neuropathy related 
neurophysiological dysfunction. As previously mentioned, studies have shown that increased 
climbing behaviour can be driven by the noreprinephrinergic component of antidepressant 
pharmacology (Cryan et al., 2005b;Detke et al., 1995;Detke and Lucki, 1996). Further, chronic 
antidepressant treatment has been shown to reverse neuropathy associated hind limb 
hypersensitivity via a β2-andrenoceptor dependant mechanism (Yalcin et al., 2009a;Yalcin et al., 
2009b).  Thus, it cannot be discounted that the reduction in climbing behaviour may, in part, be 
due to dysfunction of the noradrenergic system, which is also driving hind limb hypersensitivity.  
 
Conclusion: 
 
The present study was unable to prove the hypothesis that L5 SNT results in depression-like 
behaviour in the forced swim test. As previously stated duration of neuropathy appears to be an 
important factor in the induction of depression-like behaviour in the forced swim test. It may, 
therefore, be desirable to conduct some longer term studies into the effect of L5 SNT on 
depression-like behaviour. However, the cost of lengthy animal studies as well as the animal 
welfare implications of long term studies into putatively painful conditions should not be ignored 
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when considering the appropriateness of the forced swim as a behavioural outcome measure in 
studies investigating neuropathic pain. 
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Chapter 5 
 
 
 
Assessment of Burrowing Behaviour in a Rat Model of 
Peripheral Neuropathy  
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5.1 Introduction: 
 
As fossorial rodents rats are adapted to digging, often constructing extensive and complex 
systems of burrows in the wild (Calhoun, 1962). Comparison of the burrows constructed by wild 
rats and albinos show no apparent differences suggesting that this behaviour has been highly 
conserved despite the domestication process (Boice, 1977).  
 
Burying and digging behaviours have been extensively used as behavioural outcome measures in 
addiction and anxiety research (Darmani et al., 1991;Rayner et al., 1988;El-Kadi and Sharif, 
1995a;El-Kadi and Sharif, 1996;El-Kadi and Sharif, 1995b;Sharif and El-Kadi, 1996;Deacon, 
2006b;Brodkin et al., 2002). Recently a sensitive behavioural assay involving burrowing, the 
excavation of a hollow container, rather than digging, has been developed by Robert Deacon of 
Oxford University. Deacon and others have demonstrated that rodents presented with a hollow 
tube filled with a gravel-like substrate spontaneously and vigorously excavate it. This activity is 
thought to represent tunnel maintenance behaviour which would be engaged in following collapse 
of a burrow in the wild (Deacon, 2006a). 
 
Burrowing behaviour has been shown to be perturbed in an animal model of Alzheimer’s disease 
and by a number of CNS insults, including cortical and hippocampal lesions and prion infection 
(Deacon and Rawlins, 2005;Deacon et al., 2003;Guenther et al., 2001;Deacon et al., 2009). 
Systemic inflammation, induced by both bacterial and viral insults, has also recently been shown 
to attenuate this behaviour (Teeling et al., 2007). The wide range of pathologies affecting 
burrowing behaviour has lead to the assertion that it represents a sensitive measure of “well-being” 
in rodents (Deacon, 2006a).  
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As previously stated, the burden of negative affect associated with persistent pain combined with 
the disruption of normal work and social activities can have a profound effect on a patient’s well 
being (Craig, 2006;Galvez et al., 2007). Further there is an overlap between brain regions 
important in the expression of burrowing behaviour and those affected by nerve injury in rat 
models of neuropathic pain (Deacon et al., 2003;Metz et al., 2009;Millecamps et al., 2007). 
Therefore, an investigation was undertaken into putative changes in burrowing behaviour in two 
nerve injury based models of neuropathic pain. 
 
Hypothesis: 
 
Traumatic peripheral neuropathy, resulting in prolonged ipsilateral hind limb hypersensitivity, 
will perturb burrowing behaviour due to the affective disturbances related to altered nociceptive 
processing. 
 
5.2 Methods:  
 
5.2.1 Animals: 
 
Detailed information can be found in appendix 1. Briefly, male Wistar rats weighing 180-220g 
were obtained from B & K Universal Limited and habituated for at least 3 days before the 
commencement of any experiments. Rats were housed in groups of 4 in individually ventilated 
cages and maintained on a twelve hour light-dark cycle. 
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5.2.2 Exclusion Criteria: 
 
Animals which did not display a >30% reduction in ipsilateral paw withdrawal threshold 
following L5 SNT were excluded from the neuropathy group. In addition, animals which 
displayed a >30% reduction in ipsilateral paw withdrawal threshold following sham surgery were 
excluded from the sham group. In addition to general exclusion criteria animals with burrowing 
baselines less than two standard errors below the mean were excluded as unreliable burrowers. 
Details of excluded animals are displayed in the extended methods form in appendix 1. 
 
5.2.3 Randomisation: 
 
Animals were assigned to treatments in cage groups by picking numbers out of a hat. 
 
5.2.4 Burrowing Test: 
 
Burrowing behaviour was assessed according to a protocol modified from Deacon, 2006 (Deacon, 
2006a). Burrows consisted of a plastic tube 32 cm long and 10 cm in diameter closed off at one 
end and filled with 3kg of 10 mm pea shingle (B&Q, UK). The open end of the tube was raised 
60 mm above the cage floor by two 80mm bolts, placed 25 mm from the open end of the tube and 
spaced 70 mm apart (Fig 5.2 A).  
 
A single burrow was placed in an individually ventilated cage with the food hoppers removed and 
food and water available ad libitum. Animals were introduced to burrows in home cage groups 
for 2 hours in order to increase burrowing behaviour via social facilitation (Deacon, 2006a). At 
least 24 hours after group introduction baseline burrowing ability was assessed. Assessment of 
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burrowing was carried out under low lighting conditions (4lx). Animals were placed singly into 
individually ventilated cages containing burrows for 2 hours after which the weight of substrate 
removed was calculated. All burrowing sessions were begun shortly before the beginning of the 
dark cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 A: Diagram of burrowing apparatus. Taken from (Deacon, 2006a) 
 
5.2.5 L5 SNT, partial sciatic nerve ligation (PSNL) and sham surgeries: 
 
A detailed method for L5 SNT and sham surgery can be found in appendix 1. Briefly, rats were 
deeply anaesthetised with isoflurane. The L6 transverse spinous process was exposed by blunt 
dissection. Hemi-laminectomy was undertaken in order to expose the L4 and 5 spinal nerves. The 
L5 spinal nerve was identified, ligated and transected 1-2mm distal to the ligature. In sham 
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animals, an identical procedure was performed except hemi-laminectomy, ligation and 
transection were not executed. 
 
For PSNL surgery, rats were deeply anaesthetised with isoflurane. The left sciatic nerve was 
exposed just above its trifurcation and between 1/3 and 1/2 of the nerve was tightly ligated with a 
7–0 non-absorbable silk suture (Mersilk, Ethicon UK). In sham animals, the sciatic nerve was 
exposed in the same way but not ligated. 
 
5.2.6 von Frey Sensory Testing: 
 
A detailed method of von Frey testing can be found in appendix 1. Briefly, animals were placed 
within individual Plexiglass testing chambers for two 1 hour habituation sessions, on separate 
days, prior to testing. Baseline paw withdrawal thresholds were determined using a calibrated 
force transducer device. The transducer was applied to the mid-plantar surface of each hind paw 
in turn at a steady rate until an active limb withdrawal response was observed. Mean paw 
withdrawal threshold was calculated from a set of 5 applications to each limb. Baseline 
measurements were taken on two separate occasions, at least 24 hours apart, in order to reduce 
any variability caused by the rat’s exposure to a novel testing method. The average results 
obtained were taken to represent true baselines. Testing was carried out at post-surgery day 14. 
 
5.2.7 Post-surgery Burrowing: 
 
Post-surgery burrowing ability was then assessed as above between post-surgery days 15 and 16.  
 
 
187 
 
5.2.8 Statistical Methods: 
 
Differences between baseline and post surgery hind limb withdrawal were investigated using the 
Student’s t-test (SigmaStat version 3.5). Differences in burrowing behaviour were investigated 
using one way ANOVA Holm-Sidak method (SigmaStat version 3.5). Correlations between hind 
limb hypersensitivity and burrowing behaviour were investigated using Pearson’s Correlation 
(SigmaStat version 3.5). 
 
5.3 Results: 
 
5.3.1 Effect of traumatic peripheral neuropathy on hind limb hypersensitivity and burrowing 
behaviour: 
 
Both PSNL and L5 SNT groups exhibited a marked reduction in ipsilateral hind limb withdrawal 
threshold at post-surgery day 14 (Student’s t-test p<0.001). Indicating the presence of a 
neuropathy induced mechanical hypersensitivity in both models of neuropathic pain. A reduction 
in ipsilateral paw withdrawal threshold occurred 14 days after sham PSNL surgery (Student’s t-
test p<0.05). However, none of the reductions in hind limb withdrawal reached the 30% threshold 
after which the animals would be considered to be exhibiting a peripheral neuropathy. No 
alteration in the ipsilateral paw withdrawal threshold was detected in the naïve or sham L5 SNT 
groups, or in the contralateral paw withdrawal threshold of any of the groups tested (Fig 5.3.1 A).   
 
Rats displaying a 30% reduction in ipsilateral paw withdrawal threshold at P14 in both the PSNL 
(One Way ANOVA, P=0.005) (Fig 5.3.1B) and L5 SNT (One Way ANOVA, P=0.015) (Fig 
5.3.1D) groups exhibited reduced burrowing behaviour compared to naïve controls. Indicating the 
188 
 
presence of a neuropathy induced dysfunction in burrowing behaviour in both models of 
neuropathic pain. No significant difference in post-surgery burrowing behaviour was evident 
between naïve and sham PSNL rats or between sham PSNL and PSNL rats (Fig 5.3.1B). Nor was 
there any significant difference in post surgery burrowing behaviour between naïve and sham 
SNT rats or between sham SNT and SNT rats (Fig 5.3.1D). These results suggest that sham 
animals occupied an intermediate position between neuropathic and naive animals. 
 
No correlation was found between ipsilateral hind limb hypersensitivity and burrowing behaviour 
in either L5 SNT (Fig 5.3.1C; r=0.384; p=0.217) or PSNL (Fig 5.3.1E; r=0.483; p=0.158) groups. 
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5.4 Discussion: 
 
Investigation of burrowing behaviour in rats revealed a perturbation in the burrowing behaviour 
of L5 SNT (Fig 5.2.1D) and PSNL (Fig 5.2.1B) rats as compared to naïve animals. The sham 
operated controls in both models of neuropathic pain appear to occupy an intermediate position 
with no statistically significant difference between either the naïve of neuropathy groups.  
 
It should be noted that these data represent values obtained from at 2 hour rather than overnight 
paradigm. The 2hr test is more sensitive but also more variable and as such it may mask putative 
group differences (Deacon, 2006a;Cunningham et al., 2003). It would, therefore, be desirable to 
repeat this study using the overnight paradigm as detailed in the Nature Protocols paper (Deacon, 
2006a). 
 
As this is a preliminary investigation of a relatively new outcome measure, the validity of 
burrowing behaviour in studies investigating neuropathic pain must be discussed. It is important 
to put burrowing in context as a measure of behavioural dysfunction in animal models of 
neuropathic pain. Unlike more established behavioural measures, such as those investigating 
anxiety-like behaviour, burrowing does not appear to represent a single emotional correlate 
between rats and humans. Deacon suggests that due to its sensitivity, and attenuation in a wide 
range of conditions, burrowing behaviour represents a measure of overall ‘well being’ in rodents 
(Teeling et al., 2007;Deacon et al., 2005;Deacon and Rawlins, 2005;Deacon et al., 2003;Guenther 
et al., 2001;Deacon, 2006a;Cunningham et al., 2007).  
 
This explanation does, however, present some problems when attempting to make comparison 
between the symptomatic burden of patients and the behaviour of laboratory animals. Not the 
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least of which is the degree of anthropomorphism required to define comparable measures of 
‘well being’ between humans and rodents. Parallels can be drawn between the disruption of 
burrowing behaviour and the reduction in measures of quality of life, such as ability to work, 
often observed in those suffering from chronic neuropathic pain (Tolle et al., 2006;McDermott et 
al., 2006;Gore et al., 2006;Galvez et al., 2007;Otto et al., 2007;Deshpande et al., 2006).  
 
The predicative validity of burrowing as a measure of ‘well being’ has yet to be extensively 
investigated. However, inflammation induced reduction in burrowing behaviour has been shown 
to be attenuated by treatment with non-steroidal anti-inflammatory drugs (Teeling et al., 2007). 
 
As an activity which is spontaneously and vigorously undertaken, burrowing shares similarities 
with well established behavioural measures, such as wheel-running, and may have a rewarding 
aspect (Teeling et al., 2007;Ozburn et al., 2008;Deacon et al., 2005;Guenther et al., 2001;Deacon 
et al., 2001;Vargas-Perez et al., 2003;Deacon et al., 2008). Indeed the perturbation of glucose 
intake, an activity known to have hedonic value, follows a close temporal relationship with 
reduced burrowing behaviour following scrapie infection (Cunningham et al., 2003;Guenther et 
al., 2001;Cunningham et al., 2005). Further, altered protein expression linked to anhedonic 
behaviour has recently been demonstrated in the rat dentate gyrus, an area important in the 
expression of burrowing behaviour in rodents (Kedracka-Krok et al., 2010;Deacon and Rawlins, 
2005).  
 
Anhedonia is a common symptom of depression, an affective co-morbidity often seen in patients 
with neuropathic pain (Willner, 1990;Gore et al., 2005;Meyer-Rosberg et al., 2001). By this 
rational, attenuation of burrowing behaviour could be regarded as modelling a construct of 
depression-like behaviour associated with the affective aspects of neuropathic pain. Depression-
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like behaviour within the forced swim test has recently been observed in a number of rodent 
models of neuropathic pain (Goncalves et al., 2008;Porsolt et al., 1978;Suzuki et al., 2007;Zeng 
et al., 2008;Hu et al., 2007;Hu et al., 2009). Further, like burrowing behaviour, there appears to 
be a link between neuropathy induced depression-like behaviour in the forced swim test and 
inflammation (Norman et al., 2010;Teeling et al., 2007). However, these results have not been 
replicated in all studies (Zeng et al., 2008;Leite-Almeida et al., 2009) and could not be replicated 
using the L5 SNT model herein (See Chapter 4).  
 
In order to further investigate the hypothesis that reduced burrowing represents anhedonia, it 
would be interesting to investigate burrowing in rat strains which show a high degree of 
depression-like behaviour in behavioural tests, such as the Wistar-Kyoto strain (Pare, 2000). 
Assessment of burrowing behaviour in rats following induction of depression-like behaviour 
would also be a useful route to investigate this hypothesis. The chronic mild stress model would 
be suitable as it results in decreased expression of hedonic behaviour and has the advantage of 
having differential effects in resistant and non-resistant strains (Pucilowski et al., 1993). 
 
No correlation was found between degree of hind limb hypersensitivity and decrease in 
burrowing behaviour. Thus, it is unlikely that the reduction in behaviour is due to avoidance of 
pain caused by the burrowing process itself. Because rats use a combination of their fore and hind 
limbs during the excavation process and it may be that movement deficits caused by peripheral 
neuropathy are reducing the ability of the animals to burrow. It would be useful to investigate 
burrowing behaviour in a model of peripheral neuropathy, such as trigeminal neuralgia, which 
does not affect limb innervation (Vos et al., 1994).  
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As stated in previous sections a growing body of evidence suggests that chronic neuropathic pain 
is associated with altered activity in supraspinal nuclei (See section 1.4.3). One area of particular 
interest is the prefrontal cortex (PFC) which has been implicated in the pathophysiology of 
neuropathic pain both clinically (Hsieh et al., 1995;Gustin et al., 2010;Becerra et al., 
2006;Ducreux et al., 2006) and in animal models (Metz et al., 2009;Millecamps et al., 2007). 
Morphological changes and altered NMDA receptor expression have been demonstrated in this 
area in a rat model of neuropathic pain (Metz et al., 2009). Lesions to the PFC have been shown 
to attenuate burrowing behaviour in rodents (Deacon et al., 2003). Thus, altered function in the 
PFC may play a role in the attenuation of burrowing behaviour in rat models of peripheral 
neuropathic pain. 
 
The results herein suggest that the combined effects of surgery and peripheral neuropathy are 
required in order to attenuate burrowing behaviour. The aforementioned link between 
inflammation, burrowing and affective dysfunction in animal models of neuropathic pain may 
offer a possible explanation as both peripheral neuropathy and surgery itself result in 
inflammation (Liu et al., 2007;Norman et al., 2010;Teeling et al., 2007). The use of non surgical 
models such as the varicella zoster associated and Zalcitabine anti-retroviral induced neuropathy 
models would be useful in investigating the effects of peripheral neuropathy in isolation.  
 
Finally, it would be useful to investigate the effect of clinically efficacious drugs on burrowing 
behaviour in rat models of neuropathic pain. Treatment with an analgesic drugs such as 
gabapentin has previously been shown to ameliorate neuropathy-related affective dysfunction 
(Hasnie et al., 2007a;Roeska et al., 2008). As yet unpublished work carried out at Pfizer indicates 
that neuropathy-induced deficits in burrowing behaviour may be sensitive to amelioration by 
analgesic treatment (See Chapter 6).   
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Conclusion 
 
Burrowing behaviour appears to be perturbed by the combined effects of surgery and neuropathy. 
Future studies should investigate the effect of a non-surgical neuropathy model such as models of 
antiretroviral-related or varicella zoster-related neuropathy (Hasnie et al., 2007a;Wallace et al., 
2007b). As well as the effect of models that do not alter limb innervation (Vos et al., 1994). 
Recent studies using alternative behavioural outcome measures suggest that some behaviours 
may only be perturbed after prolonged neuropathy (Zeng et al., 2008;Suzuki et al., 2007;Hu et al., 
2009). Thus, it may be worthwhile undertaking longer term studies of burrowing behaviour in rat 
models of neuropathic pain. 
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Chapter 6 
 
 
 
Summary and General Discussion 
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6.1 Summary: 
 
The aim of this thesis was to further expand the burgeoning field of research into behavioural co-
morbidites in rodent models of neuropathic pain, in the hope of identifying novel outcome 
measures for screening analgesic agents. The importance of bias reduction is a central concern 
within this laboratory and is beginning to be recognised by basic scientists within the pain 
research field in general (Rice, 2010;Rice et al., 2008;Macleod et al., 2008;Kilkenny et al., 2010). 
As a result the experiments in this thesis were performed by blinded observers. Proper 
randomisation of the studies conducted herein would have required mixing of animals with 
peripheral neuropathies with those without nerve injuries. Recent work demonstrating an 
empathy-like emotional contagion effect in cage mates simultaneously exposed to noxious 
stimuli, lead to concern that mixing animals with and without peripheral neuropathies may alter 
their behaviour in affect-related tests (Langford et al., 2006;Preston and de Waal, 2002). Hence, 
an investigation into the effect of cage mate neuropathy status on open field behaviour was 
carried out (See Chapter 2). This study demonstrated the sensitivity of open field behaviour to 
modulation by cage mate neuropathy (Fig. 2.3.1B-D). The most striking result was a significant 
reduction in the distance moved in naive rats housed with animals with peripheral neuropathies 
(Fig. 2.3.1D). With these findings in mind the view was taken that full randomisation of 
treatment would be likely to impact adversely upon behavioural outcome measures used herein 
and treatments were randomly allocated to cage groups rather than individual animals in the 
studies that followed. 
 
In order to further expand the behavioural measures available to examine anxiety-like behaviour 
in rodent models of neuropathic pain a study investigating the effect of L5 spinal nerve 
transection (L5 SNT) on behaviour in a dark/light preference test was carried out (See Chapter 3). 
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The major anxiety-related outcome measures time spent in the dark chamber, entries to the light 
chamber and latency to enter the light chamber, were validated using the anxiogenic drug 
yohimbine (Fig. 3.3.1 A-C). L5 SNT was found to result in an increase in anxiety-like behaviour 
in the dark/light preference test as measured by time spent in the dark chamber and entries to the 
light chamber (Fig 3.3.2 B+D). Unlike a similar open field study carried out in this laboratory, no 
correlation between either of these anxiety measures and degree of ipsilateral hind limb 
hypersensitivity was found (Hasnie et al., 2007a). Principal component analysis of different 
exploratory tests of anxiety suggests that, although seemingly similar, behaviours in individual 
tests are driven to a greater or lesser extent by different underlying factors  (Belzung and Le Pape, 
1994). This fact underlines the importance of investigating neuropathy-related anxiety-like 
behaviour using various different tests and may explain the different relationship between hind 
limb hypersensitivity and anxiety-like behaviour in the open field and dark/light preference tests. 
 
Following acute intraperitoneal administration of the analgesic drug gabapentin, or a vehicle 
preparation, no differences in anxiety-like behaviour in the dark/light preference test were 
detected between groups (Fig. 3.3.3 B+C). This suggests that, using this experimental protocol, 
the dark/light preference test is not an appropriate outcome measure for use in future drug 
development studies. A number of studies have demonstrated anxiety-like outcome measures are 
sensitive to clinically efficacious analgesics in rodent models of neuropathic pain (Matsuzawa-
Yanagida et al., 2008;Hasnie et al., 2007a;Wallace et al., 2007a;Roeska et al., 2008). Work in 
another rat model of peripheral neuropathy suggests that acute administration of gabapentin 
results in only brief reversal of hind limb hypersensitivity while chronic administration causes 
more long lasting analgesia (Benbouzid et al., 2008b). It would be interesting to carry out further 
work to see whether the dark/light preference test was sensitive to this difference between acute 
and chronic treatment as this would offer an explanation for the above results. 
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A number of studies have demonstrated the presence of depression-like behaviour in rat models 
of peripheral neuropathy (Leite-Almeida et al., 2009;Hu et al., 2009;Hu et al., 2010;Goncalves et 
al., 2008;Norman et al., 2010;Suzuki et al., 2007). In order to expand the repertoire of outcome 
measures utilised in this laboratory a study into the effect of L5 SNT on behaviour in the forced 
swim depression test was carried out (See Chapter 4). The depression related outcome measure, 
time spent immobile, was validated using the anti-depressant drug amitriptyline. Repeated 
intraperitoneal injections resulted in a reduction in time spent immobile within the forced swim 
test indicating that the test was valid under the stated conditions and that behaviour was being 
correctly scored (Fig 4.3.2 A). L5 SNT did not result in an increase in depression-like behaviour, 
as measured by time spent immobile in the forced swim test, at either two or three weeks post-
neuropathy (Fig. 4.3.3 B +  4.3.4 B). The majority of studies showing an increase in depression-
like behaviour in the forced swim test following peripheral neuropathy used longer time points 
(Goncalves et al., 2008;Hu et al., 2009;Hu et al., 2010;Leite-Almeida et al., 2009). Further, there 
is evidence that this behaviour is dependent on neuroplastic changes which may take time to 
develop (Goncalves et al., 2008). It may be that a longer duration of neuropathy would have 
resulted in depression-like behaviour in the forced swim test following L5 SNT.  
 
The final study detailed herein investigated the effect of L5 SNT and partial sciatic nerve ligation 
(PSNL) on burrowing behaviour (See Chapter 5).  Both L5 SNT and PSNL resulted in a 
significant decrease in burrowing behaviour compared to naive animals with sham animals 
occupying an intermediate position between nerve injured and naive animals (Fig 5.3.1 B+D).  
Unlike the anxiety and depression tests used in the previous chapters burrowing behaviour cannot 
be easily equated to any human co-morbidity associated with neuropathic pain.  The use of such 
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naturally expressed species specific behaviours as outcome measures in pain studies may offer a 
fruitful new direction of research. 
 
6.2 Study Limitations: 
  
Although the experiments contained within this thesis were fit to answer the relevant questions 
posed in each study some limitations and possible improvements can be identified with the 
benefit of hindsight. Some of these limitations have already been addressed in the chapter 
discussions but will be summaries here. 
 
6.2.1 Housing:   
 
The rats used in these studies were housed in a room which also contained mice. Although all 
animals were housed in individually ventilated cages incidental observation of olfactory 
behaviour in these cages would suggest that odour from outside the cage was detectable within it. 
Mixed housing of rats and mice is known to cause both species stress and can alter behaviour in 
affect-related outcome measures (Arndt et al., 2010). Unfortunately, such mixed housing was 
unavoidable due to practical constraints.  
 
Rats were provided with nesting material, however, no other environmental enrichment was 
provided. As previously mentioned, enrichment is known to affect anxiety-like behaviour and has 
also been shown to improve memory and cognition (Balcombe, 2006;Belz et al., 2003;Roy et al., 
2001;Schrijver et al., 2004;Schrijver et al., 2002). It may be that, due to lack of enrichment, 
natural rat behaviour is being restricted and thus behaviour within experimental outcome 
measures is also affected. Further, it would have been advantageous to have housed animals using 
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a reversed day night cycle so that behavioural tests could have been carried out in the more active 
nocturnal period. 
 
6.2.2 Choice of Animals/Animal model: 
 
The neuropathic pain model primarily used within this thesis was the L5 SNT model. However, 
as has been mentioned previously, other more clinically relevant models are now available 
(Hasnie et al., 2007a;Wallace et al., 2007b). Despite this fact it was felt that the L5 SNT model 
represented a useful model for investigation of novel measures of affective dysfunction due to its 
reproducibility and the high level of neuropathy related hypersensitivity displayed (Hasnie et al., 
2007a). The inclusion of a naive group in the burrowing study revealed a neuropathy-related 
dysfunction in this behaviour which would not have been detected if only sham animals had been 
used (See Chapter 5). It may have been advantageous to include a naive group in the studies of 
anxiety and depression-like behaviour to investigate whether sham animals occupied an 
intermediate position in these tests as in the burrowing study.  
 
6.2.3 Behavioural Tests: 
 
One major problem with the exploration based anxiety tests used in this thesis, which has already 
been discussed, is the possible confounding effect of movement dysfunction caused by peripheral 
neuropathy (See Chapter 3). The use of an independent activity monitoring cage would solve this 
problem and has already been employed in other studies (Kontinen et al., 1999;Suzuki et al., 
2007;Roeska et al., 2008;Roeska et al., 2007). In line with the convention established in this 
laboratory animals were placed into the centre of the arena in the open field test. However, this 
placement may have the disadvantage of causing in highly anxious animals to ‘freeze’ within the 
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inner zone and thus display an apparently non-anxious phenotype when calculating time spent in 
the inner zone. Recent studies within this laboratory using a model of visceral pain have 
demonstrated the utility of placing the animal in the outer zone. Using this protocol also allows 
the use of an additional outcome measure, namely latency to enter the inner zone (Fig. 6.2.3 A).  
 
 
Figure 6.2.3 A: Latency to inner the inner zone of the open field in naive (n=10), sham (n=9) 
and bladder inflamed (n=9) animals. MEAN±SEM time of entry the inner zone in seconds. 
Difference in comparison to naive *p<0.05. Adapted with permission from A. Novejarque & R. 
Morland from unpublished data.  
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6.2.4 Pharmacology:  
 
In the study investigating the effect of gabapentin on behaviour within the dark/light preference 
test reversal of hind limb hypersensitivity was not confirmed before testing of anxiety-like 
behaviour (See Chapter 3). The reasoning behind this was that von Frey testing before the 
dark/light preference test would cause stress and, thus, might confound the results of the 
dark/light preference test. However, it would have been useful to confirm reversal of hind limb 
hypersensitivity by gabapentin as an indicator of putative analgesia. As previously stated (See 
Section 3.4) a chronic dosing regimen would have allowed testing of mechanical hypersensitivity 
at a time point unlikely to affect anxiety-like behaviour and would also have been more clinically 
relevant. 
 
6.2.3 General Discussion and Future Work: 
 
6.2.1 Introduction: 
 
The ultimate purpose of all research within this field of research, including the work detailed 
herein, is achieving a reduction in the burden painful neuropathies exert on the life of patients. 
Neuropathic pain remains an area of major unmet clinical need and advances in treatment have 
not kept pace with advances in the understanding of the underlying pathophysiology (Dworkin et 
al., 2007;Finnerup et al., 2010;Campbell and Meyer, 2006). In the five years between the 
publication of two meta-analyses by Finnerup and colleagues only four truly novel potential 
treatments for neuropathic pain have been identified and the evidence base for these compounds 
is, as yet, sparse (Finnerup et al., 2005;Finnerup et al., 2010). Further, seemingly promising 
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analgesics with preclinical efficacy, such as NK-1 receptor antagonists, have failed to translate 
effectively into the clinic (Hill, 2000). The failure to adopt appropriate bias reduction techniques 
in preclinical research has a putative role in such incidents (Macleod et al., 2008;Rice, 2010;Rice 
et al., 2008;Lindner et al., 2003;Kilkenny et al., 2010). The use of models of traumatic 
neuropathy which have limited clinical relevance may also play a part in such disappointing 
results and is beginning to be addressed (Rice et al., 2008).  Similarly, inadequate reflex 
withdrawal based outcome measures which do not reflect those used in randomised control trials 
are potentially having a detrimental effect on the drug development process (Rice et al., 
2008;Mogil and Crager, 2004;Mogil, 2009). The growing use of affective outcome measures (See 
section 1.7) is an attempt to address this issue.  
 
6.2.2 Bias Reduction: 
 
The pain field is not alone in struggling to translate results from the laboratory to the clinic, and a 
movement is underway in a number of fields of animal research to use bias reduction techniques 
from clinical drug trials as a model for preclinical research (Macleod et al., 2008;Sena et al., 
2007;Rice et al., 2008;Perel et al., 2007;Kilkenny et al., 2010).  However, preclinical studies 
using animals, and in particular those using complex behavioural measures, present novel 
challenges and bias reduction techniques must be adopted with care and forethought. This 
assertion is underlined by the results obtained in the study investigating the effect of cage mate 
status on open field behaviour detailed in Chapter 2. Randomisation of treatment groups is an 
important bias reduction technique. According to the Bandolier website, which focuses on 
evidence based thinking in health care, failure to randomise in clinical drug trials can result in a 
41% over estimation of treatment effect (Rice et al., 2008). To fully randomise in the studies 
contained within this thesis would have required the mixed housing of neuropathic and non-
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neuropathic animals which appears to affect behaviour in the open field paradigm (See Chapter 2). 
Therefore, randomised allocation of treatments was carried out by cage group in the studies 
detailed here. Other bias reduction techniques are, however, likely to be better suited to the 
affect-related outcome measures used herein than traditional reflex withdrawal based outcomes. 
von Frey sensory testing, the major outcome measure in most studies of neuropathic pain, is 
vulnerable to observer bias due to the subjectivity involved in identifying withdrawal responses 
(Bove, 2006).  To some extent this problem can be ameliorated by observer blinding which was 
carried out in all the studies herein. However, neuropathy models can, in some cases, result in 
altered paw posture which may prevent proper blinding (Attal et al., 1990). As the majority of 
affective outcome measures utilise automated scoring of behaviours an extra safeguard against 
observer bias is present. Thus, the use of affective outcome measures may help to bring the rigor 
of bias reduction in animal studies in line with clinical studies. This should be a central feature in 
future preclinical work, particularly in the field of drug development (Rice et al., 2008). 
 
6.2.3 Clinical Co-morbidities to Affective Outcome Measures: 
 
As previously mentioned a great deal of work directed at improving the clinical relevance of 
animal models of neuropathic pain has recently been undertaken. Models of neuropathic pain 
caused by common clinical conditions such as HIV, varicella zoster virus and diabetes have been 
developed (Drel et al., 2007;Fleetwood-Walker et al., 1999;Hasnie et al., 2007a;Wallace et al., 
2007a;Wallace et al., 2007b;Wallace et al., 2008;Mogil, 2009;Rice et al., 2008). Studies have 
shown that these models often share pathophysiological features with the human conditions. For 
example, in human sensory ganglia latent herpes zoster DNA is predominantly found in neuronal 
cells of the dorsal root ganglia and this pattern is also reflected in the rodent model (LaGuardia et 
al., 1999;Kennedy et al., 1998;Kennedy et al., 2001). Similarly, in a recently characterised rodent 
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model of HIV neuropathy a reduction in epidermal fibre density comparable to that seen in the 
clinic has been reported (Wallace et al., 2007b;Polydefkis et al., 2002;Verma et al., 2005). The 
same logic that has driven researchers to replicate the pathophysiology of neuropathic pain as 
closely as possible has shaped the affect-related behavioural outcome measures which have been 
investigated thus far. Therefore, behaviours reflecting clinical co-morbidities of neuropathic pain 
such as sleep disturbances, anxiety and depression, have become the focus of research (Hasnie et 
al., 2007a;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 2008;Matsuzawa-Yanagida 
et al., 2008;Narita et al., 2006a;Narita et al., 2006b;Goncalves et al., 2008;Kontinen et al., 
2003;Monassi et al., 2003;Meyer-Rosberg et al., 2001;Norman et al., 2010;Meyer-Rosberg et al., 
2001;Goncalves et al., 2008;Benbouzid et al., 2008a;Hasnie et al., 2007a;Hasnie et al., 
2007b;Kontinen et al., 1999;Leite-Almeida et al., 2009;Suzuki et al., 2007;Seminowicz et al., 
2009;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 
2008;Roeska et al., 2008;Narita et al., 2006a;Matsuzawa-Yanagida et al., 2008;Narita et al., 
2006b). The substantive body of literature demonstrating the presence of behavioural co-
morbidities related to anxiety and depression in rodent models suggests that this is a sensible 
route of investigation to pursue (See Chapter 3+4 and sections 1.7.4+5) (Hasnie et al., 
2007a;Wallace et al., 2007a;Wallace et al., 2007b;Wallace et al., 2007c;Wallace et al., 
2008;Matsuzawa-Yanagida et al., 2008;Narita et al., 2006a;Narita et al., 2006b;Roeska et al., 
2008;Seminowicz et al., 2009;Suzuki et al., 2007;Benbouzid et al., 2008a;Leite-Almeida et al., 
2009;Hu et al., 2009;Hu et al., 2010;Goncalves et al., 2008;Norman et al., 2010). Demonstrating 
a similar symptomatic profile in animal models of neuropathic pain also serves to improve their 
face validity (Rice, 2010;Willner, 1990). 
 
 Complex behavioural outcome measures have begun to demonstrate efficacy in the resolution of 
supraspinal mechanisms of affective dysfunction in neuropathic pain (Narita et al., 2006a;Narita 
206 
 
et al., 2006b). As well as demonstrating site specific supraspinal actions of analgesics, such as 
antidepressants, generally thought to derive their actions purely from spinal and peripheral 
actions (Matsuzawa-Yanagida et al., 2008;Sindrup et al., 2005). Such insights are helpful in 
reiterating the importance of supraspinal processes in analgesic efficacy, and thus, should help in 
the development of novel analgesics. Affective outcome measures offer a possible translational 
bridge between imaging studies in patients, which are limited to detecting putative changes in 
neuronal activity, and animal models where specific neurotransmitter systems can be investigated 
and manipulated. Future studies should build on this foundation to further elucidate novel 
pathophysiological mechanisms of neuropathic pain. Indeed, as part of the practical work for this 
thesis research was conducted into the contributions of ascending spinal cord projection neurons 
in driving anxiety-like behaviour. Lamina I and II nociception specific projection neurons were 
ablated using the saporin conjugated to a selective form of substance P, [sar9, Met(O2)11]-
substance-P (Lawson et al., 1997;Sakurada et al., 1994;Wiley et al., 2007;Wiley and Lappi, 
1999;Todd et al., 2000). These neurons form part of the spinoparabrachioamygdaloid pathway, 
targeting the amygdala, a major anxiety centre in the brain (Braz et al., 2005;Rezayof et al., 
2009;Truitt et al., 2009;Jellestad and Garcia, I, 1986;Werka et al., 1978). Destruction of these 
neurons has been shown to block the development hind limb hypersensitivity for a sustained 
period in rat models of neuropathic pain (Nichols et al., 1999). However, despite confirming 
ablation of these neurons, these results could not be replicated in our hands, therefore this 
investigation was abandoned (Fig 6.23 A+B).  
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Figure 6.2.3 B: Effect of L5 SNT and sham surgery on ipsilateral paw withdrawal threshold 
in animals which received intrathecal injections of SSP-SAP and Blank-SAP. MEAN±SEM 
paw withdrawal to punctuate mechanical stimuli in grams. Difference in comparison to baseline 
*p<0.001. 
 
 
A number of affective outcome measures related to clinical co-morbidities have demonstrated 
sensitivity to efficacious analgesic drugs (Wallace et al., 2008;Matsuzawa-Yanagida et al., 
2008;Hasnie et al., 2007a;Roeska et al., 2008;Hu et al., 2010). However, their predictive validity 
is questionable due to evidence of sensitivity to non-analgesic compounds such as antidepressants 
and anxiolytics (Narita et al., 2006a;Wallace et al., 2008;Roeska et al., 2008;Hu et al., 2009). The 
obvious solution to this problem is to use a battery of behavioural outcome measures reflecting 
different aspects of clinical behavioural co-morbidities alongside more traditional reflex 
withdrawal outcome measures (Leite-Almeida et al., 2009;Goncalves et al., 2008;Hasnie et al., 
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2007b;Kontinen et al., 1999;Benbouzid et al., 2008a). A novel drug which was effective in all or 
many of the behavioural outcomes in such a battery would certainly be an appropriate candidate 
for further research. Indeed, the creation of such behavioural testing batteries which measure 
multiple putative aspects of pain may offer the best hope of detecting ongoing/spontaneous pain, 
and its amelioration, in animals. It is interesting to note that many of the efficacious drugs for the 
treatment of neuropathic pain have multiple sites and mechanisms of action (Finnerup et al., 
2010;Sindrup et al., 2005;Matsuzawa-Yanagida et al., 2008;Bian et al., 2006). Therefore, the 
creation of drug screens with multiple disparate outcome measures is a logical step. The selection 
of the most appropriate models and tests for these screens presents a major challenge for future 
studies which is already beginning to be addressed by multicentre research initiatives such as 
EUROPAIN (2010a). One final concern is the sensitivity of even well established affect-related 
outcome measures to disruption by environmental factors and changes to experimental protocol, 
attempts to mitigate such factors should be a central tenant during the design of new experimental 
protocols.  
 
6.2.3 Alternative Approaches: 
 
Rather than attempting to model the affective dysfunction found in many neuropathic pain 
patients, some researchers have chosen to use stimulus induced reversal of a rodent’s innate 
behaviour as a route to investigate the ‘unpleasantness’ of pain (LaBuda and Fuchs, 2005;LaBuda 
and Fuchs, 2000a;LaBuda and Fuchs, 2000b;LaGraize et al., 2004;LaGraize et al., 2006;Ansah et 
al., 2009;Ansah et al., 2010;Bourbia et al., 2010;Pedersen and Blackburn-Munro, 2006;Pedersen 
et al., 2007). So called place aversion paradigms use a two chamber apparatus similar to the 
dark/light preference box used in chapter 3.  Having confirmed the animal’s natural preference 
for the dark chamber, stimulation of the nerve injured paw is paired with presence in the dark and 
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stimulation of the unaffected paw with presence in the light. This stimulus pairing has been 
shown to result in the reversal of dark chamber preference in animals with peripheral 
neuropathies. Proponents of this behavioural testing paradigm contend that this reversal of 
preference is driven by the unpleasant affective component of pain, an assertion supported by the 
ability of analgesics to block reversal of place preference while not affecting hind limb 
hypersensitivity (Pedersen and Blackburn-Munro, 2006). The place avoidance paradigm has been 
shown to be sensitive to a number of clinically efficacious analgesics including gabapentin and 
morphine (Pedersen and Blackburn-Munro, 2006;LaBuda and Fuchs, 2000b). Further, the 
differential effects of supraspinal manipulations on place avoidance and hind limb 
hypersensitivity have implicated the involvement of various sites and specific transmitter systems 
in affective but not sensory discriminative aspects of pain (Pedersen et al., 2007;Ansah et al., 
2010;Ansah et al., 2009;Bourbia et al., 2010;LaGraize et al., 2004). For example, injection of 
morphine into the anterior cingulate cortex prevented reversal of dark preference in L5 spinal 
nerve ligated rats, while blockade of corticotrophin-releasing hormone activity has independent 
effects on place avoidance and hypersensitivity in the right verses left amygdala (LaGraize et al., 
2006;Bourbia et al., 2010). As with the affective measures mentioned in the previous section, 
such insights into supraspinal physiology and analgesic actions are likely to help drive drug 
development. The place escape avoidance paradigm may, however, be less useful as a potential 
drug screening test. This is due to the fact that despite being capable of discriminating between 
sensory and affective aspects of pain it is still reliant of stimulus evoked pain, which may not 
correlate with analgesic efficacy and does not represent one of the IMMPACT recommended 
core outcome measure for clinical trials in pain (Eisenach et al., 2003;Dworkin et al., 2005).  
 
As previously stated, modelling of human affective dysfunction is a productive and logically 
sound research technique in the search for new behavioural outcome measures. However, it may 
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be that in striving to seek correlates of human pain-related behaviour in rodents, researchers are 
constraining their ability to properly measure the innate behaviours of these animals. Rats and 
humans have evolved under substantially different selection pressures and are, as such, likely to 
exhibit different reactions to pain and injury. Although the replication of the pathophysiology of 
neuropathic pain syndromes in vivo is a sensible goal it may be that the anthropomorphisation of 
outcome measures will serve to mask rather than reveal new information about chronic pain. As 
well as asking ‘Does this model result in behaviour that a human would exhibit when in pain?’ 
we should ask ‘How is this rodent, which is likely in pain, acting? How are its normal behaviours 
perturbed?’ (Mogil et al., 2006)  
 
This line of thought lead to the investigation of burrowing behaviour in rat models of neuropathic 
pain (See chapter 5). Although disruption of burrowing behaviour may be equated to general 
disruption in patient quality of life, or perhaps anhedonia, there is no obvious direct behavioural 
correlate as there is with anxiety and depression measures (Teeling et al., 2007;Ozburn et al., 
2008;Deacon et al., 2005;Guenther et al., 2001;Deacon et al., 2001;Vargas-Parez et al., 
2003;Deacon et al., 2008). Data from a study carried out at Pfizer continuing the work detailed 
herein has demonstrated disruption of burrowing behaviour in the tibial nerve transection model 
of neuropathic pain and shown that treatment with 30 mg/kg gabapentin restores normal 
behaviour (Fig 6.2.3 A). Treatment with 100mg/kg gabapentin did not, however, restore normal 
burrowing behaviour (Fig 6.2.3 B). This result indicates that the burrowing assay is sensitive to 
the sedative effects of analgesic drugs, giving it a significant advantage over more traditional 
measures such as the von Frey test which may give false positives due to sedation. The 
observation of natural behaviours and their perturbation by pathological and pharmacological 
interventions has been a corner stone of behavioural research for many years (Blanchard and 
Blanchard, 2003). Data from the burrowing study suggests that further investigation of innate 
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rodent behaviours which do not have an immediately obvious correlate in human patients, 
although likely to be time consuming, may offer a fertile direction for future research.  
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Conclusion: 
The work herein has revealed novel behavioural outcome measures for the study of neuropathic 
pain. It has also, however, underlined the sensitivity of complex behavioural measures to 
disruption. Many of the confounding factors of behavioural research will be unfamiliar to those 
with a grounding in the neuroscience of pain and care should be taken by new researchers to 
familiarise themselves with what is a large but rewarding subject. Research into novel 
behavioural outcome measures for the study of neuropathic pain will likely be crucial to the 
success of future therapeutic interventions and should remain at the centre of academic and 
industrial research in this area. 
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A.1 Introduction 
 
The following appendix contains detailed methods for techniques used repeatedly in the 
experimental work detailed within this thesis. Extended methods forms, developed by Rice and 
colleagues, for each experiment are also contained within this appendix.  
 
A.2 Detailed Methods: 
 
A.2.1 L5 Spinal Nerve Transection: 
 
The majority of studies into chronic pain related behaviour carried out during this investigation 
utilised the L5 spinal nerve transection model. This model was modified from the L5/L6 spinal 
nerve ligation model developed by Kim and Chung. The L5 spinal nerve transection model has 
the advantage of eliminating putative problems associated with the viability of the ligations while 
maintaining a similar profile of hypersensitivity to the Kim and Chung model. 
 
Rats were deeply anaesthetised using isoflurane. All rats received a preoperative subcutaneous 
injection of antibiotics (Baytril, 0.2ml/kg). A 2–3 cm midline skin incision was made at the level 
of the iliac crests. Blunt dissection was used to separate the left paraspinal muscles from the L5 to 
S1 vertebrae. Following identification of the L6 transverse spinal process a hemi-laminectomy 
was performed exposing the L4 and L5 spinal nerve roots. The L5 nerve root was tightly ligated 
(4-0 Mersilk, Ethicon) and then transected 1–2 mm distal to the ligature. In sham animals, an 
identical procedure was performed except hemi-laminectomy; ligation and transection were not 
executed. Finally muscle and skin were sutured closed (4-0 Mersilk, Ethicon). Postoperative 
analgesia consisted of intramuscular injection of 0.05 ml 0.5% bupivacaine at the site of the 
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incision followed by intrperitoneal (i.p.) administration of Rimadyl (20%, 0.1 ml/200 g) 2 hours 
later. 
 
A.2.2 Assessment of Punctuate Mechanical Withdrawal Threshold: 
 
Experimenters were blind to the treatment group of all animals tested. In order to reduce the 
confounding affects of stress animals were habituated to the von Frey chambers prior to testing. 
Animals were moved into the testing room in their home cage groups and allowed to acclimatise 
for at least 15 minutes. Animals were then placed within individual Plexiglas testing chambers 
(23x18x14cm), for two 1 hour habituation sessions on separate days prior to testing. On the day 
of testing, animals were moved into the testing room within their home cages and allowed to 
acclimatise for at least 15 minutes, before being moved into the Plexiglas boxes. Once within the 
testing boxes animals were allowed a further 15 minutes to acclimatise. Baseline paw withdrawal 
thresholds were determined using a calibrated force transducer device with a 0.5mm diameter tip 
(electronic “von Frey device” Somedic, type 735). The transducer was applied to the mid-plantar 
surface of each hind paw in turn at a rate of 8-15g/sec until an active limb withdrawal response, 
characterised by rapid retraction of the limb, was observed. Mean paw withdrawal threshold was 
calculated from a set of 5 applications to each limb. Baseline measurements were taken on two 
separate occasions, at least 24 hours apart, in order to reduce any variability caused by the rat’s 
exposure to a novel testing method. The average results obtained were taken to represent true 
baselines. Post-surgery thresholds were determined by a single set of five applications to each 
hind limb.  
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A.2.3 Isolation chamber: 
 
A custom built isolation chamber housed within the behavioural testing room was used, where 
practically possible, in order to reduce environmental variability. The chamber was a cuboid 
structure (1.5x1.5x2m) and constructed of black Perspex. A 50cm gap existed between the floor 
and ceiling allowing easy access to the camera and access for power cables. One section of the 
chamber was removable to allow access to apparatus for cleaning etc. and contained a small door 
(50x50cm) to through which animals were introduced to tests. 
 
A.2.4 Habituation to Isolation Chamber: 
 
Previous to any anxiety testing rats received two 1 hour habituation sessions in the isolation 
chamber. Animals were housed in individual Plexiglas boxes (23x18x14cm) within the isolation 
chamber during habituation. 
 
A.2.5 Handling: 
 
All animals received consistent and regular handling in order to acclimatise them to contact with 
experimenters before testing of affect related behaviour. The handling involved in von Frey 
testing and daily post surgery checking was viewed as sufficient for the experiments detailed 
herein. Animals that did not receive surgical interventions were handled daily alongside those 
that did.  
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A.2.6 Animals: 
 
Male Wistar rats weighing 180-220g were obtained from B & K Universal Limited and 
habituated for at least 3 days before the commencement of any experiments. Rats had access to 
R&M No. 1 expanded maintenance diet (Special Diet Services, Witham, Essex) and water ad 
libitum and were housed in individually ventilated cages. Rats were maintained in a twelve hour 
light-dark cycle (dark-7pm-7am) including simulated 40 minute dawn and dusk periods. Light 
intensity was approximately 60lux during the light phase and roughly 3lux during the dark phase. 
Rats were provided with autoclaved bedding (Corn Cob bedding and Sizzle Nest shavings, Lillico 
Biotechnology, Surrey, UK). Cages were cleaned and bedding replaced twice weekly.  
 
A.2.7 Randomisation: 
 
For all experiments animals were assigned to treatment groups using block randomisation by 
cage. Cage numbers were collected and assigned to groups by random selection of numbers from 
a hat. 
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A.3 Extended Methods Forms: 
 
A.3.1 Cage mate status study: 
 
1. Experimental Design 
Experiments Blinded Yes 
Conditions Blinded Pain Condition 
Blinding Method Identifying labels concealed during von Frey 
and open field. Open field video files saved 
with coded file names to prevent 
identification of pain condition. 
Experiments Randomised Yes, by cage. 
Power Calculation No 
Exclusions 4 
Reasons for Exclusions One animal from both the L5 SNT mixed and 
L5 SNT segregated group were excluded due 
to not displaying >30% reduction in 
ipsilateral hind limb withdrawal threshold. 
One animal from both the SNT segregated 
and naive mixed group were excluded due to  
their cage mates not  developing >30% 
reduction in ipsilateral withdrawal threshold. 
 
2. Animals 
Age Young Adult 
Sex Male 
Supplier B&K International 
Weight Range 280-350g 
Behavioural Abnormalities N/A 
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3. Environment 
.a) Housing 
Diet R&M No. 1 expanded maintenance diet 
(Special Diet Services, Witham, Essex) 
Bedding Corn Cob bedding and Sizzle Nest shavings, 
Lillico Biotechnology, Surrey, UK 
Cage Ventilation Ventilated rack 
Home Cage Enrichment None 
Habituation Time Before Experiments 1-7 days 
Handling Frequency Before Testing More than once 
Cage Cleaning Frequency Twice per week 
No. Housed per Cage 2 
Housing of Experimental Groups Dependent on experimental group 
Housing of Different Species In same room 
Lights Cycle 7:00 On, 19:00 Off  
Procedural Anaesthetic Isoflurane 
Post-operative Analgesic Intramuscular injection of 0.05 ml 0.5% 
bupivacaine at the site of the incision (. 
Followed by intraperitoneal (i.p.) 
administration of Rimadyl (20%, 0.1 ml/200 
g) 2 h later. 
 
.b) 
No. of Testers 1 
Experience of Testers 1-2 years
Light Intensity  60 
Time Testing Ends 18:00 
Noise in Test Environment  Intermittent noise 
Recent Calibration of Testing Equipment N/A 
Cleaning of Testing Equipment  Between subjects, soap and water 
Habituation Time Before Testing 30-60 minutes 
Number of Animals in Room 10 
Distance Separated Majority of animals caged, 3 m from test 
subject outside the isolation cabinet. 
Visual Contact None 
Arousal State Awake 
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A.3.2 Dark/light Preference Study: 
 
1. Experimental Design 
Experiments Blinded Yes 
Conditions Blinded Pain & Drug Condition 
Blinding Method Identifying labels concealed during von Frey 
and dark-light preference testing. Dark-light 
preference video files saved with coded file 
names to prevent identification of drug/pain 
condition. 
Experiments Randomised Yes, by cage. 
Power Calculation No 
Exclusions 9 
Reasons for Exclusions One animal from the L5 SNT group and two 
animals from the L5 SNT (Gabapentin) 
group were excluded due to a lack of >30% 
reduction in ipsilateral paw withdrawal. Five 
animals from the L5 SNT Sham (Vehicle) 
group were excluded due to 
developing >30% reduction in ipsilateral 
hind limb withdrawal threshold.   One animal 
from the L5 SNT (Gabapentin) group was 
excluded due to gaining entry to the light 
chamber during the 5 minute pre-test 
habituation. 
 
 
2. Animals 
Age Young Adult 
Sex Male 
Supplier B&K International 
Weight Range 280-350g 
Behavioural Abnormalities N/A 
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3. Environment 
.a) Housing 
 
Diet R&M No. 1 expanded maintenance diet 
(Special Diet Services, Witham, Essex) 
Bedding Corn Cob bedding and Sizzle Nest shavings, 
Lillico Biotechnology, Surrey, UK 
Cage Ventilation Ventilated rack
Home Cage Enrichment None 
Habituation Time Before Experiments 1-7 days 
Handling Frequency Before Testing More than once 
Cage Cleaning Frequency Twice per week 
No. Housed per Cage 5 
Housing of Experimental Groups Separate 
Housing of Different Species In same room 
Lights Cycle 7:00 On, 19:00 Off  
Procedural Anaesthetic Isoflurane 
Post-operative Analgesic Intramuscular injection of 0.05 ml 0.5% 
bupivacaine at the site of the incision. 
Followed by intrperitoneal (i.p.) 
administration of Rimadyl (20%, 0.1 ml/200 
g) 2 h later. 
 
.b) Testing 
 
No. of Testers 1 
Experience of Testers 6 months- 1 year 
Light Intensity  4 + 24 lx 
Time Testing Ends 18:00 
Noise in Test Environment  Intermittent noise 
Recent Calibration of Testing Equipment N/A 
Cleaning of Testing Equipment  Between subjects, soap and water 
Habituation Time Before Testing 30-60 minutes 
Number of Animals in Room 10 
Distance Separated Majority of animals caged, 3 m from test 
subject outside the isolation cabinet. 
Visual Contact None 
Arousal State Awake 
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A.3.3 Forced Swim Study: 
 
1. Experimental Design 
Experiments Blinded Yes 
Conditions Blinded Pain Condition 
Blinding Method Identifying labels concealed during von Frey 
and forced swim testing. Forced swim video 
files saved with coded file names to prevent 
identification of drug/pain condition. 
Experiments Randomised Yes, by cage. 
Power Calculation No 
Exclusions 11 
Reasons for Exclusions Three animals caught the side of the forced 
swim chamber. One animal escaped the 
forced swim chamber. Five sham animals 
displayed a 30% reduction in ipsilateral hind 
limb withdrawal. Two L5 spinal nerve 
transected animals failed to show a 30% 
reduction in ipsilateral hind limb withdrawal 
threshold. 
 
2. Animals 
Age Young Adult 
Sex Male 
Supplier B&K International 
Weight Range 280-350g 
Behavioural Abnormalities N/A 
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3. Environment 
.a) Housing 
 
Diet R&M No. 1 expanded maintenance diet 
(Special Diet Services, Witham, Essex) 
Bedding Corn Cob bedding and Sizzle Nest shavings, 
Lillico Biotechnology, Surrey, UK 
Cage Ventilation Ventilated rack
Home Cage Enrichment None 
Habituation Time Before Experiments 1-7 days 
Handling Frequency Before Testing More than once 
Cage Cleaning Frequency Twice per week 
No. Housed per Cage 5 
Housing of Experimental Groups Separate 
Housing of Different Species In same room 
Lights Cycle 7:00 On, 19:00 Off  
Procedural Anaesthetic Isoflurane 
Post-operative Analgesic Intramuscular injection of 0.05 ml 0.5% 
bupivacaine at the site of the incision. 
Followed by intraperitoneal (i.p.) 
administration of Rimadyl (20%, 0.1 ml/200 
g) 2 h later. 
 
.b) Testing 
 
No. of Testers 1 
Experience of Testers 6 months- 1 year 
Light Intensity  4 + 60 lx 
Time Testing Ends 18:00 
Noise in Test Environment  Intermittent noise 
Recent Calibration of Testing Equipment N/A 
Cleaning of Testing Equipment  Water replaced between subjects 
Habituation Time Before Testing 30-60 minutes 
Number of Animals in Room 10 
Distance Separated Majority of animals caged 2 m from test 
subject and behind wooden barrier. 3 animals 
uncaged, within Perspex boxes at any one 
time 2-3 meters from animals within 
experimental apparatus. 
Visual Contact None 
Arousal State Awake 
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A.3.4 Burrowing Study: 
 
1. Experimental Design 
Experiments Blinded Yes 
Conditions Blinded Pain Condition 
Blinding Method Identifying labels concealed during von Frey 
and burrowing test. 
Experiments Randomised Yes, by cage. 
Power Calculation No 
Exclusions 7 
Reasons for Exclusions Three animals were excluded as unreliable 
burrowers. One PSNL sham animal was 
excluded due to <30% reduction in ipsilateral 
hind limb hypersensitivity. Three L5 SNT 
animals were excluded due to not 
developing >30% reduction in ipsilateral 
hind limb hypersensitivity. 
 
 
2. Animals 
Age Young Adult 
Sex Male 
Supplier B&K International 
Weight Range 280-350g 
Behavioural Abnormalities N/A 
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3. Environment 
.a) Housing 
 
Diet R&M No. 1 expanded maintenance diet 
(Special Diet Services, Witham, Essex) 
Bedding Corn Cob bedding and Sizzle Nest shavings, 
Lillico Biotechnology, Surrey, UK 
Cage Ventilation Ventilated rack
Home Cage Enrichment None 
Habituation Time Before Experiments 1-7 days 
Handling Frequency Before Testing More than once 
Cage Cleaning Frequency Twice per week 
No. Housed per Cage 4 
Housing of Experimental Groups Separate 
Housing of Different Species In same room 
Lights Cycle 7:00 On, 19:00 Off  
Procedural Anaesthetic Isoflurane 
Post-operative Analgesic Intramuscular injection of 0.05 ml 0.5% 
bupivacaine at the site of the incision 
(Antigen Pharmaceuticals, Dublin, Ireland). 
Followed by intraperitoneal (i.p.) 
administration of Rimadyl (20%, 0.1 ml/200 
g body weight, Pfizer, Sandwich, UK) 2 h 
later. 
 
.b) Test 
 
No. of Testers 1 
Experience of Testers 6 months- 1 year 
Light Intensity  4 lx 
Time Testing Ends 21:00 
Noise in Test Environment  Intermittent noise 
Recent Calibration of Testing Equipment N/A 
Cleaning of Testing Equipment  Between subjects, soap and water 
Habituation Time Before Testing 30-60 minutes 
Number of Animals in Room 4 
Distance Separated Animal tested simultaneously within 
individually ventilated cages housed next to 
each other in a rack. 
Visual Contact None 
Arousal State Any 
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Appendix 2 
 
 
 
Experimental Set-Up and Excluded Work 
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B.1 Introduction:  
 
The following section will detail the background work undertaken during the set up of some of 
the behavioural paradigms used herein. Results from the experiments detailed in the main body of 
text that were felt to be superfluous will also be detailed in this section. 
 
B.2 Open Field: 
 
The open field paradigm was already in operation in this laboratory before the beginning of the 
work detailed herein. Neuropathy related anxiety-like behaviour was demonstrated in a number 
of rat models of neuropathic pain using this paradigm. As detailed previously, an isolation cabinet 
was constructed in order to reduce the putative cofounding effects of fluctuations in background 
noise and other environmental factors (Section A.2.3). Rats initially introduced to the open field 
within the cabinet displayed a high level of distress characterised by freezing behaviour and 
vocalisations upon subsequent handling.  It was felt that habituation to the novel environmental 
conditions within the cabinet would be likely to reduce this apparent anxiogenic effect. Two 
alternative habituation regimens were trialled using small cohorts of naive animals. The first 
consisted of three short habituation sessions each lasting fifteen minutes, while the second 
consisted of two longer one hour sessions. In both cases habituations occurred on consecutive 
days previous to the animals testing within the open field. Rats were housed in individual 
Plexiglas boxes (23x18x14cm) within the isolation chamber during habituation.  
 
There was no significant difference in the number of entries to the inner zone between the two 
groups (Student’s t-test, p=0.773, Sigma Stat version 3.5) (Fig B.2 A). Neither was there a 
significant difference in the time spent in the inner zone of the open field (Mann-Whitney Rank 
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Sum Test, p= 0.485, Sigma Stat version 3.5). However, there was a great deal more variation, as 
shown by the larger standard error, in the animals which received three short habituation sessions 
(Fig B.2 B).  Animals which received two one hour habituations moved significantly more in the 
open field that those which received three fifteen minute habituations (Student’s t-test, p=0.001, 
Sigma Stat version 3.5) (Fig B.2 C). 
 
Due to the less variable behaviour (Fig B.2 B) and increased exploratory activity, indicated by 
greater distance moved (Fig B.2 C), the two one hour habituation regime was chosen as the most 
appropriate to acclimatise animals to the isolation cabinet.  
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B.3 Dark Light Preference Test: 
 
B.3.1 Set-up of Dark Light Preference Test: 
 
In order to automate the dark light preference test, and move it with-in the isolation chamber, a 
number of practical changes to the design of the had to be undertaken. The light side of the 
chamber had previously been illuminated by ambient light entering the behavioural testing room, 
while the dark side was covered with an opaque Perspex cover. This presented two problems for 
the new experimental set up. Firstly to source a fully adjustable, noise and heat free light source 
with which to illuminate the light side of the chamber; second to devise a method of screening the 
dark chamber from illumination which would allow automated video tracking of the animal. 
 
The first issue was solved by sourcing LED track lighting with was connected to a variable 
resistor, allowing alteration of the voltage and, thus, the level of illumination of the light chamber. 
The second issue was more problematic. A number of possible solutions were investigated 
including a vertical barrier between the light dark chambers and the use of various semi-opaque 
materials to cover the dark chamber. All these solutions, however, resulted in problems ranging 
from variable shading of the chamber or problems with video tracking. The issue was finally 
solved after research revealed a company that produced UV transparent Perspex which was 
opaque to the visible spectrum. The lid for the dark chamber and the door way between the two 
chambers was replaced with this material and a UV filter was placed on the lens, thus, allowing 
continuous tracking. 
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B.3.2: Excluded Results: 
 
A number of behavioural outcome measures assessed in the dark light preference test were not 
included the main body of text. These exclusions were either made on the basis that the outcomes 
did not add significantly to the understanding of the neuropathy induced behavioural changes or 
that the changes in these outcomes could not be put into a valuable theoretical context due to a 
lack of pharmacological validation. The following outcomes were excluded from the main body 
of text: velocity by chamber; rearing rate, by chamber; and frequency of stretch attend postures 
per entry to the light chamber. Velocity was calculated automatically by Ethovision XT software. 
Rearing frequency was calculated by blinded manual assessment of videos archived by 
Ethovision XT. Stretch attend frequency was calculated by Ethovision XT and validated 
manually. EthoVision XT calculates body posture by using a logarithm that related nose head and 
tail points to the overall outline of the animal; a threshold of 90% elongation over 1 second was 
set following manual assessment of six trials.  
 
L5 SNT led to a significant reduction in velocity in the dark chamber, but no significant change 
in the light chamber compared to sham operated controls (Student’s t-test, p=0.005, Sigma Stat 
version 3.5). (Fig 3.2 A). Administration of anxiogenic drugs has been shown to reduce 
exploratory behaviour within the dark chamber (Merlo and Samanin, 1989), thus, this change 
may be indicative of increased anxiety. Taking into account putative movement deficits it may be 
that L5 SNT rats are increasing their rate of movement in the light chamber in response to an 
increased sense of threat. Due to the fact that yohimbine treated animals very rarely entered the 
light chamber validation of this theory of anxiety driven changes to velocity could not be under 
taken. As a result it was felt that this result should be excluded from the main body of text. 
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The rearing rate was lower in the dark chamber than in the light chamber in both groups, likely 
due to the fact the light chamber had an open top while the dark chamber had a lid (Student’s t-
test, p<0.001, Sigma Stat version 3.5). L5 SNT caused a significant reduction in rearing rate in 
the light chamber, however, there was no difference in dark chamber rearing rate between the two 
groups (Student’s t-test, p=0.001, Sigma Stat 3.5) (Fig B.3.2 B). It is possible that this reduction 
in exploratory rearing behaviour in the light chamber was driven by increased anxiety in the L5 
SNT group. However, as with the change in velocity behaviour, the difficulty in pharmacological 
validation caused by the lack of entries into the light chamber in yohimbine treated animals 
resulted in this outcome measure being excluded from the main body of text.  
 
There was no significant difference in the number of stretch attend behaviours per entry to the 
light chamber between the two groups, although there was a trend towards an increase in the L5 
SNT group (Mann-Whitney Rank Sum Test, P = 0.100, Sigma Stat version 3.5) (Fig 3.2 C). 
Reductions in stretch attend postures towards the light chamber have been reported following 
axiogenic treatment in the light dark preference test (Holmes et al., 2001). This suggests a 
possible neuropathy related increase in this defence related behaviour may be revealed by 
increasing n numbers (Blanchard and Blanchard, 2005). Once again the lack of entries to the light 
chamber in yohimbine treated animals meant this theory could not be validated 
pharmacologically and as a result this outcome measure was not included in the main body of the 
text.  
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 B.4 Forced Swim: 
 
The forced swim test was a completely novel outcome measure to this laboratory. In order to 
determine the correct conditions for the outcome measure a number of exploratory tests were 
undertaken with small numbers of naive animals. Initial tests were undertaken within the isolation 
cabinet. Animals displayed a great deal of distress during these initial fifteen minute sessions, 
rarely, if ever, remaining immobile and vigorously attempting escape for the majority of the 
session. This behaviour did not resemble the profile of initially vigorous escape attempts 
followed by immobility reported in the literature (Willner, 1990;Porsolt et al., 1978), and raised 
concerns from the point of view of animal welfare. Further, difficulties with positioning of the 
camera within the chamber made proper scoring of behaviour impossible. As a result the test 
apparatus was moved outside the chamber. 
 
Animal behaviour outside the chamber appeared calmer and the initial subjects appeared to be 
showing immobility behaviour similar to that detailed in the literature. At this point two 
alternative levels of illumination were tested (4lx and 80 lx) as detailed in Chapter 4. The 80 lx 
lighting level resulted in less variability (Fig 4.3.1 A). As a result this level of illumination was 
chosen for the rest of the experiments. 
 
 The initial goal was to create a set up for the experiment that would allow automated tracking of 
the animal to score immobility behaviour quickly and without the possibility for bias. Early 
attempts to track the animal’s movement from an overhead camera position lead to difficulties in 
image capture with the Ethovision XT software. Following discussion with the software suppliers 
the camera position was altered so that images were captured from the side. This new camera 
position allowed consistent tracking of the animal’s movement. The Ethovision XT software uses 
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an algorithm to detect changes in the shape of the captured image over a given time. Both the 
amount of time over which immobility is calculated, and the degree of change in the animals 
position, below which immobility is scored, can be altered manually. Multiple attempts were 
made to set values within the Ethovision software which resulted in scoring of immobility 
behaviour consistent with the manually scored data. Unfortunately this was not achievable. An 
example of data scored manually and using Ethovision XT from the same set of videos is shown 
below as a figure (Fig B.3) and as raw data (Table B.3).  
 
 
As well as allowing tracking of the animal’s movement the new position also presented the 
possibility of scoring climbing and swimming behaviour, alongside immobility. A great deal of 
time was spent characterising these behaviours with help from experienced colleagues.   
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